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During a lunch session at the slaughterhouse, a lamb jumped out of its pen and came 
unnoticed up to some slaughtermen who were sitting in a circle eating some sandwiches; the 
lamb approached and nibbled a small piece of lettuce that a man was holding in his hand. 
The men gave the lamb some more lettuce and when the lunch period was over they were so 
affected by the action of the lamb that not one of them was prepared to kill this creature, and 
it had to be sent away elsewhere - showing that within each human soul there is an element 
of pity, compassion and love in varying degrees. It is our duty to encourage the higher 




















To my thesis supervisors: Prof Harley (Chemical Pathology), thank you for providing me with 
the “ticket” allowing me to get closer to my dream of using my expertise to improve the well-
being of animals in some way, but which may also benefit humans. You leave with me the 
legacy of not shying away from “fishing in the muddy waters”. Prof Katz (Medical 
Biochemistry) (aka Arieh), thank you for your encouragement and belief in my ability to do this 
from the start. It meant a lot. To my two ‘unofficial supervisors’, colleagues and great friends, 
Lester and Dee. You guys are amazing – thank you!!  
 
I wish to thank Professors Pillay and Henderson (current and previous HOD, Chemical 
Pathology Dept.) for accepting my presence and use of the facilities in their department. Pete 
and Ingrid, thank you both for allowing me to share space in your lab, use reagents etc., and 
for the social and intellectual chats. Ingrid, thank you also for your expert culture of the 
fibroblasts. Trish, and also Felicity and Lisa, your open welcome to use the lab as I needed, 
and our friendly impromptu chats made me feel welcomed from the start – thank you. Thanks 
also to Ingrid, Dave and Abdu for all the efficient help placing orders, as well as to Juliet and 
Mara for their always friendly assistance.   
 
I also gratefully acknowledge the UCT Medical School Library staff for their always efficient 
and friendly assistance in obtaining the many scientific articles I requested for this thesis. 
 
I am greatly indebted to all the people involved in helping me to obtain the necessary animal 
samples, in particular Drs Gary Buhrmann, Koos Neuland, Sewellyn Davey, Elzette Jordan 
and Dave Cooper and Mr John Morris, as well as the UCT Medical School Animal Unit Staff 
(especially Mr Noel Markgraaf).  
 
I would like to acknowledge and thank the following organizations for their financial support: 
The National Research Foundation (South Africa) and the Deutscher Akademischer Austauch 
Dienst (DAAD, Germany) for their award of a doctoral fellowship, and the Medical Research 
Council (South Africa) for running expenses as part of a Self-Initiated Grant (E.H.Harley). 
 
To my supportive family and friends that lovingly never really understood why it was so 
endless – at last my reply is “it is done”. I promise that I will never be a student again   Mom, 
I know you were with me all the way. Thank you my very special friend, so far yet so close. To 
all my ‘babies’ at home keeping me company while I wrote up…yes, now I will take you for 
that walk. To my husband and so much more, Lester, I couldn’t have done this without you!  
 

























































                                                                                                                                                                              vi  
CONTENTS 
 
                             Page 
 
ABSTRACT          1 
ABBREVIATIONS         2 
LIST OF FIGURES AND TABLES       4 
 
Chapter 1  
Clarifying and investigating differences in low molecular weight  
metabolites in red cells from different mammalian species 
(A) Literature Review and Background Work     11 
(B) Aims          19 
(C) Materials and Methods        
(i) Samples 20 
(ii) Preparation and acid extraction of red cells and plasma 20 
(iii) Acid extraction of the buffy coat 21 
(iv) Culture and acid extraction of fibroblasts 22 
(v) HPLC analyses 22 
(vi) Determination of the identity of substances responsible for              
each peak 23 
(vii) Determination of concentration in red cells (µmol/L red cell    
         water) and plasma (µmol/L plasma) 26 
(viii) In vitro exposure of horse red cells to H2O2 or AAPH for 
determination of haemolysis  27 
(ix) Statistical considerations 27 
(D) Results and Discussion 
(i) Comparative HPLC profiling      28 
(ii) Urate riboside: inter- and intraspecies variation   30 
(iii) Free tyrosine: inter- and intraspecies variation   33 
(iv) Urate: inter- and intraspecies variation    41 
(v) Free tryptophan: inter- and intraspecies variation   56 
(vi) NAD(H) and NADP(H): inter- and intraspecies variation  58 
(vii) Inter- as well as intraspecies variability in red cell LMW     
substances at a spectrophotometric glance 60 











                                                                                                                                                                              vii  
                           Page 
 
Chapter 2  
Investigating a role for free tyrosine and tryptophan in endogenous  
antioxidant defense 
(A) Introduction         66 
(B) Literature Review        67 
(C) Aims          81 
(D) Materials and Methods 
(i) Samples        82 
(ii) The Oxygen-Radical Absorbance Capacity (ORAC) assay  82 
(iii) Statistical considerations      85 
(E) Results and Discussion       86 
(F) Summary         97 
 
 
Chapter 3   
Unsuspected H2O2-scavenging strategies in mammalian red cells 
(A) Introduction         98 
(B) Literature Review        99 
(C) Aim          108 
(D) Materials and Methods     
(i) Reagents         109 
(ii) Hb-peroxidase reactions      109 
(iii) Ferrous ion oxidation-xylenol orange (FOX) assay   110 
(iv) Statistical considerations      111 
(E) Results and Discussion       112 
(F) Summary         121 
 
 
Chapter 4   
Conclusions and Future Directions      122 
 
APPENDIX          126 











Abstract                                                                                                                                                              - 1 -  
ABSTRACT 
Elevated levels of low molecular weight substances in the red cells of some 
mammalian species imply unsuspected antioxidant strategies  
                            
Virginia Davids                   March 2009 
 
An earlier observation by E.H. Harley (supervisor of this thesis) of curious metabolic 
anomalies in the red cells of black rhinoceros, and in particular a high free tyrosine level, 
suggested that a range of unusual, but presumeably physiological, processes might be 
found in mammalian red blood cells.  
 
As a follow-up to this, low molecular weight metabolites were examined in a range of 
mammalian species, using HPLC-based methods to compare levels in red cells with 
plasma levels. A remarkable interspecies diversity in red cell HPLC profiles was 
observed, with the unprecedented accumulation of substances including tyrosine, 
tryptophan, urate, and urate riboside occuring within the red cells of some species. 
Whereas novel evolutionary adaptations may characterise most of these species-specific 
variations, the ability of red cells to produce urate is proposed to be an inducible feature 
common to the red cells of many, or possibly even all, mammalian species. A surprisingly 
high degree of intraspecies genetic heterogeneity was evident in tyrosine and urate 
levels within horse, and urate riboside levels within cow red cells. This was in contrast 
with the greater homogeneity seen in levels of these and other low molecular weight 
substances in red cells from the other species evaluated.  
 
The next phase of investigation addressed the potential function(s) of these soluble 
substances accumulating within the red cell, particularly relating to a role in antioxidant 
defense. Using in vitro antioxidant assays such as the ‘oxygen radical absorbance’ 
(ORAC) and ’ferrous ion oxidation-xylenol orange’ (FOX) assays, results were obtained 
consistent with a role for these substances as endogenous red cell antioxidants against a 
variety of reactive species produced by pathophysiological processes in the body. The 
demonstration that haemoglobin is involved in facilitating some of this activity further 
substantiates the idea that the red cell may be playing a crucial role in maintaining 
circulatory redox balance, and hence protecting other tissues from oxidative damage. If 
indeed such low molecular weight substances contribute to systemic antioxidant activity 
in some mammalian species, then apart from the intrinsic interest of such unexpected 
biological phenomena, these findings could pave the way for a plethora of further 
investigations, geared towards potential clinical applications (eg. as biomarkers or 
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are not at equimolar concentrations. 
* The peak purity index, information which is provided by the HPLC Beckman System Gold for 
every profile, but not shown in the figures above, indicates if more than 1 substance is 
responsible for every peak. Therefore, the first-eluting peak in (A) would have been shown to 
represent multiple co-eluting substances. On the other hand, peaks h, i and l in (A) would 
have shown peak purity i.e. each representing a single eluting substance.  
 
Figure 6. L-tyrosine standard curve for determination of tyrosine concentration in red cell or 
plasma extracts evaluated on reverse-phase HPLC.  
 
Figure 7. Anion-exchange and reverse-phase HPLC absorbance profiles at 260nm (solid line) 
and 280nm (dashed line) of neutralised, acid-soluble red cell extracts from a human (A,B), a 
white rhinoceros (C,D), a cow (E,F), and a standards mix (G,H). The standards in the mix are 
a-uric acid, b-tyrosine, c-hypoxanthine, d-xanthine, e-inosine, f-tryptophan, g-AMP, h-NAD+, i-











List of Figures and Tables                                                                                                                                 - 5 - 
Figure 8. Phylogeny of the Artiodactyla. The arrow indicates where the mutation responsible 
for red cell urate riboside production is predicted to have occurred. 
 
Figure 9. (A) Scatter plots of red cell urate riboside concentration in cow, buffalo, kudu and 
sheep. The Unpaired t test was used to determine P values. (B) Red cell urate riboside 
concentration in four cows that were bled once, and then again 30 days later  
 
Figure 10. Reverse-phase HPLC absorbance profiles at 260nm (solid line) and 280nm 
(dashed line) of a neutralized, acid-soluble extract of (A) washed red blood cells, (B) buffy 
coat, and (C) cultured primary dermal fibroblasts from a cow. 
 
Figure 11 (see below). Reverse phase HPLC profiles (260nm black solid line and 280nm red 
dotted line) of a standards mix (bottom) and the red blood cell and plasma acid extracts from 
animal species belonging to 6 different mammalian Orders. The HPLC profiles for buffalo red 
cells and plasma are not shown, but other than for a smaller urate riboside peak they were 
essentially identical with that from cows. The standards in the mix are a-uric acid, b-tyrosine, 
c-hypoxanthine, d-xanthine, e-inosine, f-tryptophan, g-AMP, h-NAD+, i-IMP, j-ADP, k-NADP+ 
and l-ATP.  
 
Figure 12. Tyrosine concentrations in the (A) red cells, and (B) respective plasmas from 
various mammalian species, including humans. Comparison of the tyrosine concentration 
within red cells and in plasma for (C) humans and (D) horses. Horizontal bars indicate means. 
The Mann Whitney test for non-parametric data was used to determine P values between 
horses and other species in figure A; otherwise the Unpaired t test was used. The Paired t 
test was used to determine P values when comparing plasma and red cell tyrosine levels 
within species, except for horses where the Wilcoxon signed rank test was used. The 
Pearson test was used to determine statistical significance of correlation in figure C, and the 
Spearman test in figure D. 
#Black rhino red cell tyrosine concentrations are taken from a previously published report [2]. 
*Individual black rhino plasma tyrosine levels were not available. However the mean plasma 
tyrosine level was similar to that of humans [4]. 
 
Figure 13. (A) Red cell tyrosine concentrations in three blood samples taken on different days 
from the same four horses, illustrating the significant stability of tyrosine within a period of one 
month. (B) Red cell tyrosine levels in Thoroughbred (n=8) and Arabian Cross bred (n=11) 
horses. Horizontal bars indicate medians. The Mann Whitney test was used to determine that 















List of Figures and Tables                                                                                                                                 - 6 - 
Figure 14. Reverse-phase HPLC absorbance profiles at 260nm (solid line) and 280nm 
(dashed line) of neutralized, acid-soluble red cell extracts from (A) a horse with a very large 
amount of the unknown LMW substance; (B) a horse showing a large amount of red cell 
tyrosine but also some of the LMW substance accounting for the unknown peak, (C) a horse 
with significant tyrosine but with no detectable amount of the unknown LMW substance (D) a 
horse with a low tyrosine level and no detectable amount of the unknown LMW substance, 
and a typical profile of a human (E) red cell and (F) plasma acid extract. 
 
Figure 15. Modified representation of data previously reported by Harley et.al. (2004) [4]. Red 
cell urate levels in eight horses bled before, and then immediately, 1hour, 24 hours and 72 
hours after an endurance race of 80km, with a mean duration of 5.1 hours. The horizontal 
bars indicate median values. The Wilcoxon signed rank test was used to determine P values. 
 
Figure 16. (A) Urate concentrations in the red cells from various mammalian species, 
including humans. Horizontal bars indicate means. It should be noted that due to the highly 
skewed distribution of red cell urate in these horses, the median for red cell urate in horses 
was 74M, being much lower than the mean. The Mann Whitney test for non-parametric data 
was therefore used to determine P -values between horses and other species; otherwise the 
Unpaired t test was used. (B) Urate concentrations in the plasma from the same individuals 
as in (A). The Unpaired t test was used to compare plasma urate levels between the different 
species The Paired t test was used to determine P values when comparing plasma and red 
cell urate levels within a species. 
 
Figure 17. (A) Red cell urate concentrations in three blood samples taken on different days 
from the same four horses, illustrating the significant stability of urate within a period of one 
month. 
 
Figure 18. Comparison of red cell urate and tyrosine in horses (n=20). No correlation was 
evident using the Spearman test. 
 
Figure 19. Comparison of the urate concentration within red cells and plasma for humans 
(open circles, n= 25) and horses (black, full circles, n=20). The Pearson test was used to 
determine statistical significance of correlation for humans, and the Spearman test for horses. 
 
Figure 20.  Baseline urate concentrations in the red cells from the athlete horses, as sampled 
by Harley and co-workers in a previous study (n=20) (unpublished [5]), and those sampled in 
the current study (n=20). Horizontal bars indicate means. The Mann Whitney test for non-
parametric data was used to determine that there was a statistically significant difference 













List of Figures and Tables                                                                                                                                 - 7 - 
Figure 21. Red cell urate levels in the elite athletes horses of figure 20, now separated by 
breed into Thoroughbred (n=8) and Arabian-Crossbred (11). Horizontal bars indicate 
medians. The difference between the two groups was not statistically significant (Mann 
Whitney P  = 0.2153). 
 
Figure 22.  Red cell suspensions (1% Hct) from four racing horses (black, purple, green, dark 
blue) and four endurance-trained horses (red, pink, orange, light blue) were exposed to 50mM 
H2O2 (in PBS, at 37
oC), and the supernatants evaluated for haemolysis after (A) 1 minute, (B) 
1 hour and (C) 20 hours. (D) Suspensions of the red cells from two of these racing horses and 
one of the endurance horses were also incubated with 20mM AAPH, and the supernatants 
evaluated after 1 hour. (E) Total triton-X-induced haemolysis of a suspension of red cells from 
each of the eight horses. 
 
Figure 23. Tryptophan concentrations in the (A) red cells and (B) respective plasmas from 
various mammalian species, including humans. Horizontal bars indicate means. The 
Unpaired t test was used to determine P values to compare tryptophan levels between 
species. The Paired t test was used to determine P values when comparing plasma and red 
cell tryptophan levels within species. 
 
Figure 24. Comparison of the tryptophan concentration within red cells and of plasma for (A) 
cows, (B) humans, C) sheep and (D) horses. The Pearson test was used to determine 
statistical significance of correlation. 
 
Figure 25. (A) NAD+ and (B) NADP+ concentrations in the red cells from various mammalian 
species, including humans. Horizontal bars indicate means.  
 
Figure 26. (A) Characteristic absorption profile of diode array scans of the red cell acid 
extracts of human (black), cow (green) buffalo (red) and horse (blue). The dashed blue line is 
the extract from a horse that was shown on HPLC to have a large concentration of both urate 
and tyrosine (horse C in Fig 9). Maximum absorption for urate riboside is 297-298nm, whilst 
that for urate is 293nm. A nanodrop (Qiagen) was used, pathlength = 1mm. (B) Diode array 
scans of standard solutions of tyrosine (dashed), urate (solid) and ATP (dotted) (100M each 
in phosphate buffer, pH 7.4). Note that due to the significantly lower extinction coefficient of 
tyrosine compared with urate, ATP and many other LMW substances, that even large 
amounts of tyrosine in an extract may at first glance be significantly underestimated when 
observing HPLC profiles at 260/280nm and most other wavelengths.  
 
Figure 27. Comparison of a single absorbance reading versus HPLC peak area (measured at 
280nm) for (A) urate riboside (single reading at 298nm), and (B) urate (single reading at 











List of Figures and Tables                                                                                                                                 - 8 - 
Figure 28. Schematic representation of O2·
- and H2O2 - neutralising pathways within the red 
cell. All reactions, other than oxyhaemoglobin auto-oxidation and reduction, also occur in 
other cell types. The source of O2·
- and H2O2 in nucleated cells is mainly from the respiratory 
chain in the mitochondria.  
(SOD=superoxide dismutase; CAT=catalase; GPx=glutathione peroxidase; GR=glutathione 
reductase; MR=methaemoglobin reductase) 
 
Figure 29. Free tyrosyl radical and dityrosine formation via the oxidation of free tyrosine by 
various RS, or the peroxidase/H2O2 antioxidant system (adapted from DiMarco et. al. (2007) 
[6]). 
 
Figure 30. Part of the tryptophan oxidative metabolic pathway (adapted from Streete et. al. 
(2004) [7]). 
 
Figure 31. Oxidative modifications of tryptophan [8]. 
Figure 32. Time-dependent fluorescence decay of fluorescein after the addition of AAPH in 
the presence of serial dilutions of Trolox antioxidant, and control reactions and a typical 
sample (black line). 
 
Figure 33. Trolox standard curve. The Goodness of Fit test was used to determine the linear 
regression. The ORAC value (as moles Trolox Equivalent per liter) of a sample is 
determined by extrapolation from the standard curve. 
 
Figure 34. Time-dependent fluorescence decay of fluorescein after the addition of AAPH in 
the presence of 30M solutions of urate, tyrosine, tryptophan, xanthine, NADH, or 12.5M 
Trolox as standard, or no antioxidant. 
 
Figure 35. The mean (and SD) ORAC values of equimolar (30M) solutions of some LMW 
substances. Results represent 4-7 replicates (performed on different days) for each 
substance. 
 
Figure 36. Time-dependent fluorescence decay of FL after the addition of AAPH in the 
presence of (A) plasma extracts, and (B) red cell extracts from humans, cows, buffalo and 
horses, illustrating the very different ORAC kinetics profiles for the red cell extracts from 
different mammalian species. Note that some profiles may start at different fluorescence 
intensities because the reactions were not all performed in the same run – this would however 
be taken into account when extrapolating the TE value from the respective Trolox standard 













List of Figures and Tables                                                                                                                                 - 9 - 
Figure 37. Box and whisker plots of the ORAC values of deproteinised red cell (empty boxes) 
and plasma (grey boxes) extracts from four mammalian species. The Mann Whitney test for 
non-parametric data was used to determine P values between horses and humans; otherwise 
the Unpaired t test was used. The Paired t test was used to determine P values when 
comparing plasma and red cell tyrosine levels within species, except for horses where the 
Wilcoxon signed rank test was used.  
 
Figure 38. Stacked bar graphs of the contribution of tryptophan, tyrosine, urate and urate 
riboside to the ORACLMW of red cells and plasma from a number of individual humans, horses, 
cows and buffalo. The red cell and plasma samples from the same individual are always 
aligned. 
 
Figure 39. Comparison of the horse red cell ORACLMW value and (A) horse red cell tyrosine 
concentration, and (B) combined ORACLMW contribution from red cell tyrosine and urate in 
horse red cells. The Pearson test was used to determine statistical significance of correlation. 
 
Figure 40. Comparison of red cell ORACLMW and urate riboside concentration in (A) cow and 
buffalo red cells.  Linear regression graphs of red cell ORACLMW and urate riboside 
concentration in (B) cows and (C) buffalo. The Pearson test was used to determine statistical 
significance of correlation. 
Figure 41. Auto-oxidation of oxyhaemoglobin. 
 
Figure 42. Reactions of oxyhaemoglobin, ferrylhaemoglobin and methaemoglobin with H2O2 
(as reviewed and proposed by Nagababu et. al. (2004) [9]). 
 
Figure 43. Catalase-dependent removal of H2O2 (above), and the catalatic activity of metHb, 
as proposed by Nagababu et al. (2004) [9] (below). 
 
Figure 44. Non-specific peroxidase activity of horseradish peroxidase (HRP) (above), and the 
peroxidase-like activity of metHb (below). ED = electron donor. 
 
Figure 45. FOX assay standard curve for H2O2 concentration. The Goodness of Fit test was 
used to determine the linear regression. 
 
Figure 46. (A) The initial and then (B) sequential absorbance readings (at 560nm) of 
reactions in which the removal of H2O2 by the peroxidase-like activity of metHb in the 
presence of equimolar amounts of various LMW substances was evaluated. Absorbance 
readings directly reflect the H2O2 concentration left in each reaction. Each profile represents 
the average of two separate experiments, and each of the curves in the separate experiments 
showed the identical trend. Reactions (pH 7.4) contained 10M metHb, 500M H2O2 and 











List of Figures and Tables                                                                                                                                 - 10 - 
Figure 47. (A) Sequential absorbance readings (at 560nm) of control reactions (no metHb 
added) for the peroxidase-like activity of metHb in the presence of equimolar amounts of 
various LMW substances. Absorbance readings directly reflect the H2O2 concentration left in 
each reaction. Each result represents the average of two separate experiments, in the same 
trend was obtained. Reactions (pH 7.4) contained 500M H2O2 and 250M LMW substance. 
(B) As determined from figure A, metHb concentration dependence of the peroxidase-like 
activity of metHb at 15min. 
 
Figure 48. Absorbance readings (at 560nm), at time 0 and 160min, for control reactions (no 
metHb added). Absorbance readings directly reflect the H2O2 concentration left in each 
reaction. Each result represents the average of two separate experiments, in the same trend 
was obtained. Reactions (pH 7.4) contained 500M H2O2 and 250M LMW substance.  
 
Figure 49. Anion-exchange HPLC of neutralized acid-soluble cow red cell extracts exposed, 
for 10min at room temperature, to (A) 0mM H2O2, (B) 2mM H2O2 and (C) 2mM H2O2 plus 
10M bovine hemin (Sigma). 
 
Figure 50. Stability, whilst in storage at -80o C, of (A) urate, tyrosine and NAD+ in a human 
red cell extract, and (B) urate and tyrosine in a human plasma extract. Multiple aliquots of the 
extracts were made and then frozen simultaneously. An aliquot of the red cell and plasma 




Table 1. Absorbance ratios (260nm:280nm) and spectrophotometric diode array patterns of 
LMW substances of interest, each dissolved in phosphate buffer (pH 7.4). The vertical dotted 
lines indicate 260nm and 280nm on the x-axes. 
 
Table 2. The mean levels of various soluble antioxidants found in the red cells/plasma (where 
applicable) from various mammalian species relative to levels in human red cells (set as the 
100% control), as determined from the reverse-phase HPLC profiles. In brackets are the 
actual concentrations (M) of these substances. Where levels are greater than that present in 
human red cells/plasma, these are highlighted in blue. Urate riboside is not included because 
it is undetectable in all species other than Bovinae. 
 
Table 3. The mean (+ SD) ORAC values for red cell and plasma extracts from four 
mammalian species. 
 
Table 4. Comparative levels of various antioxidant enzyme activities and GSH content in the 
red cells of different mammalian species relative to levels in human red cells, which is set as 










Chapter 1: Literature Review and Background Work                                                                                      - 11 -  
CHAPTER 1 
Clarifying and investigating differences in low 
molecular weight metabolites in red cells from 
different mammalian species 
 
 
(A) LITERATURE REVIEW AND BACKGROUND WORK 
 
Until the 1940’s, the red blood cell/erythrocyte was 
viewed merely as an inert bag of haemoglobin. Due to 
the absence of a nucleus or any other normal cellular 
organelles, no new protein synthesis takes place in the 
mature red cell of most vertebrates and all mammals, 
and there is an unusual paucity of intracellular pathways compared with other cell 
types. For example, ATP generation via the Kreb’s cycle and oxidative 
phosphorylation does not occur in the red cell because it lacks mitochondria. The 
only biochemical pathways known to be retained are those necessary to preserve its 
own cellular integrity and shape, and to allow it to efficiently perform its well known 
functions, namely as a reversible O2/CO2 carrier and in the control of blood pH [10]. 
Whilst on the one hand this makes the red cell worthless for the study of 
unrepresented intracellular pathways, on the other hand it has facilitated the study of 
the represented pathways because interference by unwanted pathways is minimal 
[11]. Moreover, despite the red cells relatively long lifespan in circulation with no new 
protein synthesis, the only enzymes that appear to decline in activity during aging of 
the red cell are pyrimidine-5’-nucleotidase and AMP-deaminase [12]. Certainly no 
other eukaryotic cell is as readily available for study as the red blood cell, making up 
almost half of the whole blood volume and being easily separated from other 
circulating cells and plasma in sufficient quantities for most analytical methods. 
Consequently, today the red cell membrane is the most thoroughly studied, and 
remains the paradigm for ongoing studies of the membranes from other cell types 
[13]. Similarly much of today’s knowledge on numerous ubiquitous major metabolic 
pathways has been gained through study of the human red blood cell [11]. However, 
despite the abundant literature available on such studies, very little further 
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apparently simple and unassuming oxygen transporter may still be quite 
underestimated. 
 
The first part of glucose metabolism, namely glycolysis (or the Embden Meyerhoff 
pathway), is a good example of a major ubiquitous metabolic pathway which has 
been well studied in the red cell as a model for other cell types (although the 





Figure 1. (A) Glucose metabolism, and (B) the hexose monophosphate (HMP) shunt/pathway of the red 
blood cell in more detail [1]. 
 
 
During glycolysis, each glucose molecule leads to the net formation of two ATP 
molecules, this being the only source of energy in most red cells. Interestingly, 
glucose is unable to enter the pig red cell, which uses inosine for ATP production, 
[14-16]. Glycolysis also recycles the reduced form of nicotinamide adenine 
dinucleotide (NADH) from its oxidized form (NAD+). Similarly, NADPH is recycled 
from NADP+ via the hexose monophosphate (HMP) shunt (Fig 1B), which branches 
off from glycolysis at glucose-6-phosphate. Both of these purine dinucleotide 
coenzymes play vital but different roles in redox reactions and maintenance of an 
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Much about the purine metabolism (Fig 2) has also been learnt through study of the 
human red cell [17]; however differences do exist between red cells and nucleated 
cells, such as: 
 No de novo purine synthesis occurs in the red cell, which relies instead on the 
salvage pathways for AMP and GMP synthesis from adenine (and also 
adenosine) and guanine respectively [1]. 
 The nucleotidase isozyme present in red cells is uniquely restricted to 
pyrimidine substrates (pyrimidine nucleotidase), and this presumably 
preserves AMP levels [18-20].  
 The dephosphorylation of IMP to inosine occurs by action of a different red 
cell nucleotidase isozyme, namely deoxyribonucleotidase (dNase) [21].  
 Red cells reportedly have no xanthine oxidase/xanthine dehydrogenase 
(XO/XD) enzyme activity [22]. 
 
 
AMP IMP          GMP
ADP GDP
































































































Figure 2. Basic pathway of purine metabolism in mammalian cells. Red annotations indicate steps that 
are reportedly absent in the red cell. AK=Adenosine kinase; ADA=adenosine deaminase; 
APRT=adenine phosphoribosyltransferase; dNase=deoxyribonucleotidase; HGPRT=hypoxanthine-
guanine phosphoribosyltransferase; XO=xanthine oxidase; O2
·- =superoxide radical. 
 
 
Evaluation of the highly UV-absorbant nucleotides present in cells has been greatly 
facilitated by the development and refinement of ion-exchange chromatography 
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(circa 1970) [17]. After precipitation of all proteins via an acid-extraction step from a 
blood or tissue sample, UV-absorbing nucleotides/sides and their bases, as well as 
any other UV-absorbant acid-(and water-) soluble low molecular weight (LMW) 
substances in the neutralised extract can be rapidly and accurately quantified 
simultaneously, as long as they don’t co-elute. Anion-exchange HPLC of human red 
cell acid extracts reveals that the major component detectable is the highly anionic 
purine nucleotide ATP, with smaller peaks of AMP, NAD(H), ADP and NADP(H) 







































Figure 3. (A) Anion-exchange, and (B) reverse-phase HPLC absorbance profiles, monitored at 260nm 
(solid line) and 280nm (dashed line), of a neutralised, acid-soluble human red cell extract. 
 
 
A small amount of the purines GTP and GDP, as well as the pyrimidine nucleotide 
UDPG, may also be evident with some HPLC systems [23]. Uncharged, positively 
charged and non-polar substances are not retained on the anion exchange column – 
their peaks thus co-elute and their identities cannot be determined. However, use of 
reverse-phase HPLC (Fig 3 B), which separates substances based on their polarity 
(with the more polar substances eluting earlier), usually allows the determination of 
the identity of substances not retained on anion-exchange.  
 
The human red cell HPLC profile is well documented [23], but does not reflect the 
profile of all other mammalian species. Distinct differences in the ion-exchange 
chromatographic profiles of the red cells from various animal species has long been 
reported [24, 25], but given surprisingly little attention since first described. Such 
differences are not unexpected given the fact that significant interspecies differences 
in purine metabolism and also transport of substances into red cells have been 
described [26]. The most noticeable difference on chromatography is the large 
variation in levels of ATP, with human, rat, mouse, pig and rabbit red cells having 
relatively large amounts of ATP in comparison to the low levels present in the red 
cells of cow, sheep, and horse [15, 25, 27-29]. The high levels found in humans and 
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remain the same; it is just the turnover which is faster. Only about 15% of the 
available ATP is necessary to power the known energy requirements of the Na-K 
pump [15]. Moreover, in the anucleate mammalian red cell all the substrate utilizing 
reactions (ion pumps etc) are low Km (micromolar for ATP) reactions; therefore, as 
long as ATP levels exceed about 5-10M, the rate of these reactions is not increased 
by higher levels of ATP. Furthermore, none of the allosteric effects that exist in 
nucleated cells, and for which millimolar amounts of ATP are required, are operative 
in the red cell. High levels of ATP may therefore merely reflect levels originally found 
in red cells when they were nucleated. In fact, it has been proposed that low red cell 
ATP may be an evolutionary adaptation in some species conferring a selective 
advantage against common red cell parasites [30].  
 
Besides the striking variability in ATP concentration, another very distinct HPLC 
profile difference seen is the large amount of urate riboside present in cow red cells. 
Urate riboside was first observed in the red cells of cattle in 1922 [31], and 
subsequently shown to be present in buffalo red cells too [32]. It was found to be 
undetectable in the red cells of all other species evaluated, including humans [25, 32, 
33]. Urate riboside is formed through condensation of the purine degradation product, 
urate, with 5-phosphoribosyl-I-pyrophosphate (PPRP). This reaction is catalysed by 
the enzyme uridine monophosphate synthase (UMP synthase, also known as orotate 
phosphoribosyl transferase), to form 3-N-ribosyluric acid 5’-monophosphate (also 
termed urate ribotide). The phosphate moiety is subsequently removed to form 3-N-
ribosyluric acid, commonly termed urate riboside [32, 34]. Bovine red cells have 
much higher levels of UMP synthase than most species investigated, having about 
50 times more than is present in human red cells [35]. This may explain the presence 
of large amounts of urate riboside in cow red cells, yet apparent absence in human 
red cells.  
 
In an attempt to elucidate the role for urate riboside in the red cells, Smith and co-
workers found urate riboside to have a similar antioxidant capacity as its precursor 
urate, a well-established antioxidant. They showed that both urate riboside and urate 
were able to protect human red cells against haemolysis by the reactive species t-
butylhydroperoxide [36, 37] and sodium nitrite [38]. In the process, urate riboside (as 
for urate) is oxidized by these oxidants. These investigators also showed that in vitro 
exposure of bovine red cells to sodium nitrite leads to a decrease in red cell urate 
riboside level [38]. They therefore hypothesized that the high levels of urate riboside 
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that proposed by Ames et. al. (1981) for the high plasma levels of urate in humans 
[39] (see also Results and Discussion, section iv). 
 
In addition to the above-described variations in mammalian red cell profiles, Brown 
et. al. (1972) also detected large, but variable early-eluting peaks reflecting elevated 
levels of LMW substance(s) in the red cells of some species (eg. horse and sheep). 
Because a number of non-ionic LMW substances could have been contributing to 
these peaks (NAD(H), nucleosides and bases all co-eluted early on their ion-
exchange HPLC system), they were unable to determine the identity of the species-
specific peaks. Although these variable early-eluting peaks all contributed to the 
reproducible and distinctive whole blood chromatographic profile evident for each 
species [25], these interspecies differences were never clarified since no significant 
further comparative HPLC studies on mammalian red cells were performed 
subsequently. That is until collaboration between E.H. Harley and D.E. Paglia led to 
the evaluation of the HPLC nucleotide profile from healthy black rhinoceros red cells.   
Emeritus Professor Eric H. Harley, supervisor of this thesis, has published widely in 
the field of purine/pyrimidine nucleotide metabolism [2, 4, 23, 40-59]. Harley and co-
workers (1988) also reported that a characteristic human erythrocyte nucleotide 
pattern is identifiable in certain inherited purine and pyrimidine enzyme defects where 
there is clinical evidence of cellular toxicity [23], and which may provide a useful 
diagnostic tool.  
 
On comparison of human and black rhinoceros red cell anion-exchange HPLC 
profiles, Harley and co-workers found that the rhinoceros red cell acid extracts show 
a number of very unusual features [2]. 
Besides confirming an extremely low red cell 
ATP level previously noted by Paglia et. al. 
(1986) (approximately 2-5% relative to 
humans) [30, 60, 61], Harley and co-workers 
detected a large amount of uncharged UV-
absorbant LMW material, this peak 
dominating the anion-exchange HPLC profile. 
As for Brown et. al., they were initially unable to determine the identity of the 
uncharged substance(s) from the anion-exchange HPLC profile alone, although the 
peak had a similar 260:280nm ratio and early elution time to that seen in the human 
red cell profile (Fig 3A). By using reverse-phase HPLC technology, Harley and co-
workers determined that the substance responsible for the large peak in the 
rhinoceros red cell extracts was not the same as that responsible for the peak in 
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human red cells, as these were differentially retained on reverse-phase HPLC. The 
absorption spectrum of the substance present in the rhinoceros red cells could then 
be visualized on the HPLC’s built-in diode array spectrophotometer (whilst the extract 
eluted), and its array was determined to be identical with that of commercially-
available L-tyrosine. Confirmation that the peak in rhinoceros red cell extracts was 
indeed produced by large amounts of free tyrosine was then achieved by co-elution 
with a tyrosine standard, by ninhydrin positivity on cation-exchange amino acid 
analysis, by excitation and emission properties on fluorescence spectrophotometry, 
and by mass number identity with tyrosine on mass spectrometry [2].  
 
Harley and co-workers (2004) were thus first to report that the red cells from black 
rhinoceros (n=8) are highly unusual in containing very large amounts of the free 
amino acid tyrosine, with a mean level of 780 + 110M [2].  In comparison, the 
reported mean level of tyrosine in human red cells is 59 + 9 M [3] (Fig 4). This 
finding of such extraordinary free tyrosine levels in red cells from any species (being 
up to 20 times greater than is present in human red cells) was unprecedented.  
 
Figure 4. Modified representation of previously 
published data on rhinoceros red cell tyrosine 
levels [2]. The human red cell tyrosine level* is 






The mean tyrosine level in the red cells from white rhinoceros (n=3) was similar to 
the level in black rhinoceros, but somewhat lower in Sumatran (n=3), and in one 
Asian greater one-horned rhinoceros [2]. In contrast with these high red cell levels, 
plasma levels of tyrosine in all these rhinoceros were low and very similar to human 
plasma levels of tyrosine (unpublished [62]), as had also previously been reported by 
Dierenfeld et. al. (1995) [63]. Primary cultures of rhinoceros fibroblasts also showed 
very low levels of intracellular tyrosine (personal communication [64]). These results 
taken together suggest that the red cells specifically, from rhinoceros but not from 
humans, accumulate high levels of free tyrosine.  
 
In preliminary investigations the same investigators found that horses, being of the 
same mammalian Order as rhinoceros, namely Perissodactyla, did not seem to have 
elevated red cell free tyrosine levels compared with humans. They reported a mean 
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level of 68.18 + 4.1M free tyrosine in the red cells from 6 horses [2], although some 
unpublished results suggested that higher levels could sometimes be found [5]. 
Zebra (n=4), also Perissodactyla, had levels of 54.57 + 2.77M.  
 
The Harley group began to investigate the possible role(s) for such elevated levels of 
the free form of tyrosine in red cells. They first considered whether this might be 
providing an alternative energy source in the form of tyrosine phosphate, particularly 
since rhinoceros red cells have such low levels of ATP – they however dismissed this 
as a possibility by showing that this red cell tyrosine was not phosphorylated 
(unpublished [62]). They then began to investigate the possibility that free tyrosine in 
the rhinoceros red cells was providing antioxidant protection for these cells. Their 
proposition was supported by the fact that:  
 
(1) human spermatic fluid has even higher levels of free tyrosine, 2000M [65], and 
that this tyrosine is hypothesized to play a moderating antioxidant role due to its 
relatively slow but continuous ability to quench oxygen radicals [66, 67].  
 
(2) the accumulation of the β-amino acid taurine in various cell types has been 
suggested by some to be providing crucial antioxidant protection. Taurine is present 
at very high concentrations in neutrophils (10-50mM) [68, 69] and heart epithelial 
cells (6-35mM) [70], where it may protect against the respiratory burst oxidants 
released by the neutrophils during acute inflammation and protect the epithelial cells 
against the reactive species generated during reperfusion-associated phenomena in 
the heart [71] respectively. Notably though, whilst taurine has been shown by some 
to have antioxidant activity [72, 73], others have found that hypotaurine, although 
present at lower concentrations than taurine in leukocytes, is a much better 
antioxidant [74] and may be providing more effective antioxidant protection than the 
taurine in these cells [8].  
 
(3) the in vitro antioxidant activity of the phenolic amino acid tyrosine, like the well-
known polyphenolic antioxidant substances such as resveratrol [75-77] has been 
reported more recently (see also Chapter 2). Harley et. al. (2004) also reported that 
tyrosine seems to have similar in vitro antioxidant activity to that of the well known 
physiological antioxidant urate, and that it is oxidized by hydrogen peroxide (H2O2) in 
the presence of haemoglobin (Hb). They proposed that the unusual accumulation of 
large amounts of free tyrosine in the red cells of rhinoceros, analogous to the high 
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above), may have evolved as a species-specific red cell antioxidant defense strategy 
[4].  
 
It is possible that, as for rhinoceros red cells, some of the ‘as yet unidentified’ large 
early-eluting peaks previously noticed in the red cells of other mammalian species on 
ion-exchange HPLC may also be produced by an elevated level of tyrosine, or else 
reflect evolutionary adaptations in other biochemical pathways that are likely to be 





To produce and compare anion-exchange and reverse-phase HPLC profiles of the 
acid-soluble extracts from the red cells (and plasma) of various mammalian species 
in order to further clarify baseline data on UV-absorbant LMW substances within 
these red cells, with a particular interest in urate riboside, tyrosine, and any other 
LMW substance(s) found to be elevated in the red cells from any of the species 
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(C) MATERIALS & METHODS  
 
(i) Samples 
Blood samples were obtained from human donors and various animals (in 
collaboration with veterinarians, either opportunistically or from the local abattoir). 
Approval from the Human and Animal Research Ethics Committees (Health Sciences 
Faculty of the University of Cape Town) was obtained prior to commencement of the 
study, and written, informed consent was obtained from every human volunteer prior 
to venepuncture. All blood donors were healthy, and blood samples were obtained 
whilst at rest and non-fasting - thus data obtained from these blood samples were 
presumed to reflect baseline/normal levels for each species. 
 
Blood was collected into sterile, plastic, lithium-heparin vacutainers (17 IU spray-
coated LH/ml blood, Beckton Dickinson, UK). Heparin is recommended as 
anticoagulant because of the high UV absorbance of EDTA [78]. For all human 
donors, needle bore size was not smaller than 21 gauge and not larger than 23 
gauge in order to minimise haemolysis [79, 80], particularly since plasma levels of 
LMW substances were also to be determined. Blood-filled vacutainers were 
immediately inverted 8-10 times, as prescribed, to ensure complete anticoagulation. 
The blood samples were processed as soon as possible within 2 hours of 
phlebotomy, except where this was not possible for some wild animal samples (and 
as indicated in the results section). Until processing was begun, the whole blood 
samples were maintained at ambient temperature - such sample handling has been 
shown to improve the stability of red cell nucleotides [78, 81, 82] and minimise in vitro 
haemolysis [80] when compared with storage of whole blood at either 4oC or 37oC.  
 
(ii) Preparation and acid extraction of red cells and plasma 
The method that was used is a modification of the basic 
protocol previously described by Bartlett et. al. (1986) [17]. 
Whole blood samples were centrifuged at 4000rpm (1350g) for 
10 minutes at 22oC (if the extent of red cell lysis was thought 
to be more than minimal, by visual inspection of the plasma 
colour, the sample was discarded). An amount of 200l of 
plasma was transferred to a 5ml tube already containing 300l of normal 
(physiological) saline (N/S) at ambient temperature. The residual plasma, entire buffy 
coat and very top layer of the red cells in the vacutainer were carefully removed with 
a plastic pipette. The remaining packed red cells were then washed once(a) (see 










Chapter 1: Materials and Methods                                                                                                                   - 21 -  
vacutainer 5-10 times until all the red cells were well resuspended, and centrifuging 
this suspension at 4000rpm for 10 minutes at 22oC.  The N/S plus very top layer of 
red cells were then removed using a plastic pipette. The remaining washed, packed 
red cells were well mixed (by ‘finger-flicking’ the bottom of the blood tube) so as to 
prevent selective sampling based on size (and hence maturity) of red cells. A volume 
of 200l of packed red cells was then transferred to a 5ml tube already containing 
300l N/S(b) - a blue disposable pipette tip which had its very tip cut off at an angle 
was used, this facilitating transfer of an accurate amount of the highly viscous packed 
cells.  
 
For most of the earlier samples in this thesis, two milliliters of ice-cold 0.9M perchloric 
acid (PCA, Merck, USA) were then added drop-wise to the 500l red cell and plasma 
suspensions, whilst vortexing constantly on high. This gave a final PCA concentration 
of 0.72M, Bartlett having recommended at least 0.6M PCA [17]. A thick brown protein 
precipitate is formed as the pH decreases. The acidified samples were immediately 
centrifuged at 4000rpm for 10 minutes at 22oC to sediment the protein precipitate, 
leaving behind a volume of 2300l of acid-soluble extract. Two milliliters of this 
protein-free extract were transferred to a fresh 5ml tube, and neutralized by the slow 
addition(c) of between 150l-200l of freshly made 5M K2CO3 until the extract pH was 
approximately 7, as determined using Whatman’s pH paper. However, towards the 
end of this thesis, use of a novel, alternative neutralizing method was developed(d).  
 
The resultant KClO4 is extremely water insoluble, and this precipitate is easily 
removed by centrifugation, leaving behind a volume of 2100µl of supernatant. As per 
the recommendation of Bartlett, the neutralized extract was left on ice for 1-2 hours in 
order to ensure complete crystallization of the KClO4. The extracts were stored at      
-80oC(e) prior to HPLC analysis. 
 
The resultant extracts were a 17-fold or a 12-fold dilution of red cell water and 
plasma respectively:  
 
 Red cell concentration =     extract concentration (µM)  X    2100  X 2300    
    (µmol/litre red cell water)                           2000 X 146* 
             (*0.73 X 200µl = 146µl) 
  
 Plasma concentration  =     extract concentration (µM)  X     2100  X 2300    
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These factors take into account both the dilution during extraction, as well as that red 
cells contain 0.73kg water/litre (with the rest being made up by the protein mass 
[83]), whereas protein content is negligible in plasma.  
 
(iii) Acid extraction of the buffy coat 
The buffy layer, isolated as above from approximately 100ml cow blood, was washed 
with N/S and then centrifuged at 2500rpm for 10minutes at 22oC. As much of the 
white cell pellet was then transferred to a fresh tube, leaving behind most of the 
underlying residual red cells. This wash step was repeated 4-5 times, until no red 
cells were visible in the white cell pellet, which was then extracted as above for red 
cells. The extract was stored at -80oC.  
 
(iv) Culture and acid extraction of fibroblasts  
A small section of skin obtained from a slaughtered cow’s ear was scrubbed in 
hibitane and the hair scraped off with a scalpel. The skin was then immersed in 70% 
ethanol for a few seconds. The clean tissue was dissected into sections of < 2mm in 
a drop of culture medium (DMEM plus 10% fetal calf serum, both from Invitrogen, 
NZ). The dissected pieces were transferred, with some medium, to a few 25X10mm 
Petri dishes (Corning, USA) and coverslips placed over the tissue. The dishes were 
filled with 2.5ml medium and placed in a 37oC, 10% CO2 incubator, to allow dermal 
fibroblasts to grow out from the explants. Confluent cultures were transferred to 
larger culture dishes. When the fibroblasts were optimally confluent, the medium was 
discarded and the adherent cells washed gently with N/S (repeated three times). 
Then 0.9M PCA was added directly to the adherent cells so as to form a thin film 
over the cells, and the dishes were left on ice for 5 min. The PCA from the first dish 
was transferred to the next dish in order to minimise the dilution factor of the extracts. 
Notably, the PCA causes the adherent cells to release their contents without lifting 
the cells, so microscopic evaluation of the dishes after acid extraction is deceiving 
because the cells still look intact. The resultant acid-soluble extract was neutralized 
with K2CO3, the KClO4 precipitate allowed to form completely and then removed by 
centrifugation as above for the red cells. The extract was stored at -80oC.  
 
(v) HPLC analyses 
Each extract was thawed and filtered through a 0.45m syringe filter just prior to 
HPLC injection. The HPLC system consisted of a Beckman System Gold, model 126 
programmable solvent module connected to a 168-detector, providing a 
spectrophotometric diode array profile (200-350nm) of each peak as the extract 
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chromatography, extracts were fractionated on a 250X4.6mm Hypersil APS-2 5m 
column (Thermo Electron Corporation), while reverse phase chromatography was 
performed using a 250X4.6mm Hypersil ODS 5m column (Thermo Electron 
Corporation). Buffers were made with deionised water, and were filtered/degassed. 
Phosphate buffers older than 48hours were discarded. HPLC gradient conditions 
were as follows: 
 
For anion-exchange chromatography, buffers were 5mM KH2PO4 (pH 2.8) and 0.5M 
KH2PO4/1M KCl (pH 3.5). Initial conditions were 99% buffer A and 1% buffer B. After 
1min these conditions changed over 15min to 1% buffer A and 99% buffer B. 
Conditions were maintained as such for 1min, and then returned to the initial 
conditions over 5min. These baseline conditions were then maintained for another 
18min, by which time no more UV-absorbance (from specific substances or buffer 
mixing) was detectable on the diode array screen (200-350nm). Total running time 
was 40min.  
 
For reverse-phase chromatography, buffers were 10mM KH2PO4 (pH 5.6) and 50% 
HPLC-grade methanol (Sigma, USA). Running conditions were identical to those for 
anion-exchange, except that the final conditions were maintained for only 8min, by 
which time no more UV-absorbance was detectable on the diode array screen. Total 
running time was therefore 30min.  
 
(vi) Determination of the identity of substances responsible for each peak 
A reverse phase (Fig 5A) and anion-exchange profile (Fig 5B) was produced of a 
‘standards mix’ of 12 commercially-available LMW substances (in phosphate buffer, 
pH 7.4). The UV-absorbing substances chosen to make up the mix were those 
known to be present (or inducible) within red cells. This mix was used as a rapid 
reference guide for the initial determination of the identity of substances in the acid 
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Figure 5. (A) Anion-exchange, and (B) reverse-phase HPLC profiles of the standards mix. The 
substances in the mix are as follows: a-uric acid, b-tyrosine, c-hypoxanthine, d-xanthine, e-inosine, f-
tryptophan, g-AMP, h-NAD+, i-IMP, j-ADP, k-NADP+ and l-ATP. The substances are not at equimolar 
concentrations. 
*The peak purity index, information which is provided by the HPLC Beckman System Gold for every 
profile, but not shown in the figures above, indicates if more than 1 substance is responsible for every 
peak. Therefore, the first-eluting peak in (A) would have been shown to represent multiple co-eluting 
substances. On the other hand, peaks h, i and l in (A) would have shown peak purity i.e. each 
representing a single eluting substance.  
 
An HPLC profile for each of the standards substances making up the mix (in 
phosphate buffer, pH 7.4) was first produced in order to determine its reverse-phase 
and anion-exchange HPLC elution positions, its 260:280nm absorbance ratio, and to 
visualise its absorbance spectrum on the HPLC’s built-in diode array 
spectrophotometer. Table 1 shows the 260:280nm ratios and absorbance spectra of 
some of these LMW substances (in phosphate buffer, pH 7.4).  
 
Note that absorbance spectra for some substances differ with varying pH; for 
example, whereas the 260:280nm ratio for xanthine in buffer pH 7.4 = 0.87, on 
reverse phase HPLC (where the exact pH would be < 7) the 260:280nm ratio is = 
1.6. An HPLC profile of the standards mix was also produced regularly as a control 
for HPLC column retention.  
 
Confirmation of the identity of substances in the extracts was obtained when a 
solution of the commercially-available LMW substance suspected to be responsible 
for the peak was spiked into the extract, and this co-eluted with the unknown peak 
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Table 1. Absorbance ratios (260nm:280nm) and spectrophotometric diode array patterns of some LMW substances 
of interest, dissolved in phosphate buffer (pH 7.4). The dotted lines indicate 260nm and 280nm on the x-
axes. 
LMW substance 260:280nm ratio Diode array patterns 
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(vii) Determination of concentration in red cells and plasma  
The concentration of a LMW substance in an extract (µM) was determined from the 
HPLC profile by multiplying its peak area with a specific constant unique for each of 
the commercially-available substances. Peak areas for each HPLC profile were 
retrieved from the System Gold (1992) package (Beckman Coulter, USA). The 
constant for each substance to be evaluated was derived off a pre-determined 
standard curve (Fig 6), as the ratio between concentration (µM) and peak area. For 
example, the constant for tyrosine was 7.6 (see standard curve below), and that for 
urate was 1. The correct concentration of the highest standard solution from which 
the serial dilutions were then made for each standard curve was confirmed 
spectrophotometrically.  
 
Figure 6. L-tyrosine standard curve to determine 
tyrosine concentration in red cell and plasma 







The intra-erythrocytic concentration of each LMW substance (µmol/litre red cell 
water) was then determined by multiplying the neutralised red cell extract 
concentration for that substance by a factor of 17 (see section ii above). For plasma, 
this factor was 12 (see section ii above). The concentrations of LMW substances 
present in human red cells as determined in this study were always comparable with 
previously reported data for human red cells. 
 
If a small degree of lysis of a blood sample was noticed, the validity of the 
determined plasma levels of LMW substances was always confirmed by ensuring 
that insignificant amounts of the dominant red cell peaks were present in the plasma 
extract. 
 
Since commercially-available urate riboside preparations are not available, red cell 
concentrations of this LMW substance had to be determined differently. Smith et. al. 
(1981) previously described how to determine urate riboside concentrations 
spectrophotometrically [84]. Accordingly, the absorbance at 298nm of K2CO3-
neutralised cow red cell extracts was measured, and urate riboside concentration in 
these extracts calculated using a molar absorbance of 16.4 X 103 (absorbance X 
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106/16 400 = M concentration). The red cell concentration was then determined by 
multiplying the extract concentration by 17, as for other red cell substances (see 
above). Although most of the cow red cell extracts evaluated earlier on in the current 
study were only evaluated on HPLC, and not with spectrophotometry, a standard 
curve of urate riboside HPLC peak area versus spectrophotometric absorbance (at 
298nm) (r2=0.9975) was produced using extracts for which both measurements were 
available (n=10). This standard curve gave a ratio (constant) of 54 for HPLC pea k 
area:absorbance (298nm), which was then used to extrapolate absorbance 
measurements from HPLC peak areas, were necessary.  
 
(viii) In vitro exposure of horse red cells to H2O2 or AAPH to determine haemolysis 
A suspension of red cells from different horses was each incubated with 50mM H2O2 
or 20mM AAPH (2,2’-azobis(2-amidinopropane) dihydrochloride)(Sigma-Aldrich, 
USA) in 10mM phosphate buffered saline, at 37oC. AAPH decomposes 
spontaneously in solution at 37oC to release a constant flux of peroxyl free radicals. 
The reaction tubes were incubated with continuous, gentle rotation, on a mini 
labroller rotator (Labnet International, USA), in order to maintain the red cells in 
suspension. The supernatants were evaluated at different time points for haemolysis 
by diode array spectrophotometry. No inhibitors of red cell antioxidant enzymes were 
added. The diode array profile of a triton-X treated sample (no oxidant) of the red cell 
suspension from each horse was also evaluated, as control for Hb content.   
 
(ix) Statistical considerations 
Unless otherwise indicated, data are presented as mean + SD. When comparing 
means, the Unpaired t test was used to determine statistical significance, unless the 
data were skewed, in which case the Mann Whitney test was used. The Paired t test 
was used when comparing plasma and red cell levels within the same species, 
except where the data were skewed, in which case the Wilcoxon signed rank test 
was used. The Pearson test was used to determine statistical significance of 
correlation, unless the data were skewed in which case the Spearman r was 
determined. The Goodness of Fit test was used to determine linear regression. A P-
value < 0.05 was considered statistically significant. Five repeat extractions and 
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(D) RESULTS AND DISCUSSION 
 
(i) Comparative HPLC profiling 
In figure 7, typical anion-exchange (left side) and reverse-phase (right side) HPLC 
profiles of red cell extracts from human (A,B), rhinoceros (C,D) and cow (E,F) are 
depicted.  
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Figure 7. Anion-exchange and reverse-phase HPLC absorbance profiles at 260nm (solid line) and 280nm (dashed 
line) of neutralised, acid-soluble red cell extracts from a human (A,B), a white rhinoceros (C,D), a cow (E,F), and a 
standards mix (G,H). The standards in the mix are a-uric acid, b-tyrosine, c-hypoxanthine, d-xanthine, e-inosine, f-
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By comparison with Brown et. al. (1972) who produced comparative (ion-exchange) 
HPLC profiles for extracts from whole blood extracts [25], the use of red cell extracts 
eliminates the influence of variable haematocrit and allows determination of red cell 
levels of LMW substances that are present in both red cells and plasma.  
 
One of the more notable red cell profile differences evident in figure 7 is that the ATP 
level in healthy rhinoceros red cells is strikingly low – this was also shown in previous 
investigations by Paglia et. al. (1986) [60]. In addition, as shown by the reverse-
phase profile of figure 7D and as previously reported by the Harley group [2], 
rhinoceros red cells have a markedly greater amount of free tyrosine when compared 
with human red cells (Fig 7B). It is clear that use of anion-exchange chromatography 
alone would have made it very difficult to elucidate the identity of the substance(s) 
accounting for the large amount of early-eluting UV-absorbing material in the 
rhinoceros red cell extract (Fig 7C, oval), which appears similar to the peak seen in 
the human anion-exchange profile (Fig 7A, oval). Complimentary use of reverse-
phase HPLC, however, revealed that whereas in humans the main component of this 
peak is urate (Fig 7B, oval), in rhinoceros red cells it is tyrosine (Fig 7D, oval).  
 
Comparative HPLC, as opposed to targeted analysis, is therefore useful to screen for 
unsuspected differences in the range and level of UV-absorbing LMW substances 
present in the red cells from different species. Limitations of the protocol should 
however be noted: The use of acid-extraction to remove proteins including the 
membrane lipoproteins will remove lipophilic LMW substances such as Vitamin E.  
Ascorbate is unstable in aqueous solutions [85], and is likely to be degraded in the 
freeze-thawed acid-extracts. Any LMW substance that is not UV-absorbing, for 
example glutathione (GSH), will go undetected.  
 
The very large and dominant UV-absorbing peak seen in cow red cell profiles (Fig 
7E,F), and which was undetectable in human and rhinoceros red cell profiles, 
displayed HPLC characteristics consistent with previously described urate riboside 
[84]. Since the discovery of urate riboside in 1922, fewer than 25 publications have 
appeared on this substance (pubmed search), with R.C. Smith and co-workers being 
the authors of all the more recent ones. Further investigations of this potent LMW 
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(ii) Urate riboside: inter- and intraspecies variation 
It is known that large, yet variable amounts of the antioxidant urate riboside are 
present in the red cells from cow and buffalo (Order Artiodactyla, Family Bovidae, 
Subfamily Bovinae, and Tribe Bovini) [86, 87]. It is absent in the red cells from all 
other species evaluated, including the only other Artiodactyls investigated to date, 
namely pigs (Family Suidae) and even sheep (Family Bovidae, Subfamily Caprinae) 
which belong to the same Family as cow/buffalo [32]. The exact phylogenetic position 
of the evolutionary mutation for urate riboside formation has however never been 
determined. In order to address this, red cells from cow, buffalo, sheep, as well as 3 
further Artiodactyls not investigated before, namely one grysbok (Family Bovidae, 
Subfamily Caprinae), one bontebok (Family Bovidae, Subfamily Caprinae), and two 
kudu (Family Bovidae, Subfamily Bovinae, and Tribe Strepsicerotini) were evaluated. 
Because processing of these wild animal blood samples was delayed by 48 hours 
post phlebotomy, it was first confirmed that urate riboside levels remain unchanged in 
a blood sample, whether processed within 2 hours or kept at room temperature for 48 
hours prior to processing.  
 
HPLC profiles revealed that urate riboside was absent in the grysbok and bontebok 
red cells, but present in both kudu. As expected, urate riboside was present in the 
red cells from all cows and buffalo sampled, but undetectable in sheep. Hence urate 
riboside is present in the red cells of both major Tribes of the Bovinae Subfamily 
(namely Bovini and Strepsicerotini), but not in any of the other Bovid Subfamilies 
evaluated. This almost certainly proves that the evolutionary mutation for urate 
riboside formation within red cells is specific to the Bovinae Subfamily, and is thus 













Tribe: Strepsicerotini  
 
Figure 8. Phylogeny of the Artiodactyla. The arrow indicates where the mutation responsible for red cell 
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As previously reported [33], urate riboside was undetectable in the plasma from 
cows. Since urate riboside is resistant to the action of uricase [84], the liver enzyme 
specific for urate degradation, its absence in plasma implies that once formed 
(presumably inside the red cell) that it is trapped within the cell, possibly by virtue of 
the large ribose moiety. 
 
Levels of urate riboside present in the red cells of the 3 different Bovinae were then 
determined. The red cells from the two kudu had levels of 530M and 237M. The 
mean level of urate riboside in cows (n=24) was 2560 + 735M, and in Cape buffalo 
(Syncerus caffer) (n=6) it was 665 + 245M (Fig 9A). Levels in cows were 
significantly higher than levels in buffalo (P < 0.0001). 































































Figure 9. (A) Scatter plots of red cell urate riboside concentration in cow, buffalo, kudu and sheep. The 
Unpaired t test was used to determine P values. (B) Red cell urate riboside concentration in four cows 
that were bled once, and then again 30 days later  
 
 
A study by Smith et. al. (1981) comparing urate riboside concentrations in cows and 
buffalo reported a much lower mean urate riboside level in both cows and buffalo, 
with a greater concentration in the red cells from buffalo than cow: 700M + 360M 
versus 920M + 210M in cow (n=115) and buffalo (n=10) respectively [86]. In the 
only other study to report urate riboside levels in cows (n=50), Smith et. al. (1985) 
found a mean level of 1210M + 190M [87].  
 
Urate riboside levels are known to vary widely. In this study, levels in cows ranged 
between 1000M and 4000M i.e. a 4-fold difference within the same species. In 
order to determine if the highly variable red cell urate riboside concentrations 
fluctuate within an individual, or are stable and thus specific to each cow, two blood 
samples from the same four cows were obtained with an interval of 30 days between 
the two bleeds. The cows were all healthy, all came from the same herd and the 
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Figure 9B shows that urate riboside level varied very little in each cow over 30 days – 
this finding, together with the report by Smith et. al. (1985) of a positive correlation for 
urate riboside concentration in the red cells of calves with that of their dams, is 
consistent with the likelihood that such normal/baseline variability in urate riboside 
level is genetically determined. One possibility to account for such normal variability 
is that there is intraspecies heterogeneity in UMP synthase enzyme level. In support 
of this, it has been shown that urate riboside levels in cows with inherited deficiency 
of UMP synthase fall within the lower range of normal levels [87]. Smith et. al. (1981) 
offered another explanation, suggesting that such variation may result from variable 
permeability of red cells to urate riboside [84]. However, this possibility is unlikely 
considering that no urate riboside is detectable in plasma, as it should be if leaking 
out of the red cells. Extrinsic factors (physiological/non-pathological) could 
theoretically also influence baseline/normal urate riboside levels. For example, 
variable levels of physiological oxidant production could theoretically lead to variable 
levels of urate riboside oxidation (see also Chapter 4). 
 
Interestingly, although it is known that the mature red cell of the cow has active UMP 
synthase as well as the substrate PPRP [88], urate (the other substrate) is actually 
undetectable by HPLC in cow/buffalo red cells, and plasma urate level in cows is 
negligible (see later, section iv). It is probable that any small amount of urate entering 
the red cell from these low levels present in plasma is immediately incorporated into 
urate riboside. But is this enough to account for the high levels of this LMW 
substance trapped within the red cells? It is possible that urate riboside production in 
the red cell occurs only under certain conditions of elevated urate substrate levels. 
The enzyme xanthine oxidase/xanthine dehydrogenase (XO/XD), which produces 
urate (see also section iv), is present at very high levels in cow milk [89]. Lactation 
may lead to an increased level of plasma urate, which may then provide the red cells 
with sufficient substrate to form urate riboside. However the presence of urate 
riboside in bulls as well as cows [84] would make this possibility less likely.  
 
As previously mentioned, bovine red cells have a much higher level of UMP synthase 
than the red cells from other species [35]. But there is no record of whether other 
bovine cell types also have such elevated levels of this enzyme, and the possibility 
that urate riboside is also made by other cell types in the cow has to date not been 
reported on. This was investigated, and figure 10 shows that, unlike cow red cell acid 
extracts (Fig 10A), extracts from the buffy coat (white blood cells and platelets) (Fig 
10B), and cultured primary fibroblasts (pinnae dermis) (Fig 10C) of a cow had no 
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Figure 10. Reverse-phase HPLC absorbance profiles at 260nm (solid line) and 280nm (dashed line) of 
a neutralized, acid-soluble extract of (A) washed red blood cells, (B) buffy coat, and (C) cultured primary 
dermal fibroblasts from a cow. 
 
 
This suggests that the mutation leading to the formation of urate riboside finds 
expression only in the red cells of these animals, and raises a number of questions. 
For example, is it made in most cells, but rapidly degraded in cells other than red 
cells? 
 
(iii) Free tyrosine: inter- and intraspecies variation 
Harley and co-workers (2004) previously reported that rhinoceros red cells are 
unusual in having very high levels of free tyrosine. They suggested that this ability to 
accumulate such large amounts of free tyrosine may have evolved in rhinoceros to 
provide antioxidant protection to their red cells [2, 4] in the same way that the 
accumulation of free tyrosine in human seminal plasma has been suggested to have 
arisen in order to provide antioxidant protection to the spermatozoa. Although in vitro 
assays show that tyrosine does have antioxidant activity (see Chapter 2), the 
possibility that elevated levels of free tyrosine (exogenous source, or as a naturally 
occurring phenomenon in some tissues) may provide antioxidant protection in vivo 
has been virtually ignored.  
 
Such an evolutionary adaptation may not be limited to rhinoceros if indeed it plays an 
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species also have elevated levels of red cell tyrosine, levels in the red cells (and 
plasma) from 20 horses (Equidae), being the closest evolutionary relative to the 
Rhinocerotidae (both being members of the Order Perissodactyla), and from at least 
2 individuals of various other mammalian species were compared with levels in 25 
humans. A blood sample from 1 white rhinoceros was also obtained for comparative 
purposes (this blood sample was processed 48 hours post-phlebotomy).  
 
Values were determined from reverse-phase HPLC profiles (an example HPLC 
profile for each species that was evaluated is shown in figure 11 below). These 
profiles were later also used to evaluate other differences in red cell LMW 
substances between species. The paucity of, and lack of much variability between 
UV-absorbant LMW substances in the HPLC profiles of plasma from the different 




Figure 11 (see below). Reverse phase HPLC profiles (260nm black solid line and 280nm red dotted 
line) of a standards mix (bottom) and the red blood cell and plasma acid extracts from animal species 
belonging to 6 different mammalian Orders. The HPLC profiles for buffalo red cells and plasma are not 
shown, but other than for a smaller urate riboside peak they were essentially identical with that from 
cows. The standards in the mix are a-uric acid, b-tyrosine, c-hypoxanthine, d-xanthine, e-inosine, f-
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The mean tyrosine level in human red blood cells was determined to be 67.5 + 
23.8M (Fig 12A), which is in accordance with previously published levels [3, 83, 90, 
91]. By comparison, the mean red cell tyrosine level in horses were 279.0 + 
199.3M. Levels in horses were significantly higher than in humans (P < 0.0001), 
and also significantly higher than previously reported for 6 horses by this group [2]. 
One possible reason for this discrepancy is that the red cells in this earlier cohort of 
horses were washed three times in N/S prior to extraction, a procedure which has 
been found to wash out significant amounts of tyrosine from red cells [83] (see also 
Appendix, section (a)). Confirmation that this peak in horse red cells was indeed due 
to tyrosine was achieved by visualization of its absorption profile on diode array scan, 
which was identical for that of a commercial tyrosine preparation, by its co-elution 
with the peak produced from a solution of tyrosine spiked into a horse red cell extract 
(and purity of the peak was maintained), and by disappearance of the peak in 
question on exposure of a horse red cell extract to the tyrosine-specific enzyme 
tyrosinase (Sigma-Aldrich, USA)(0.1IU per ml of extract for 1hour at 37oC), with no 
other profile changes. 
 
Although red cell tyrosine levels in horses were significantly lower (P = 0.0004) than 
that previously reported for black rhinoceros red cells (778.8 + 40.0M) [2], and for 
one white rhinoceros sampled for the current study (1010M), the range in horses 
was very large (137.4M - 876.1M), and the data skewed to the right. Thus a few 
horses had levels as high as that seen in rhinoceros, and the median [and 
interquartile range] for horses was 194.7 M [168.8 M – 300.7M].  
 
The finding of elevated levels of red cell tyrosine in members from both major 
Families of the Perissodactyla Order (Rhinocerotidae and Equidae) relative to 
humans was initially suggestive that this was a feature peculiar to this Order of 
Mammalia. Unexpectedly however, cats, which are of a completely different Order 
(Carnivora) to rhinoceros and horses, were also found to have high red cell tyrosine 
concentrations, with a mean level (365.1 + 55.8M) even higher than for horses. 
Dogs (also Carnivora) and sheep (Artiodactyla) also had significantly higher red cell 
tyrosine levels compared with humans, but significantly lower than in cats and 
horses. Humans, however, were not alone in having relatively low levels of red cell 
tyrosine - rats (Rodentia) had levels similar to humans, while naked molerats (also 
Rodentia) had no HPLC-detectable tyrosine in their red cells. Levels of tyrosine in the 
red cells of cow and buffalo eluted very closely with another small peak, this most 
likely being urate ribotide, the precursor to urate riboside (see Literature Review) 
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extracts could therefore not be accurately determined using HPLC, although it was 
































































































































































     






































Figure 12. Tyrosine concentrations in the (A) red cells, and (B) respective plasmas from various 
mammalian species, including humans. Comparison of the tyrosine concentration within red cells and in 
plasma for (C) humans and (D) horses. Horizontal bars indicate means. The Mann Whitney test for non-
parametric data was used to determine P values between horses and other species in figure A; 
otherwise the Unpaired t test was used. The Paired t test was used to determine P values when 
comparing plasma and red cell tyrosine levels within species, except for horses where the Wilcoxon 
signed rank test was used. The Pearson test was used to determine statistical significance of correlation 
in figure C, and the Spearman test in figure D. 
#Black rhino red cell tyrosine concentrations are taken from a previously published report [2]. 
*Individual black rhino plasma tyrosine levels were not available. However the mean plasma tyrosine 
level was similar to that of humans [4]. 
 
 
Human plasma tyrosine levels (60.0 + 17.6M) (Fig 12B) were very similar to the red 
cell levels. Red cell and plasma tyrosine levels showed a strong correlation, with an 
‘erythrocyte to plasma’ (E:P) tyrosine ratio + SD of 1.12 + 0.15 (and ranging between 
0.75 to 1.48 for individuals) (Fig 12 C). Hagenfeldt et. al. (1980) previously reported a 
mean human plasma tyrosine level of 54 + 11M, and an E:P tyrosine ratio of 1.22 + 
0.17 [83], but no reports on whether the red cell and plasma values within individuals 
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In humans, the presence of tyrosine in the red cell, and its correlation of effectively 
1:1 with plasma level, is consistent with non-concentrative, facilitated diffusion 
transportation of tyrosine, from plasma, across the red cell membrane via both the L-
system and T-system of amino acid transporters [92-94]. As has been shown in vitro, 
tyrosine is also easily able to exit the human red cell [5, 83]. But this system of 
tyrosine movement/transport across the human red cell membrane cannot explain 
the very high red cell tyrosine levels found in some of the other mammalian species.  
 
The mean E:P tyrosine ratio was clearly highly variable between species, with 
plasma tyrosine levels showing much less interspecies variability than red cell 
tyrosine levels.  
 
Only rats and sheep had plasma tyrosine levels that were significantly higher than 
human plasma tyrosine levels (P < 0.0001 and P = 0.004 respectively) - this may 
relate to diet. In contrast, horses, rhinoceros, cats and dogs - the species that 
actually had a significantly higher red cell tyrosine level compared with humans - had 
mean plasma tyrosine levels that were very similar to human plasma levels, being 
56.6 + 35.6M, 61.1 + 31.2M and 44.9 + 12.4M for horses, dogs and cats 
respectively. As a consequence, plasma tyrosine levels in these species were all 
significantly lower than the respective red cell levels of tyrosine (P < 0.0001). And in 
contrast with humans, red cell and plasma tyrosine levels showed no correlation in 
horses (Fig 12D). This demonstrates that tyrosine is accumulating in the red cells of 
some species by some active process(es).  
 
Is it possible that tyrosine is being made within the red cells of some species? 
Tyrosine is a non-essential amino acid, being formed by hydroxylation of the 
essential amino acid phenylalanine by the enzyme phenylalanine hydroxylase. This 
enzyme is present at high levels in liver tissue, and has also been identified in human 
kidney, pancreatic and brain tissue [95]; its presence in red cells, however, has not 
been reported (pubmed search and [1, 3]). It is therefore unlikely that tyrosine is 
being formed de novo in the red cell.  
 
The more likely explanation, however, is that as for human red cells, in horses, 
rhinoceros, cats and dogs the tyrosine in their red cells originates from the plasma; 
but that unlike in humans where red cell tyrosine essentially equilibrates with plasma 
tyrosine levels, in these other animals tyrosine may be actively pumped into the red 
cells against a steep concentration gradient, and is then trapped within the red cells. 










Chapter 1: Results and Discussion                                                                                                                  - 39 -  
acids across the red cell membranes of different species, very little comparative data 
is available regarding tyrosine transportation. 
 
The very different tyrosine gradients evident between the plasma and red cells of 
these different species with elevated red cell tyrosine also indicates that different 
processes/mechanisms may be responsible for its accumulation (or removal) in each 
species. Alternatively, heterogeneity in levels of the same protein transporters for 
tyrosine within the red cells of different species may have evolved. The large 
variability of red cell tyrosine levels just amongst horses themselves (ranging from 
140M to 880M), as well as within the rhinoceros species (560M to 890M), was 
particularly interesting, and rather reminiscent of the highly variable levels of urate 
riboside present in the red cells of cows (Fig 9A, section ii above). However, the fact 
that horse red cells in particular are reported to show heterogeneity in the 
transportation of the amino acid L-alanine [96-98] may be indicative that 
heterogeneity in the transportation of the aromatic amino acid tyrosine may also 
exist, particularly amongst horses. Since all the horses were being housed and fed 
identically (as reflected by very consistent plasma tyrosine levels), it is probable that 
the significant range in baseline tyrosine level found in these horses is because of 
genetically-determined variable tyrosine transport across the red cell membranes of 
different horses.  
 
In further support of this variability being genetically-determined, analysis of blood 
samples from four horses repeated on three different occasions over a month 
showed that these wide-ranging red cell tyrosine levels were highly stable within 
each individual horse (Fig 13A), this being similar to the results obtained for urate 
riboside in cow red cells (see Fig 9B).  
 





































































Figure 13. (A) Red cell tyrosine concentrations in three blood samples taken on different days from the 
same four horses, illustrating the significant stability of tyrosine within a period of one month. (B) Red 
cell tyrosine levels in Thoroughbred (n=8) and Arabian Cross bred (n=11) horses. Horizontal bars 
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Since most of the horses evaluated were of two different breeds (Thoroughbred and 
Arabian Crossbred), red cell tyrosine levels in these two breeds were compared. 
Although levels in the Thoroughbred horses tended to be higher than in the Arabian 
Crossbred horses, this difference did not reach statistical significance (Fig 13B). 
Gender had no influence on tyrosine red cell level (data not shown). Hence genetic 
variability in red cell tyrosine cannot be linked to gender or breed alone. 
 
Extrinsic factors may however also be playing some part in the variable tyrosine 
levels found in horse red cells. The fact that all the horses sampled happened to be 
competitive athletes may be of some relevance. Physical exertion in horses and 
humans, particularly when exhaustive, is associated with a significantly increased 
production of reactive species, measurable by an increased degree of oxidative 
modification to various molecules [99-108]. Tyrosine residues within proteins may 
react with some reactive species both in vitro and in vivo. It is possible that free 
tyrosine molecules similarly would be degraded by such oxidants, and levels of 
tyrosine may be decreased (see also Chapter 2, Literature Review). Although none 
of the horses had taken part in any racing event for at least 1 month prior to blood 
sampling, it is possible that the large variability in red cell tyrosine level seen in these 
horses was because some of them had been exercised more than others prior to the 
quarantine period (but for no longer than a period equivalent to the red cell’s 
lifespan), accounting for lowered levels in some of these horses. If so this would 
constitute not a genetically-determined variability, but variability arising because of a 
‘non-pathological’ extrinsic influence. Red cell tyrosine levels for athlete horses may 
therefore not be representative of baseline levels in non-athlete horses. It is possible 
that non-athlete horses have a higher mean red cell tyrosine level, and a lot less 
variability, compared with athlete horses, but this remains to be tested.  
 
Finally, it is necessary to consider that other explanations for the elevated levels of 
tyrosine found in the red cells of some species may need to be sought. Harley and 
associates had found that in the presence of exogenous tyrosine, whereas washed 
human red cells accumulate tyrosine (which can subsequently also exit the red cells), 
that the red cells evaluated from one rhinoceros and from one horse showed no 
significant tyrosine uptake under the same conditions [2, 5]  If tyrosine is unable to 
enter the red cells of these species (or some individuals at least) in vitro, then how 
might tyrosine have accumulated in the red cells of these animals? One possible 
explanation is that tyrosine may be able to enter the red cell of these animals in a 
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in human red cells under certain conditions. Although taurine has no transport 
system in human red cells, it can enter in the hypochlorous acid (HOCl)-oxidized 
form (taurine chloramine) [70, 72] produced on reaction of neutrophil-released HOCl 
and taurine within the surrounding plasma. At higher HOCl levels taurine 
dichloramine is formed which is very toxic but can enter red cells. Amines are readily 
regenerated by reducing agents such as thiols [109], and in the red cell they are 
readily reduced by GSH back to taurine. It is believed that in this way the red cell is 
able to remove the potentially toxic taurine derivatives from sites of imflammation. 
Taurine is then trapped and accumulates within the red cell [71]. This may be the 
reason why reported red cell taurine levels are so discrepant, with one very early 
report finding a red cell concentration of 30M [110](this value being referenced by a 
more recent publication [71]), while a later report found a 5-fold higher level of taurine 
in human red cells [83](this value being referenced in a current hematology text book 
[3]). This compares with human plasma taurine concentration reported as 50-70M 
[70, 83].) On in vitro exposure of red cells to activated neutrophils (which release 
HOCl and taurine during the respiratory burst, see Literature Review and Background 
Work), red cell taurine content rises significantly (300-fold) [71]. Tyrosine may 
similarly be able to enter the red cells of some species only in its oxidized form, and 
once reduced back to tyrosine, it would then be trapped in these red cells. If this was 
the case, then recent, excessive neutrophil activation, such as occurs with a bacterial 
infection, but also in association with strenuous physical exertion [111-114] could 
theoretically lead to a high level of red cell tyrosine in an individual animal. Halliwell 
et. al. (2007) also indicate that tyrosine may be formed from the hydroxyl radical-
mediated oxidation of phenylalanine [8]. This is however unlikely to explain the 
elevated levels of tyrosine found in the red cells of some healthy mammalian species.  
 
(iv) Urate: inter- and intraspecies variation 
Whilst investigating tyrosine levels in the red cells of horses, very noticeable was the 
presence of what appeared to be extremely variable levels of urate in the red cell 
extracts of the different horses, to the extent that it became the dominant peak in 
some horses (Fig 14A), yet was undetectable in almost 50% of the horses (Figs 14C 
and D). This peak had the same anion-exchange and reverse-phase elution times, 
260:280nm ratio and diode array spectrum to that produced by the distinct peak of 
urate detectable in human red cells and human plasma (Figs 14E and F), and also 
that of a urate standard. The identity of the substance accounting for this HPLC peak 
in horse red cells was confirmed to be urate by co-elution with a solution of urate 
spiked into the red cell extract shown in figure 14B (purity of the peak was 
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on exposure of the red cell extract to the urate-specific enzyme uricase (Sigma-
Aldrich, USA)(0.1IU per ml of extract for 1hour at 37oC), with no other profile 
changes. The levels of red cell urate present in some of the horses in the current 












































Figure 14. Reverse-phase HPLC absorbance profiles at 
260nm (solid line) and 280nm (dashed line) of 
neutralized, acid-soluble red cell extracts from (A) a 
horse with a very large amount of the unknown LMW 
substance; (B) a horse showing a large amount of red 
cell tyrosine but also some of the LMW substance 
accounting for the unknown peak, (C) a horse with 
significant tyrosine but with no detectable amount of the 
unknown LMW substance (D) a horse with a low tyrosine 
level and no detectable amount of the unknown LMW 
substance, and a typical profile of a human (E) red cell 
and (F) plasma acid extract. 
 
 
Harley and coworkers had previously observed that a few horses sampled by them 
had small amounts of urate in their red cells (unpublished [5]). Although these levels 
(20.2 + 38.5M) were within the lower range known to be present in human red cells 
[3], this in itself was intriguing to the investigators, considering the near absence of 
urate in the plasma from horses [115, 116], and there being no previous reports on 
the presence of urate in horse red cells. Moreover, when eight of these horses took 
part in an endurance racing event, Harley et. al. (2004) found that red cell urate level 
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many of these horses (the median level increasing from 0M to 35M), with levels in 
one horse rising from 0M to 824M (Fig 15). These elevated levels of red cell urate, 
in most cases, dropped back to baseline levels by 24 hours. Surprisingly, the median 
level was increased again at 72 hours (to 78M); however levels at this time point 







































Figure 15. Modified representation of data previously reported by Harley et.al. (2004) [4]. Red cell urate 
levels in eight horses bled before, and then immediately, 1 hour, 24 hours and 72 hours after an 
endurance race of 80km, with a mean duration of 5.1 hours. The horizontal bars indicate median values. 
The Wilcoxon signed rank test was used to determine P  values. 
 
 
The production and disappearance of uric acid was also observed over short time 
periods in rhino, horse, and human erythrocytes incubated on the bench 
(unpublished). This was a chance and sporadic observation seen during their HPLC 
analyses of UV-absorbing compounds in red cell extracts (personal communication 
[64]).  
 
Now, in the current study, although none of the 20 horses sampled had undergone 
any significant exertion for at least one month prior to sampling, just by viewing the 
HPLC profiles it was clear that some of these horses had baseline red cell urate 
levels exceeding even human plasma urate levels (Fig 14F above). All of these novel 
findings in red cell urate metabolism were unprecedented, not readily explainable, 
and of particular interest because of the well-established physiological role of urate 
as an important LMW antioxidant in human plasma.  
 
Urate is a product of purine nucleotide degradation (see Fig 2, Literature Review and 
Background Work). The enzyme required to make urate is xanthine oxidase/xanthine 
dehydrogenase (XO/XD), also known as xanthine oxidoreductase (XOR). It catalyses 
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activity has been detected in all species examined, including bacteria. As the name 
implies, it exists in two interconvertible active forms: the oxidase form (XO) and the 
dehydrogenase form (XD). Most of the cell-bound enzyme exists in the 
dehydrogenase form in vivo, whilst circulating (plasma) enzyme is mostly in the 
oxidase form due to conversion by serum proteases. The electron-acceptor for the 
XD form is preferentially NAD+, whereas for XO it is solely O2. Reduction of O2 by 
either form of the enzyme yields the superoxide free radical. In mammalian tissues, 
although activity is widely distributed, degree of activity is very tissue-specific [117]. 
In humans very low levels of XO/XD activity are present in blood, and the highest 
levels are found in liver, intestine and mammary tissue [118]. The urate formed in 
these cells enters the plasma and is present as the sodium salt at biological pH 7.4 
(uric acid has a pKa = 5.8). Most (95%) of it exists as the free form, but a small 
proportion is bound to albumin [119]. In most mammalian species, the hepatic 
enzyme urate oxidase (uricase) then rapidly converts urate into allantoin as the final 
step in purine degradation, keeping plasma urate levels to a minimal. Humans and 
apes have however lost uricase; a number of distinct mutations are known to have 
occurred over about 60 million years of evolution to eventually make uricase non-
functional [39, 120]. In addition, in humans the kidneys reabsorb > 90% of the filtered 
urate. As a consequence humans have a significantly higher plasma urate level, 
being at least 10-fold higher than in animals with uricase [116, 121]. Normal human 
plasma levels range between 50 and 900M [122], reaching a mean of about 350M 
in men. Since the solubility limit of sodium urate is about 420M [119], such an 
elevated level of urate in humans is associated with a significant risk of precipitation 
(gout, and urinary uric acid crystals). Yet it is believed that the evolutionary changes 
leading to an elevated plasma urate level occurred despite these risks because of the 
significant advantages associated with the potent antioxidant activity of urate. Urate 
is non-enzymatically degraded by various oxidants and is well known to be a potent 
antioxidant (see also Chapter 2). In 1981, Ames et. al. first suggested that by virtue 
of this antioxidant activity, the evolution of high plasma urate levels was 
advantageous by contributing to human longevity and a reduction in cancer rates 
[39].  
 
Unlike for plasma urate levels, data on urate levels in red cells is not available for any 
animal species other than for humans – in vitro experiments have shown that urate 
can enter the human red cell in the anionic form [123], most likely via the non-
selective band-3 protein membrane transporter [124]). Therefore, in humans, the 
presence of urate in the red cells is presumed to arise from entry of some of the high 
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paucity of plasma urate, together with the fact that the red cell supposedly lacks the 
enzyme XO/XD necessary to make urate (see below) seems to justify the 
assumption that urate levels would be negligible in the red cells from most 
mammalian species [125].  
 
In 1965, Al-Khalidi et. al. reported that the red cells of mammals lack the enzyme 
XO/XD necessary to make urate [22], and to date no-one has challenged this 
conclusion. These investigators measured XO/XD activity in both whole blood and 
serum samples, separately, from various vertebrate species including humans (n= 
40). In all the mammals that showed whole blood activity, they found that the serum 
activity was always approximately double that found in whole blood. Given that the 
haematocrit in most animals is very roughly almost 50%, they concluded that red 
cells of all mammals including humans do not contain substantial amounts of the 
XO/XD enzyme. Nucleated red cells from chicken, tortoise and turtle, in contrast, had 
significant XO/XD activity with their detection method.  
 
In view of the above points, the detection of urate in the red cells of horses is clearly 
fascinating. Investigation of urate levels in the red cells and plasma of horses and 
other mammalian species (as evaluated for tyrosine) was therefore undertaken. 
 
Humans (n=25) had a significant (although relatively variable) amount of urate in 
their red cells (Fig 16A), levels ranging from 23.7M to 214.5M, with a mean of 
117.5 + 39.7M, which is in agreement with the text book values of 113M [3] and 
130M [126]. Although red cell urate levels in horses (n=20) did not differ significantly 
from levels in human red cells (P = 0.5423), the range of urate levels in horses was 
huge, and skewed to the right. Thus whilst 50% of the horses had a red cell urate 
level of less than 50µM, the other 50% had levels ranging between 50µM and 
750µM, giving a mean of 181.4 + 231.3M, and a median [and interquartile range] of 
73.7 M [8.3 M – 284.4M]. None of the other mammalian species evaluated had 

































































































































Figure 16. (A) Urate concentrations in the red cells from various mammalian species, including humans. 
Horizontal bars indicate means. It should be noted that due to the highly skewed distribution of red cell 
urate in these horses, the median for red cell urate in horses was 74M, being much lower than the 
mean. The Mann Whitney test for non-parametric data was therefore used to determine P -values 
between horses and other species; otherwise the Unpaired t test was used. (B) Urate concentrations in 
the plasma from the same individuals as in (A). The Unpaired t test was used to compare plasma urate 
levels between the different species The Paired t test was used to determine P values when comparing 
plasma and red cell urate levels within a species. 
 
 
Furthermore, analysis of blood samples from four horses repeated on three different 
occasions over a month showed that baseline (i.e. not whilst racing) red cell urate 






Figure 17. (A) Red cell urate concentrations in three 
blood samples taken on different days from the 
same four horses, illustrating the significant stability 




Because the skewed pattern of distribution and stability of red cell urate was 
reminiscent of the skewed yet stable red cell tyrosine levels in horses (as reported in 
section iii above), levels of each of these two substances were compared in each 
horse; however no correlation was evident between red cell urate and tyrosine levels 
(Fig 18). Gender had no influence on red cell urate level (data not shown).  
 











































Figure 18. Comparison of urate and tyrosine in 
horse red cells (n=20). No correlation was evident 




Evaluation of plasma urate levels showed that, as expected, humans had a 
significantly higher mean level than that found in any other animal species evaluated. 
Human plasma levels ranged from 92.9M to 360.7M, with a mean of 238.1 + 
66.6M (Fig 16B above). As shown in figure 19, plasma and red cell levels of urate 
were well correlated in humans (open circles), with an average E:P ratio of 0.49 - this 
ratio and correlation have not been reported on before.  
 
                        





r = 0.0814 (P  = 0.7330)




























Figure 19. Comparison of the urate concentration within red cells and plasma for humans (open circles, 
n= 25) and horses (black circles, n=20). The Pearson test was used to determine statistical significance 
of correlation for humans, and the Spearman test for horses. 
 
 
In contrast with this correlation in humans, the extensively ranging red cell urate 
levels in horses showed no correlation whatsoever with plasma urate levels (Fig 19, 
black circles). As expected, because of the presence of uricase, the mean plasma 
urate level in horses, as for all the other species evaluated (Fig 16B above) was 
negligible, being 3.2 + 5.9M, with a range of 0-17M in horses, which is in 
accordance with a previously published range of 7.3-17.4M [115] and mean level of 
9.0 + 1.6M [116]. Similarly, the increases in red cell urate level found by Harley et. 





r = 0.2507 (P = 0.2864)
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al. in some horses post-exertion (Fig 15 above) could not be explained by the lesser 
increases in plasma urate level found in the same horses [64], and that are reported 
by others to be associated with physical exertion in horses [115, 127].  
 
It is possible that, as hypothesized to account for the elevated red cell tyrosine levels 
in horses, urate is being actively pumped from the plasma into the red cells of 
horses. However this would be occurring against a concentration gradient of more 
than 1mM in some horses, and would have to proceed very rapidly to account for the 
increased levels detected 1 hour post-exertion, as seen in the exercised horses of 
figure 15. Such a mechanism to explain the presence of high red cell urate levels in 
the horses is further unlikely since Harley and associates found that, in the presence 
of 500M urate in the incubation medium, whereas human red cells accumulated 
urate to a concentration of approximately 170M, the red cells from a horse showed 
no significant uptake [5]. Therefore, whilst all of the urate found within human red 
cells is by all accounts entering from the plasma, in horses significant amounts of 
urate are accumulating in the red cells by an active process which is highly unlikely to 
be related to plasma urate levels, particularly considering the negligible plasma urate 
levels in horses. 
 
The only other plausible explanation for the presence of urate in the horse red cells is 
that urate is actually being produced and then trapped within the red cells. For this to 
occur, active XO/XD enzyme (see also above) would have to be present in these red 
cells. Considerable variation in the distribution and level of XO/XD in tissues exists 
between species [118], and it is possible that as for urate riboside which is detectable 
exclusively in the red cells from bovines, that horses may be a unique species in 
having XO/XD enzyme activity in their red cells (horse red cells were not actually 
evaluated by Al-Khalidi). However, an alternative explanation is suggested by 
observations in various other tissue types: it was found that measures of XO/XD 
activity often do not reflect protein levels (as measured using antibodies or ELISA) 
because inactive forms of the enzyme exist in vivo – two forms of naturally-occurring 
inactive XO/XD enzyme are described - demolybdo-XO/XD lacks molybdenum (Mo), 
and in desulfo-XO/XD the Mo=S grouping, essential for catalytic activity, is replaced 
by Mo=O [128-130]. As much as 60% of purified bovine milk XO/XD is inactive 
towards xanthine [129]. In other tissues, the ratio of inactive to active forms varies 
significantly, and depends on the animal species and the specific tissue investigated 
[117]. However mammalian red cells were never re-evaluated for the presence of 
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mammalian species, may similarly have significant protein levels of inactive XO/XD 
within their red cells.  
 
The production of urate in the red cells is then proposed to occur when the inactive 
form of the enzyme in the red cells becomes activated via post-translational 
modifications under specific conditions. This is supported by studies using cell culture 
experiments which show that upregulation of XO/XD activity occurs not only at the 
transcriptional, but also at that post-transcriptional level in nucleated cells, 
(depending on the stimulus and tissue), and that such post-translational modifications 
may include the incorporation of Mo and also sulfuration reactions [117, 131]. 
 
A variety of factors such as hypoxia, various inflammatory cytokines, hormones etc. 
have been found to lead to increased levels of XO/XD activity in nucleated cells in 
vitro [117]. Increased XO/XD activity was reported in the lung tissue of a mouse 
model of acute viral pneumonia [132], and a 20-fold increase of enzyme activity (and 
30-fold increase in urate) was found in the brains of rats with induced bacterial 
meningitis versus healthy controls [133]. Urate levels were also elevated in the 
cerebrospinal fluid from patients with bacterial meningitis and other inflammatory 
brain diseases such as multiple sclerosis, viral meningitis and stroke [117]. The 
production of urate in skeletal muscle was shown to increase after submaximal 
exercise in fit humans [105]. The production of urate in brain and skeletal muscle is 
unexpected considering that normal human brain tissue and skeletal muscle have 
been shown by Sarnesto et. al (1996) to have no detectable XO/XD by western 
blotting [134], yet Hellsten et. al. (1997) showed that the number of xanthine oxidase 
structures observed by immunohistological methods in exercised muscle was up to 
eightfold higher than control from day 1 to day 4 after exercise. The increase was 
attributed to an enhanced expression of xanthine oxidase predominantly in 
microvascular endothelial cells - this again illustrates the potential for some tissues 
that don’t normally have detectable XO/XD to upregulate enzyme level/activity when 
required.  
 
What would be the advantage of having such a carefully regulated system of 
inducibility for XO/XD activity? Certainly compared with many other animals, only low 
baseline levels of XO/XD are present in most human tissues [117, 134]. XO/XD 
activity leads to the production of potentially damaging reactive species (superoxide 
and thus H2O2, nitric oxide and even peroxynitrite [117, 135]), and has been 
implicated in ischemia-reperfusion injury [136-139], although others feel that this is 
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Conversely, its involvement in normal physiological processes has been much less 
studied, and the fact that XO/XD activity is inducible infers some useful role of this 
enzyme under particular conditions. The fact that XO/XD is the only metabolic source 
of the protective antioxidant urate, the presence of which can limit oxidative damage 
[142, 143](see also Chapter 2), has generally been overlooked by investigators in the 
field [144]. As such, it is not surprising therefore that many of the above-mentioned 
conditions, where an increased XO/XD activity or urate level have been measured in 
tissues, are known to be associated with oxidative stress, and where an increase in a 
potent antioxidant would be clinically advantageous.  
 
Certainly it is known that organisms will often increase levels of their antioxidant 
defense systems in response to oxidative stress in an attempt to restore the 
prooxidant/antioxidant balance. For example, some yeast cultures exposed to H2O2 
for 30min showed significantly increased activities of the antioxidant enzymes 
catalase and superoxide dismutase (see also Chapter 2, Literature Review), although 
another strain of the same species showed no activation and its survival was much 
lower. Notably, whereas a certain concentration of H2O2 caused an increase in 
catalase activity, a higher concentration of H2O2 resulted in a decreased catalase 
activity in the same strain [145]. A single bout of exhaustive physical exertion is well 
known to induce in vivo oxidative stress and damage in various species including 
humans and horses [99, 101-103, 108, 146-149]. An increase in antioxidant enzyme 
activities has been observed in humans in association with acute physical exertion. 
For example, red cell catalase and glutathione reductase (GR) activities have been 
shown to increase during a long-distance cycling event in humans [108], although 
another study showed no increase in antioxidant enzyme activity [114]. Post-exertion 
increases in red cell antioxidant enzyme activities, including that of plasma XO/XD, 
have also been shown in horses [102, 150], although in other studies increases in 
red cell antioxidant enzyme activity were not found [151, 152]; this may be due to 
variations in study protocol. Plasma levels of urate are well known to increase after 
exhaustive exertion both in humans [105, 108, 153] as well as in horses [115, 127, 
150]. The increases in antioxidants all tend to return to pre-exertion levels within a 
few hours after the exertion. Of note is that the reported increase in plasma urate 
levels reported in horses (these being similar to that observed by Harley and 
coworkers (personal communication [64]) was considerably lower is highly unlikely to 
be able to account for the much higher post-race increases in horse red cell urate 
observed by Harley et. al. (2004) [4]. Rather, it is proposed that post-exertion 
increase in red cell urate levels seen in some horses occurred via increased 
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oxidative stress) [4]. The significant increase in circulating hypoxanthine which is 
associated with physical exertion [154], would most likely be an important 
contributing factor to the increased level of urate observed (both in plasma and red 
cells), by providing the substrate for XO/XD. The subsequent decrease in red cell 
urate level (usually within 24 hours) could be attributed to continued oxidation of the 
urate (to form allantoin) by the residual levels of circulating oxidants post-exertion.  
 
Baseline levels of antioxidant enzymes may also be increased with more prolonged 
or repeated in vivo exposure to mild-moderate oxidative stress, a process termed 
‘adaptation’. For example, rats exposed to daily bouts of restraint stress show 
elevated baseline red cell catalase and glutathione peroxidase activity [155]. The red 
cells from smokers (smoking induces oxidative stress [156, 157]) have higher 
catalase [158], superoxide and  GPx activity [159] than red cells from nonsmokers. 
The increased antioxidant levels may allow individuals to better tolerate mild-
moderate oxidative stress, although the increased level of antioxidant defenses are 
often not enough to completely inhibit oxidative damage. An 
‘overcompensating’/protective adaptive response is suggested to be the mechanism 
behind “body hardening”, defined by Siems et. al. (1994) [160] as “exposure to a 
natural, e.g., thermal stimulus, resulting in an increased tolerance to stress e.g. 
diseases”. The amount of oxidative stress induced by the stimulus would be such so 
as to not induce any significant oxidative damage, yet enough to stimulate an 
antioxidant response. An example of hardening is that induced by exposure to 
repeated intensive short-term cold stimuli, which increases oxidant production [8, 
160] – this is often applied in hydrotherapy. Siems et. al. showed that the baseline 
concentration of reduced GSH was increased and the concentration of oxidized GSH 
was decreased in the red cells of subjects who swim regularly in ice-cold water 
during the winter (winter swimming) as compared to those of nonwinter swimmers 
[160]. Ischaemic preconditioning would be another example of oxidant-stimulated 
hardening which protects against subsequent severe ischaemia-reperfusion oxidant-
induced damage [161].   
 
Relevant to the current study is that all the horses sampled in the current study, 
unlike the other mammalian animals sampled, were ‘professional’ athletes, and 
therefore extremely fit individuals. Regular controlled physical exercise/training, 
unlike strenuous/exhaustive exercise, may also induce ‘body hardening’. Increases in 
baseline antioxidant defenses are evident in the blood and/or muscle cells in humans 
[114, 162-164] and animals, including horses that undergo fitness training [165-170], 
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terms of general health. It is therefore possible that high, stable levels of red urate 
found in these horses, which had not taken part in any racing event for at least 1 
month prior to sampling, reflects an adaptive/hardening response in antioxidant 
defenses, via an increased level of baseline XO/XD activity in these fit individuals 
compared with the sedentary animals sampled. This could be the basis of future 
investigations. 
 
Notably, red cell urate levels in the 20 athlete horses of the current study were 
significantly higher (P = 0.0023) than pre-race levels in another 20 horses previously 
sampled by Harley and coworkers (unpublished work [5], as shown in figure 20).  
 
Figure 20.  Baseline urate concentrations in the 
red cells from the athlete horses, as sampled by 
Harley and co-workers in a previous study (n=20) 
(unpublished [5]), and those sampled in the 
current study (n=20). Horizontal bars indicate 
means. The Mann Whitney test for non-
parametric data was used to determine that there 
was a statistically significant difference between 
these two groups of horses (P  = 0.0023).  
 
The only difference between the horses from the previous study, and the horses of 
the current study was that the latter were ‘elite’-athletes (highly trained and 
competing race/endurance horses, awaiting exportation after having been sold for 
high prices). It is possible that the elite-athlete horses from the current study had a 
higher mean red cell urate level because they had a higher level of red cell XO/XD 
activity, perhaps induced by their special fitness regime.  
 
Despite the very high red cell urate levels in some of the elite athletes, the variance 
was large, with some of these horses having almost undetectable levels of red cell 
urate. Since they were all being housed in the same quarantine facility, with the 
identical diet, such environmental contributing factors could be excluded. Genetic 
factors were considered. Horses are a species that seem to show much 
heterogeneity in the transport of substances across their red cell membranes, for 
example, as mentioned earlier, in amino acid transport. Relevant here is the report by 
Jarvis et. al. (1998) that horses show significant heterogeneity in the inward transport 
of hypoxanthine into their red cells, with 15% of Thoroughbred horses tested (n=25) 
failing to transport hypoxanthine [26]. This could be a reason why some of the elite-
athlete horses had no detectable urate in their red cells. It is also possible that 
transport of urate out of the red cell may also show individual variation. Alternatively, 
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heterogeneity in protein levels of red cell XO/XD may exist. Kirschvink et. al. (2006) 
evaluated blood oxidant/antioxidant status in thoroughbreds, standardbreds and 
jumping horses and concluded that breed, gender and age were all influencing 
factors [171]. Red cell urate levels in the Arabian-Crossbred versus the 
Thoroughbred horses were thus compared in order to determine what influence, if 
any, horse breed had on the variability seen (Fig 21), but levels of red cell urate 
between these two breeds were not significantly different.  
 
Figure 21. Red cell urate levels in the elite athletes 
horses of figure 20, now separated by breed into 
Thoroughbred (n=8) and Arabian-Crossbred (11). 
Horizontal bars indicate medians. The difference 
between the two groups was not statistically 




In order to determine if red cells with higher levels of urate were more resistant to 
H2O2-lysis, the red cells from horses with varying levels of urate were exposed in 
vitro to H2O2- and AAPH-induced oxidative stress - no correlation was found between 
urate level and resistance to lysis (data not shown). However, an unexpected and 
striking difference in red cell susceptibility to lysis was found between the Arabian-
Crossbred and Thoroughbred horses, with the red cells from the Arabian-Crossbred 
horses being much more resistant to H2O2- and AAPH-induced lysis than the red 
cells from the Thoroughbred horses (Fig 22).  
 
Notably, the Thoroughbred horses were all trained for sprinting events (racehorses), 
whilst all the Arabian-Crossbred horses were endurance-trained athletes - this seems 
to fit in with the study by Kinnunen et al. (2005) reporting that, compared with trotters, 
endurance-trained horses had higher baseline activity of some red cell antioxidant 
enzymes and higher baseline total antioxidant capacity. These investigators reported 
that, unlike the trotters, the endurance horses did not show evidence of increased 
oxidative stress after exhaustive exertion, although they had higher baseline levels of 
oxidative stress compared with the trotters [172]. Marlin et. al. (2002) also found 
endurance horses to exhibit much lower signs of oxidative stress and oxidative 
damage than anticipated after a prolonged bout of exhaustive exercise [115]. It is 
possible that endurance training induces a greater adaptive antioxidant response 
than the training used for racehorses. However, since endurance-trained horses are 
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factor is a greater influence in the resistance of this group of horses to episodes of 
acute oxidative stress: genetics or training mode?   
 
 





























   


















































Figure 22.  Red cell suspensions (1% Hct) from four Thoroughbred (black, purple, green, dark blue) and 
four Arabian-Crossbred horses (red, pink, orange, light blue) were exposed to 50mM H2O2 (in PBS, at 
37oC), and the supernatants evaluated for haemolysis after (A) 1 minute, (B) 1 hour and (C) 20 hours. 
(D) Suspensions of the red cells from two of these Throroughbred horses and one of the Arabian-
Crossbred horses were also incubated with 20mM AAPH, and the supernatants evaluated after 1 hour. 
(E) Total triton-X-induced haemolysis of a suspension of red cells from each of the eight horses. 
 
 
Next, a literature search was performed, and two reports found to support the idea 
that human red cells must have significant levels of XO/XD protein. Kaynar et. al 
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known red cell antioxidant enzymes, in healthy human subjects versus lung cancer 
patients. They reported that, in addition to having elevated red cell catalase activity, 
the red cells of the cancer patients had significantly increased XO/XD activity 
compared with the red cells of the healthy subjects, which had very low but 
nevertheless measurable XO/XD activity [173]. Since red cells cannot synthesize 
new proteins, the increased activity of red cell XO/XD seen in these patients implies 
that much inactive XO/XD protein is present in healthy human red cells - surprisingly, 
these investigators made no reference to Al-Khalidi’s conclusions, and to the fact that 
their results challenged the dogma. 
 
The other report supporting the presence of XO/XD in human red cells is by Tavazzi 
et. al (2000) [174]. These investigators exposed a suspension of washed, catalase-
inhibited (1mM NaN3) human red cells (5% Hct) to increasing concentrations of H2O2 
(0-10mM, in phosphate buffer with 10mM glucose). They found an H2O2-
concentration-dependent decrease in ATP, accompanied by an increase in IMP (see 
below), inosine, hypoxanthine, as well as xanthine and urate!! Again, surprisingly, 
these investigators made no mention of the fact that red cells do not supposedly 
have the machinery to make xanthine and urate from hypoxanthine, but their results 
indicate that horses are not unique amongst mammals in having the potential to 
produce urate within their red cells.  
 
The above-mentioned report by Tavazzi et. al. highlights the possibility that red cell 
XO/XD may also be activated by a single exposure to in vitro or in vivo oxidative 
stress (such as with an exhaustive bout of exercise). However, on attempting to 
replicate the Tavazzi experiment (for this thesis), despite finding an H2O2-
concentration-dependent increase in hypoxanthine and decrease in ATP level, no 
urate or xanthine became detectable, even at the highest H2O2 concentration. An 
opportunity then arose to examine the red blood cells of rats being forced to undergo 
exhaustive physical exertion. None of the rats however showed any red cell urate 
production at any of the various time points evaluated after the stressor (data not 
shown). These findings point rather that XO/XD activity in red cells may only increase 
detectably on repeated or chronic exposure to oxidative stress (an adaptive-type 
response). It is hypothesized that red cell basal XO/XD activity in the blood donor in 
Tavazzi’s study might have been greater than in the red cells from the donors used in 
the current study (fitter individuals, or smokers possibly used in the Tavazzi study?). 
Tavazzi et. al. subsequently found that, whereas AMP deaminase (see Fig 2, 
Literature Review and Background Work) from other mammalian cells is 
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red cells is activated by exposure to H2O2 [175], explaining how xanthine and 
hypoxanthine were formed in their earlier study. Therefore, under conditions of 
oxidative stress, the benefit of providing substrate to produce urate in the red cell 
under conditions of oxidative stress may be considerably greater than in other cell 
types (see also Chapter 3). 
 
(v) Free tryptophan: inter- and intraspecies variation 
On comparison of the reverse-phase HPLC profiles of the red cells from the various 
mammalian species, as illustrated in figure 11 of section iii, further species-specific 
differences in the size of three other peaks were observed. The identities of the LMW 
substances responsible for these peaks were initially determined by their shared 
characteristics with known substances present in the standards mix. Support for a 
suspected identity was always provided by co-elution with a standard solution of that 
substance.  
 
Species differences in tryptophan levels were evident for both red cells and plasma. 
A visibly higher level of free tryptophan was present in the red cells of some species 
compared with humans. Tryptophan, as for tyrosine, is a phenolic, UV-absorbing 
amino acid. As for tyrosine, although it has numerous well-described physiological 
roles in nucleated cells, none of these roles are apparently present in the red cell. 
Significantly however, although little mentioned in the literature, is that tryptophan 
and its oxidative metabolites have also been shown to have in vitro antioxidant 
activity [132, 176] (see Chapter 2); however, a physiological role in antioxidant 
defense has not been suggested before. 
 
In human red cells, the mean free tryptophan level was 7.5 + 1.6M (Fig 23A). 
Beutler’s 2001 textbook value is given as 24 + 4M [3], but this value is referenced 
from publications dating from the 1950’s and 1960’s. Another report found that 
tryptophan was observed only irregularly in whole blood and washed red cells [83]. 
Such discrepancy may be because different washing protocols for the red cells were 
used, and as for tyrosine, tryptophan may be easily lost from the red cells in the wash 
steps [83].  
 
As for tyrosine, tryptophan levels in the red cells from many of the other species 
evaluated were significantly higher compared with human levels, with horses and 
buffalo having a 5-fold, and cows having a 7-fold higher red cell tryptophan level. 
Notably, although tryptophan levels were in a much lower range than tyrosine levels, 
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distribution (compare with Fig 12A, section iii). In other words, the same animal 
species that had high red cell tyrosine levels relative to humans also had elevated 
red cell tryptophan relative to humans. Since tryptophan and tyrosine transport into 
human red cells, occurs via both the L-system and the aromatic amino acid-specific 
T-system [92, 177], heterogenous expression or activity level of these transport 
systems amongst different species may be one explanation for the similar trend of 









































































































































Figure 23. Tryptophan concentrations in the (A) red cells and (B) respective plasmas from various 
mammalian species, including humans. Horizontal bars indicate means. The Unpaired t test was used to 
determine P values to compare tryptophan levels between species. The Paired t test was used to 
determine P values when comparing plasma and red cell tryptophan levels within species. 
 
 
However, in contrast with what was found for tyrosine, the mean plasma tryptophan 
level (Fig 23B) was at least equivalent or higher than the respective mean red cell 
level for each species, (except for cows and buffalo, see below). The mean plasma 
tryptophan level in humans was 56.2 + 18.7M (which compares well with a previous 
report of 45 + 9M [83]). Horses and particularly rats had the highest plasma 
tryptophan levels. The elevated plasma levels in these animals may be due to dietary 
factors - for example, horse diets are often supplemented with tryptophan because of 
its calmative properties [178], and this has been shown to increase plasma 
tryptophan levels [179]. However, despite the high plasma tryptophan levels, rats had 
red cell tryptophan levels similar to human levels. Therefore mean E:P tryptophan 
ratios (as for tyrosine) varied significantly between species. Most interestingly, 
whereas levels in the red of this essential amino acid cell were generally lower than 
the respective plasma level, this was not the case for cows and buffalo. In these two 
related species, red cell tryptophan levels were significantly greater than the plasma 
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Surprisingly, red cell tryptophan levels in cows (Fig 24A) and buffalo (not shown), as 
for humans (Fig 24B), correlated positively with plasma levels, with an E:P ratio of 
1.4, 1.7 and 0.15 respectively. In contrast, red cell levels in horses (Fig 24C) and 
sheep (Fig 24D) showed no correlation with plasma levels.  
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Figure 24. Comparison of the tryptophan concentration within red cells and of plasma for (A) cows, (B) 
humans, C) sheep and (D) horses. The Pearson test was used to determine statistical significance of 
correlation, except in (D) where the Spearman r was determined. 
 
 
Therefore, whereas in humans (and all the other non-bovid species evaluated, 
particularly rats) there appears to be a relatively restricted entry of plasma tryptophan 
into the red cells, the red cells from cows and buffalo seem to accumulate 
tryptophan, analogous to the accumulation of tyrosine in the red cells of some other 
species. This accumulation is plasma-level dependent. Such active uptake is likely to 
utilize a significant amount of the red cell’s energy, implying an active role for the 
elevated tryptophan (and tyrosine) levels in the red cell.  
 
(vi) NAD(H) and NADP(H): inter- and intraspecies variation 
In addition to the pronounced interspecies variability in red cell levels of urate 
riboside, urate, tyrosine and tryptophan, levels of the major electron-transfer 
substances NAD(H) (Fig 25A) and NADP(H) (Fig 25B) were also highly variable 
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many of the species evaluated appearing to have much higher levels than seen in 
human red cells.  
 
It is necessary to note that, although these co-enzymes exist in vivo both in an 
oxidized and reduced form, acid extraction of the red cell contents leads to complete 
oxidation of all the NADH and NADPH. Therefore, although only NAD+ and NADP+ 
(oxidized forms) are present in the extracts, as represented by figures 25A and B, 




















































































































































Figure 25. (A) NAD+ and (B) NADP+ concentrations in the red cells from various mammalian species, 
including humans. Horizontal bars indicate means.  
 
 
Surprisingly little comparative data is available on levels of NAD(H), and even less on 
NADP(H) within red cells. In this study, the mean level of NAD+ in human red cells 
was 94.2 + 2.6M - this compares with a previous report by Harkness et. al. (1969) of 
70M NAD in human red cells [27], and another relatively more recent report by 
Micheli et. al. (1993) of 50.8 + 7M for combined reduced and oxidized NAD(H) in 
human red cells [180]. The mean level of NAD+ in sheep red cells was almost 4-fold 
greater than in human red cells, with similarly high levels in rats and naked molerats. 
Our finding that both rats and sheep have higher mean levels of NAD(H) than the 
other species, being 345M and 383M respectively, is in accordance with another 
published report comparing levels in the red cells of rats and sheep with those from 
horses, rabbits and guinea pigs using a spectrophotometric assay [181]. The only 
other report found to compare NAD levels amongst various mammals was the study 
by Harkness et. al. in 1969 using low resolution chromatography [27]. Although these 
investigators did not measure levels in sheep or rats, they found similarly high levels 
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clearly had higher concentrations of NAD(H) than was present in the human red 
cells, rat and human fibroblasts did not show such a difference in NAD(H) levels 
(HPLC profiles not shown). 
 
Although red cell extract levels of NADP+ also varied between species, the difference 
in mean level of NADP+ between the species with the lowest (buffalo) and the highest 
(naked molerat) level was only 2.5-fold, this being much less than the variation for 
NAD+ which was almost 8-fold. No other reports comparing NADP(H) levels in 
different animals were found. The NADP+ and NAD+ levels clearly did not correlate. 
As expected, no NAD+ or NADP+ was present in the plasma extracts (see Fig 11, 
section iii).  
 
New molecules of both NAD+ and NADP+ can be synthesized through a salvage 
pathway in the red cell, whereby NAD+ is enzymatically synthesized from nicotinic 
acid and PPRP. After attachment of AMP, glutamine provides an amino group for 
completion of the synthesis of NAD+. Enzymatic phosphorylation of NAD+ by ATP 
then forms NADP+ [1]. Large oral doses of nicotinic acid have been shown to promote 
an increase in NAD+ (but not NADP+) concentration in human red cells [182], so it is 
at least theoretically possible that differences in NAD(H) levels within the red cells of 
different species may reflect differences in dietary nicotinic acid intake; this would 
however not explain the large intraspecies difference found in NAD(H) level in sheep 
red cells since they all came from the same herd. Notably, tryptophan is a precursor 
molecule for nicotinic acid, and rats had particularly high plasma tryptophan levels 
(presumably diet-related) (see Fig 23B, section v). Rats may thus have large 
amounts of nicotinic acid formed in their plasma. On the other hand, plasma 
tryptophan levels were relatively low in sheep, and thus are unlikely to explain the 
elevated NAD(H) in this species. Alternatively the differences in interspecies 
differences in NADH level may be genetic, having been induced by different species 
requirements of this important antioxidant within the red cell. The much more 
consistent levels of NADP(H) amongst mammalian species, and the fact that 
changes in NAD+ production do not influence NADP+ production may reflect that 
maintenance of NADP(H) levels within a narrower range is more crucial to survival. 
 
(vii) Inter- as well as intraspecies variability in red cell LMW substances at a 
spectrophotometric glance 
A simple and rapid spectrophotometric diode array scan (absorbance spectrum 
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more striking differences evident in the red cell extracts of some mammalian species 
(Fig 26).  
 
Figure 26. (A) Characteristic absorption 
profile of diode array scans of the red cell 
acid extracts of human (black), cow (green) 
buffalo (red) and horse (blue). The dashed 
blue line is the extract from a horse that was 
shown on HPLC to have a large 
concentration of both urate and tyrosine 
(horse C in Fig 9). Maximum absorption for 
urate riboside is 297-298nm, whilst that for 
urate is 293nm. A nanodrop (Qiagen) was 
used, pathlength = 1mm. 
 
(B) Diode array scans of standard solutions 
of tyrosine (dashed), urate (solid) and ATP 
(dotted) (100M each in phosphate buffer, 
pH 7.4). Note that due to the significantly 
lower extinction coefficient of tyrosine 
compared with urate, ATP and many other 
LMW substances, that even large amounts of 
tyrosine in an extract may at first glance be 
significantly underestimated when observing 




The fact that the spectrophotometric diode array pattern of red cell extracts varies so 
significantly between some animals may enable this method to provide a forensic tool 
for an initial rapid determination of whether blood is of human origin or not. 
 
Possibly even more useful is that a single absorbance reading of cow and buffalo red 
cell extracts measured at 298nm correlates significantly with the respective urate 
riboside HPLC peak area (measured at 280nm) (Fig 27A), since urate riboside 
completely dominates the HPLC profile at this wavelength. Smith et. al. (1981) 
quantified urate riboside in cow red cells by extrapolation from a spectrophotometric 
reading [84], and this same method was used in the current study.  
 
Similarly, in the current study it was further shown that single absorbance readings of 
horse red cell extracts at 293nm correlate significantly with the respective urate 
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HPLC peak areas (measured at 280nm) (Fig 27B). Tyrosine level could not however 
be determined using a single spectrophotometric reading. 
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Figure 27. Comparison of a single absorbance reading versus HPLC peak area (measured at 280nm) 
for (A) urate riboside (single reading at 298nm), and (B) urate (single reading at 293nm). A nanodrop 




Thus a single spectrophotometric reading, as opposed to HPLC, may be used as a 
simpler, more rapid and cost-effective method to determine levels of some of these 
substances in acid extracts. This may be particularly useful if levels of these 












Chapter 1: Summary                                                                                                                                        - 63 -  
(E) SUMMARY  
Using ion-exchange HPLC, interspecies differences in the variety and levels of UV-
absorbing LMW substances within red cells have previously been reported to exist. 
For example, many mammalian species have significantly lower levels of red cell 
ATP compared with humans. However the identities of some unretained substances 
responsible for large early-eluting peaks seen on ion-exchange HPLC of red cell 
extracts from some species were never determined. In order to begin to clarify some 
of these evolutionary differences, a combination of anion-exchange and reverse-
phase HPLC was used to determine the identity of the LMW substances accounting 
for some of the species-specific variability in red cell profiles. Levels of these 
substances in the red cells and plasma of the various mammalian species were 
determined, and are summarized in table 2 below. 
 
Compared with levels in human red cells, high levels of tyrosine were found in the 
red cells not just of the Perissodactyla Order, as was anticipated, but also in various 
other mammalian Orders (Carnivora and some Artiodactyla). In the red cells of the 
same species, levels of tryptophan were also significantly higher than for humans. 
Urate riboside was the prominent peak in the red cells from cows and buffalo and 
seems to be specific to the Bovinae Subfamily. Its absence in both the plasma and 
fibroblasts from these animals indicates that its formation is likely to be limited to their 
red cells. The red cells from sheep, rats and naked molerats had particularly high 
levels of NAD(H) (which is not present in plasma) relative to the red cells from the 
other species, whereas NADP(H) showed less interspecies variation. The red cells 
from horses were particularly interesting; in addition to having high levels of tyrosine, 
horses were the only mammalian species (other than humans) to have urate in their 
red cells, with extraordinarily high levels (800M) found in the red cells of some 
horses. Unlike for humans where red cell urate may be explained by the high urate 
levels, plasma levels of urate in horses were negligible (as expected), and could not 
therefore account for the high levels of red cell urate in this species. Similarly, plasma 
levels of tyrosine were very similar and low across all mammalian species, and could 
not account for the very high levels of tyrosine found in the red cells of some species. 
In cows and buffalo, red cell levels of tryptophan were also higher than plasma 
levels. Therefore, it may be concluded that the red cells of these mammalian species 
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Table 2. The mean levels of various soluble antioxidants found in the red cells/plasma (where 
applicable) from various mammalian species relative to levels in human red cells (set as the 100% 
control), as determined from the reverse-phase HPLC profiles. In brackets are the actual concentrations 
(M) of these substances. Where levels are greater than that present in human red cells/plasma, these 
are highlighted in blue. Urate riboside is not included because it is undetectable in all species other than 
Bovinae. 
 Tyrosine Tryptophan Urate NAD(H) NADP(H) 














































































































Note: $ Because of the skewed data, these values significantly underestimate the very high levels 
            present in some horses.  
          * This value in 8 black rhinoceros was 778.8M, and 1145% that for humans [2]. 
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Whereas evolutionary adaptations are likely to explain most of these interspecies 
differences in red cell LMW substances, the accumulation of large amounts of urate 
in the red cells of horses is thought to reflect an inducible biochemical pathway of 
urate production which may be common to the red cells of many, or even possibly all 
mammals - it is proposed that mammalian red cells have inactive XO/XD enzyme, 
which may become activated, and even upregulated under certain conditions, 
including regular physical exertion as in the case of the athlete horses sampled for 
this study. 
 
The unexpectedly large degree of intraspecies variation in red cell levels of some of 
these substances, particularly of tyrosine and urate in horses, and urate riboside in 
cow/buffalo reflects significant intraspecies genetic heterogeneity for the ability to 
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CHAPTER 2 
Investigating a role for free tyrosine and tryptophan in 





In Chapter 1, some of the differences in the variety and level of red cell UV-
absorbant, low molecular weight (LMW) substances amongst mammalian species 
were clarified and quantified. High levels of free tyrosine and tryptophan, as well as 
NAD(H), NADP(H), urate and urate riboside were shown to be accumulating in the 
red cells of some species. It is logical that red cells would only make use of their 
limited energy supplies to synthesize/accumulate such substances if this served a 
useful physiological role. Urate and NADH both have well-established antioxidant 
functions, although an antioxidant role for urate within red cells has never been 
suggested. Urate riboside, a LMW substance unique to the red cells of some bovids 
(see Chapter 1, Background Work and Literature Review), has been shown to have 
similar in vitro antioxidant properties to urate [36-38].  
 
Specifically within the mature, anucleate mammalian red cell, elevated levels of 
tyrosine and tryptophan would not be required for protein synthesis. Although these 
amino acids also serve as precursor molecules for acetyl-CoA and various other 
specialized biomolecules such as melanin, epinephrine, thyroxin, and serotonin 
[183], neither the Krebs cycle nor any of the other specialized biochemical pathways 
are represented in the mature red cell. Could the significant accumulation of free 
tyrosine and tryptophan in the red cells of some mammalian species be 
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(B) LITERATURE REVIEW 
 
Reduction-oxidation (redox) reactions occur continuously as part of an O2 -rich (21%) 
environment for both biotic and abiotic processes, for example the (abiotic) rusting 
process. Although O2 is poorly reactive with most biological molecules, oxidation 
reactions do nevertheless occur in biological organisms, thought probably to involve 
the presence of transition metal ions. The more reactive superoxide (O2·
) free 
radical is produced, which will then further accelerate the oxidation process [8]. The 
simplest defense to limit such non-specific oxidation reactions is to reduce O2 
concentration within the organism. In complex organisms such as mammals, the 
circulating red blood cells safely deliver a minimum intracorporeal amount of O2 to 
the peripheral tissues by regulating its release from haemoglobin (Hb) as required. 
 
Many reactive species (RS), including reactive oxygen species (ROS) such as O2·
, 
reactive nitrogen species (RNS) and reactive chlorine species (RCS) are however 
generated ‘deliberately’ under physiological conditions within cells. One of the largest 
sources of RS in most nucleated animal cells is the respiratory chain in the 
mitochondria that converts molecular O2 to water. A few percent of O2 molecules 
continuously leak from the electron transport chain as O2·
, which will then form 
hydrogen peroxide (H2O2) enzymatically, or by spontaneous dismutation. This 
process alone results in a substantial basal level of oxidants in vivo. Although the 
mammalian red cell is spared from producing mitochondrial-derived O2·
, a low 
continuous flux of O2·
 and hence H2O2 is produced within the red cell via the auto-
oxidation of oxyhaemoglobin (oxyHb) to methaemoglobin (metHb) - approximately 3-
4% of the oxyHb is estimated to undergo auto-oxidation every day [184, 185].  
 
Investigation of the physiological role played by H2O2 and other RS in intracellular 
signaling via redox reactions is a rapidly developing field [8, 186, 187]. The RNS, 
nitric oxide (NO·), is synthesized within various cells by the NO· synthase enzymes 
and has many important physiological roles [8]. The enzyme xanthine 
oxidase/xanthine dehydrogenase (XO/XD) (see Chapter 1, Results and Discussion, 
section iv) can produce O2·
 , thought to play a role in defending the gastrointestinal 
tract against pathogens [188]; XO/XD also produces NO· [189]. Phagocytic cells 
produce large amounts of intracellular O2·
 via NADPH oxidase during the respiratory 
burst, and this O2·
 has been shown to be crucial in the eradication of certain 
bacteria. Hypochlorous acid (HOCl) is produced in activated neutrophils by the heme 
enzyme myeloperoxidase (MPO) through chlorination of H2O2 [109]. Although HOCl 
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questioned [190]. RS such as H2O2 and NO· produced within cells readily move 
across membranes into the extracellular fluid and plasma [8, 191], and HOCl is 
released into surrounding tissues during an inflammatory reaction. The O2·
 radical 
however does not readily cross biological membranes unless specific channels exist 
[8], such as the anion channel of the red cell [192].  
 
Although O2·
 and H2O2 themselves react relatively slowly with most biological 
molecules, reaction of O2·
 and H2O2 with other molecules to form more highly 
reactive RS leads to significant cellular damage. Such oxidative damage has been 
implicated as a primary or at least contributing pathophysiological factor in a wide 
range of disease processes [8]. For example, H2O2 will react with unbound transition 
metal ions, especially iron, manganese and copper ions via Fenton chemistry to form 
the highly oxidising hydroxyl radical (OH·). The OH· radical reacts with a wide range 
of molecules and will damage DNA, proteins and lipids. Carbon-centered radicals 
may be formed (eg. in lipid membranes) on reaction with OH·. These carbon radicals 
can then combine with O2 to form peroxyl radicals, which themselves oxidize 
adjacent lipids, thus initiating the propagation of lipid peroxidation [8]. Peroxyl radical 
formation and peroxidation of proteins also occurs in vivo [193-195]. Similarly, the 
reactivity of the physiologically important NO· molecule is greatly enhanced by its 
rapid reaction with O2·
 to form peroxynitrite (ONOO-), which can lead to both the 
oxidation and nitration of various susceptible biological molecules [196]. HOCl is a 
highly reactive oxidizing and chlorinating species, and has been shown to be 
involved in causing inflammation-associated cellular damage [109, 197]. Singlet 
oxygen, formed on photosensitisation of some molecules which then transfer the 
excitation energy to an adjacent O2 molecule, can be highly damaging and plays a 
large part in the aging process (especially in the skin and eye). It may also be 
produced in activated neutrophils [8]. In addition to being formed endogenously, 
various damaging RS may be also be derived exogenously (eg. oxidant drugs).  
 
In order to survive an oxidizing environment, aerobic organisms have necessarily 
evolved an array of antioxidant defense mechanisms. A “disturbance in the 
prooxidant-antioxidant balance in favour of the former”, is the classic definition of 
‘oxidative stress’ by Sies (1991) [198], and is most usually initiated by an increased 
level of RS. Oxidative stress can eventually lead to oxidative damage, including cell 
death, if adaptation by upregulation of the antioxidant defenses does not re-establish 
the prooxidant-antioxidant balance. The new simplified definition of an antioxidant 
according to Halliwell and Gutteridge (2007) [8], two names well-known in the field of 
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damage to a target molecule”. The term antioxidant defense thus encompasses 
many different substances that all ultimately serve to limit oxidative damage.  
 
Antioxidants may be classified in various ways [8], including whether they are 
proteins or LMW antioxidants. The antioxidant proteins may perform their role 
enzymatically or non-enzymatically. Proteins such as transferrin and ferritin act by 
decreasing the formation of damaging RS; they sequester and thus minimise the 
availability of pro-oxidant iron ions within plasma and nucleated cells respectively. 
Other proteins such as albumin can act as antioxidants by scavenging various RS.  
 
Three enzyme processes, namely superoxide dismutase (SOD), catalase and the 
glutathione peroxidase (GPx)/reduced glutathione (GSH) system are responsible for 
the catalytic removal of O2·
 and H2O2. The SOD family of enzymes is responsible for 
removing O2·




 + 2H+  → H2O2 + O2 
 
The SOD enzymes are present in almost all eukaryotic cells [8]. Copper and zinc-
containing SOD is located mainly in the cytosol and is composed of two protein 
subunits, each of which has one copper and one zinc ion at the active site. 
Manganese-containing SOD (from higher organisms) is composed of four protein 
subunits, and contains manganese at its active site. It is located largely in the 
mitochondria. Both SODs are also present in the peroxisomes of cells [199]. The 
selenium and manganese ions at the active sites of these SODs catalyse the 
dismutation reaction by undergoing alternate oxidation and reduction [8]. 
 
Catalase and GPx then both function to remove the H2O2 (GPx can also remove 
organic peroxides [200]). Catalase is present in the cytoplasm, peroxisomes and 
nucleus of eukaryotic cells [199]. Especially high levels of this enzyme are present in 
liver and red blood cells [8]. Catalase contains four subunits, each of which has a 
Fe(III)-haem at its active site [201]. As shown in the reaction below, catalase donates 
2 electrons to reduce one H2O2 molecule and forming compound I, where the iron is 
an Fe(IV) species with an additional electron having been removed from the 
porphyrin ring to form a porphyrin-cation radical (haem·+), and sometimes referred to 
as +heme-Fe(V)=O [9]. Compound I then receives 2 electrons from another H2O2 
molecule to return to its ferric state (the H2O2 is oxidized to water and oxygen in this 
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catalase Fe(III)  + H2O2 → compound I + H2O 
 
compound I + H2O2 → catalase Fe(III) + H2O + O2 
-------------------------------------------------------------------- 
Net : 2H2O2 → 2H2O + O2 
 
The catalytic rate of mammalian catalase activity is amongst the highest of the known 
enzymatic rates [202]. Catalase activity is proportional to the H2O2 concentration over 
a wide range of the latter i.e. it is efficient at high H2O2 concentrations, but slower at 
destroying low concentrations of H2O2. Certainly catalase appears to be essential for 
protection against higher levels of H2O2 - acatalasemic red cells are very sensitive to 
exogenous H2O2 [203]. The finding that metHb levels in acatalasemic red cells from 
both humans [203] and mice [204] are normal supports the proposal that catalase 
has a limited role to play in unperturbed red cells. During exposure to lower 
concentrations of H2O2, slower peroxidatic reactions of catalase are noticeable, and 
the one-electron reduction of compound I can also form inactive catalase (compound 
II). In this way, exposure to H2O2 that is generated at a constant rate, catalase can 
reach a steady state in which much of it is inactive. One role of bound NADPH may 
be to help maintain enzyme activity by acting as a preferred electron donor to 
compound I under conditions where H2O2 supply is limited. NADPH may also 
reconvert compound II to active catalase [202].  
 
The GPx family of enzymes is widely distributed in animal tissues, and is present in 
all cellular compartments [199], with especially high levels present in liver and kidney 
tissue. At least four types exist - cytosolic GPx (GPx1), is the classical enzyme, while 
another type of GPx (GPx2) is present in the cells lining the gastrointestinal tract as 
well as liver cells. GPx3 is present in plasma. GPx1-3 are each composed of four 
protein subunits, each of which bear an atom of selenium (present as 
selenocysteine) at the active site [8]. The GPx enzymes, unlike catalase, follow 
Michaelis-Menten relationships and efficiently remove low concentrations of H2O2, as 
well as organic peroxides, by coupling reduction of these RS with the oxidation of the 
cofactor GSH to form GSSG [207]. It has been proposed that the primary 
physiological role of GPx lies in its ability to detoxify organic peroxides [205, 208]. 
 
H2O2 + 2GSH   →   GSSG + 2H2O 
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The GSH cofactor, a tripeptide, is synthesized in the cytoplasm of all animal cells, the 
liver being the most active organ [8]. High levels of GSH are present intracellularly 
eg. 2mM in the red cells [1]. Catalase activity is also dependent on the reducing 
potential of its attached reduced NADPH cofactor [209], which can provide the 
required 2 electrons to compound I when H2O2 levels are low, so as to limit formation 
of the inactive compound II [8]. Hence, maintenance of an adequate baseline level of 
the reduced forms of the LMW cofactors GSH and NADPH via the hexose 
monophosphate (HMP) shunt (see below) is crucial to the adequate functioning of 
the 2 main H2O2-removal systems in cells. In the red cell (Fig 28), the continuous 
removal of H2O2 is particularly necessary because the auto-oxidation of OxyHb is 
accelerated by H2O2, as well as by various other oxidants. Excessive MetHb 
formation leads to reduced oxygen-carrying capacity, and haemoglobin denaturation, 
precipitation and cell lysis may occur if red cells are exposed to sufficient oxidative 








































Figure 28. Schematic representation of O2·
- and H2O2 - neutralising pathways within the red cell. All 
reactions, other than oxyhaemoglobin auto-oxidation and reduction, also occur in other cell types. The 
source of O2·
- and H2O2 in nucleated cells is mainly from the respiratory chain in the mitochondria.  




Oxidised NADP+ is reduced back to NADPH via the HMP shunt (see also Fig 1, 
Chapter 1). In turn, NADPH serves to provide the electrons for the reduction of 
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therefore continuously cycled between the oxidized and reduced forms without being 
consumed. The balance (ratio) between the oxidised and reduced forms of these 
substances is an important component of what is termed the redox state of cells 
[212]. Under physiological conditions, most (up to 99%) of the cellular glutathione 
exists in the reduced GSH form [8]. Similarly, the NADP+/NADPH ratio is 
approximately 0.04 in human red cells [180] (and about 0.005 in other mammalian 
tissues [213]). Regulation of glucose flux through the HMP shunt is dependent on the 
availability of NADP+ [1, 15], but is also inhibited by NADPH [214]. Any oxidant 
substance/drug that oxidizes GSH, and hence increases the NADP+/NADPH ratio, 
will stimulate the shunt. In the normal red cell, the rate of the HMP shunt can be 
increased significantly by shunt activators [40], and by as much as forty-fold [215].  
 
As shown in figure 28, NADH plays a vital role in the red cell as the main electron-
donating cofactor for the reduction of metHb back to Hb via methaemoglobin 
reductase (MR), although NADPH can function as an alternative cofactor [216]. The 
oxidised form, NAD+, is reduced back to NADH via glycolysis. In contrast with the 
NADP+/NADPH, the NAD+/NADH ratio in healthy mammalian tissue has been 
reported to be around 1 [212]. However within red cells (human), the ratio is 
approximately 27 [180]. Therefore in the red cell specifically, low levels of the 
reduced form relative to the oxidized form are maintained, this however obviously 
being sufficient to provide the electrons for the critical reduction of metHb, which is 
maintained so as to account for only 1% of total Hb [217]. In fact, any surplus NADH 
in the red cell is oxidised back to NAD+ by the reduction of pyruvate to lactate, this 
being the major product of glycolysis in red cells under normal circumstances [1].  
 
Extracellular fluids including plasma contain little or no catalase activity. Only low 
activities of SOD and GPx (the GPx3 form only) are present in plasma [218] and in 
some extracellular tissues such as in seminal plasma [219, 220], the extracellular 
tissues of the eye [8, 221] and the mucus linings of the respiratory and intestinal 
tracts [8]. Therefore unlike within the intracellular environment, extracellular fluids 
including plasma do not have significant O2·
- or H2O2- removing capacity. Levels of 
GSH in plasma are also much lower than within cells, being only 2M in human 
plasma [222]. Higher levels (40-200M) are however present in alveolar lining fluid 
[8]. GSH, as for NADH and NADPH, can also donate electrons directly to various RS 
[8, 223], for example HOCl [224] and ONOO- [225] in vitro. Therefore, in tissues 
where GSH is present at high concentrations, direct scavenging of these RS is 
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Cells and extracellular fluids including plasma are also equipped with an array of 
LMW antioxidant substances, many of these acting as ‘sacrificial agents’ by being 
preferentially oxidised by RS to prevent damage to essential enzyme systems” 
biomolecules. These LMW antioxidant substances are either synthesised in vivo (eg. 
urate), or are derived from the diet (eg. vitamin C/ascorbate, which cannot be 
synthesized by some vertebrates, including humans [226]). Besides its important role 
as cofactor for numerous enzymes, and various other metabolic functions, in vitro 
data suggests that ascorbate is likely to be providing significant in vivo LMW 
antioxidant protection against various RS. Mammalian cells accumulate ascorbate 
from the surrounding body fluids against a concentration gradient, with intracellular 
levels reaching millimolar concentrations. Levels in plasma are relatively low (30-
90M), but are higher in cerebrospinal fluid, aqueous humour of the eye, seminal 
fluid, gastric and respiratory tissue fluids. Ascorbate is a powerful reducing 
substance, reacting with most RS including the radicals formed from oxidation of 
other antioxidants such as urate and -tocopherol radicals. The one-electron 
oxidation of ascorbate yields the semidehydroascorbate (SDA) radical (also known 
as ascorbyl). This product is very non-reactive, this being the essence of ascorbate’s 
antioxidant activity. Left to themselves, 2 ascorbyl molecules will undergo slow 
disproportionation, regenerating some ascorbate and forming dehydroascorbate 
(DHA).  
 
2SDA → ascorbate + DHA 
 
DHA is unstable and breaks down into a mixture of products. In healthy mammalian 
tissues, the ascorbate/DHA ratio is high, and most cells possess enzymes that 
convert DHA or SDA back to ascorbate at the expense of GSH or NADH [8]. In 
addition, red cells (as well as neutrophils) take up plasma DHA and convert it back to 
ascorbate [227](see also Chapter 3). 
 
Vitamin E is believed to be one of the most important endogenous, lipophilic LMW 
antioxidants. Yet, as for vitamin C, although much in vitro evidence of its antioxidant 
activity exists, evidence for its antioxidant effect in healthy humans is limited [8].  
Vitamin E is not a specific substance, but rather the term Vitamin E is a nutritional 
term first used to refer to a fat-soluble ‘factor’, a dietary lack of which caused a 
variety of specific symptoms in various animals. Vitamin E is now known to refer to 
eight naturally-occurring substances that have such lipophylic anti-oxidant activity, -
tocopherol being one of these substances. Blood tocopherol levels in healthy 
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interior of cell membranes and in lipoproteins. The significant antioxidant activity of -
tocopherol is by virtue of its ability to inhibit lipid peroxidation - it is able to scavenge 
lipid peroxyl radicals before they have a chance to react with the adjacent fatty acid 
side chain. Alpha-tocopherol is capable of reacting with a second peroxyl radical, 
producing a non-radical product. Various LMW antioxidants (including GSH) are 
known to be able to reduce the -tocopherol radical back to -tocopherol in vitro, 
with ascorbate-dependent recycling thought to be the most important in vivo. Singlet 
oxygen is also quenched by -tocopherol [8]. 
 
Urate, traditionally considered to be a metabolically inert end-product of purine 
metabolism, is believed to provide potent antioxidant protection, particularly at the 
very high levels present in human plasma (mean of 350M) (see also Chapter 1, 
Results and Discussion, section iv). The concentration of urate in human plasma is 
several-fold higher than that of the other recognized LMW antioxidant substances 
present in plasma, namely ascorbate and -tocopherol [39, 228]. In humans, urate is 
also present intracellularly [8], including within red cells (approximately 120M), and 
in various other body fluids such as saliva (100-200M) [229], and respiratory tract 
lining fluids (90-250M) [230].  
 
Urate can act as an antioxidant by binding iron and copper ions [231], and also by 
directly scavenging many different RS in vitro. It reacts with ozone [232], ONOO- 
[233, 234], HOCl [235], singlet oxygen and peroxyl radicals [39]. Urate has also been 
found to stabilise ascorbate in biological fluids, without itself being consumed. This 
stabilizing effect appears to be due to an inhibition of iron-catalyzed oxidation of 
ascorbate due to iron chelation by urate [236]. Urate is able to protect red cell 
membrane ghosts from lipid peroxidation [39], and cell culture experiments have 
been used to show urate’s ability to protect other cells against various RS such as 
ozone [237, 238]. In isolated organ preparations, urate protects against reperfusion 
damage induced by activated granulocytes, cells known to produce a variety of 
radicals and oxidants. There is now evidence for such processes not only in vitro and 
in isolated organs, but also in the human lung in vivo [239-241], a site of direct 
exposure to many exogenous RS, and which has relatively high urate levels. Infusion 
of urate was also found to have neuroprotective effects in some animal models [142, 
143], and infusion of urate into humans during severe physical exertion leads to a 
smaller rise in markers of oxidative damage [242]. In the process, urate radicals may 
be formed that are themselves capable of oxidizing other molecules [8]. Ascorbate is 
able to reduce these radicals [243]. Otherwise urate is converted to innocuous 
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and other unidentified products, are also formed when urate reacts with H2O2 plus Hb 
(or hemin) [235] (see also Chapter 3, Literature Review). An increased concentration 
of allantoin has been observed in the body fluids from patients with various chronic 
conditions known to be associated with oxidative stress, such as rheumatoid arthritis 
[244], chronic renal failure [245] and diabetes [246], as well as after acute exhaustive 
exertion [104, 105] and after short-term whole body exposure to extreme cold [160], 
this taken as evidence that urate does indeed react with RS in vivo.  
 
Many other LMW substances have been shown in vitro to have antioxidant activity 
against various RS, but their contribution to antioxidant defense in vivo is still 
unconfirmed (eg. bilirubin, ergothioneine [8])  
 
Measures of the antioxidant capacity of biological samples can either focus on 
determining levels of individual antioxidants (eg Vitamin C content), or alternatively 
can act to provide an estimation of the total antioxidant capacity (TAC) of the sample. 
The latter approach attempts to ‘summarise’ the activity of all antioxidants present in 
the sample into a single value. Various ‘TAC assays’ exist, for example the ‘oxygen 
radical absorbance capacity’ (ORAC) and the ‘total radical trapping antioxidant 
parameter’ (TRAP) assays. Such TAC assays and have been used to evaluate and 
compare the antioxidant capacity of a range of pharmacological compounds, foods, 
beverages [247, 248] and also biological samples such as plasma and seminal 
plasma. A change (usually a decrease) in plasma TAC in individuals over time, or 
between healthy controls and diseased individuals, is often used in clinical studies as 
an indirect measure of the association of oxidative stress with the event or disease 
process, or of response to antioxidant therapy [8, 249].  
 
The contribution of a putative antioxidant to the sample’s TAC can also be 
determined, this being calculated from its concentration in the sample and its TAC 
value (determined using a standard solution of the substance). In this way, urate has 
been found to be a major contributor to the TAC of human plasma with several of the 
TAC assays [8]. Important to note, however, is that by virtue of the different chemistry 
behind these assays (in particular different oxidants), and because the time-course 
over which they are conducted is different (see Results and Discussion), the various 
assays to measure TAC contributions often do not always give the same results 
[249]. Using the TRAP assay, for example, the major contributors to the TAC of 
human plasma were found to be protein (10-50%), urate (35-65%), ascorbate (up to 
24%) and vitamin E (5-10%) [250]. Using the ORAC assay on total/whole (ORACT) 










Chapter 2: Literature Review                                                                                                                         - 76 -  
the precipitated fraction (which would include proteins as well as lipoproteins and 
their associated lipophilic antioxidants) account for 85-90% of the ORACT value of 
human plasma against peroxyl radicals [116, 251]. Another study showed that the 
lipophilic components of plasma account for 28-33% of this value [252]). Hence, 
certainly if using the ORAC assay and the interest is in LMW antioxidant molecules, 
proteins in plasma samples should first be precipitated, allowing determination of the 
TAC of just the LMW components of the sample (TACLMW) in order to prevent 
‘masking’ of the LMW substance’s antioxidant value by the proteins. 
 
In human plasma the sum of the TAC contributions from the known plasma 
antioxidants is less than the TAC of plasma i.e. there are as yet ‘unidentified’ 
antioxidant components.  This could reflect synergy between antioxidants such that 
they work better in combination than individually. This could also reflect a contribution 
from unsuspected LMW antioxidant substances to the TACLMW of plasma [8]. Various 
pieces of scientific evidence exist that together seem to provide sufficient grounds for 
the proposal that endogenous levels of free tyrosine and/or tryptophan may be 
playing a yet insufficiently appreciated antioxidant role. This evidence is presented 
next.  
 
Most tyrosine molecules in biological tissues are present as residues within proteins. 
These tyrosine residues are targets for redox reactions. Much attention has therefore 
focused on the reactions of protein-bound tyrosine residues with various RS. 
Although reaction with these protein residues often eliminates the initiating RS to 
form more stable, non-reactive products (see below), these reactions are generally 
unfavourable because the protein is usually damaged and marked for degradation 
[253-255]. 
 
In vitro experiments show that free tyrosine is a target for most of the same RS that 
attack protein-bound tyrosine including singlet oxygen [256], ONOO- [257] and HOCl 
[109]. As for protein-bound tyrosine residues, the oxidation of free tyrosine leads to 
various end-products, depending on the RS. For example, exposure of free or 
protein-bound tyrosine to singlet O2 forms tyrosine peroxides [256] which can be 
removed by GSH and ascorbate and the GPx/GSH enzyme system (although the 
latter cannot remove protein-bound peroxides, consistent with substrate size being a 
key factor) [258]. Exposure to most other RS leads to the formation of free or protein-
bound tyrosyl radicals. Free and protein-bound tyrosyl radicals may be reduced back 
to tyrosine by various reducing substances such as GSH, ascorbate, urate, and also 
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via the ortho-ortho cross-linkage of two tyrosyl radicals [265] (Fig 29). Dityrosine is 
also formed when tyrosine reacts with H2O2 plus a non-specific peroxidase (for 
example horseradish peroxidase [265] or Hb [4, 254]) – see also Chapter 3. 
Dityrosine is a very stable end-product [6], and will therefore not take part in further 















Figure 29. Free tyrosyl radical and dityrosine formation via the oxidation of free tyrosine by various RS, 
or the peroxidase/H2O2 antioxidant system (adapted from DiMarco et. al. (2007) [6]). 
 
 
When dityrosine crosslinks form between protein-bound tyrosyl radicals, this can lead 
to protein unfolding and eventual degradation. However, Moosmann et. al. (2000) 
have suggested that tyrosine and tryptophan residue-enriched peptides representing 
stretches from the transmembrane domains of integral membrane proteins serve to 
protect cells from oxidative destruction, with these amino acids acting as ‘sacrificial’ 
residues [176]. The distributional pattern of such tyrosine and tryptophan-enriched 
peptides seems to constitute a general principle of membrane protein architecture, 
being found in many diverse classes of membrane proteins independent of their 
primary function, and they do not seem to be a requirement for membrane protein 
stability or correct insertion. Moosmann et. al. suggested that oxidized tyrosine and 
tryptophan residues could then be reduced by various electron-donating LMW 
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protein, neuronal membranes to oxidative stress, as is seen in neurodegenerative 
disorders [176]. 
 
Free tyrosine may, as for these membrane bound tyrosine residues, play a role in 
antioxidant defense as a ‘sacrificial’ amino acid by being preferentially targeted by 
RS. Phenolic ring-containing substances are known to have antioxidant potential 
[266], and various phenolic compounds, including tyrosine, have more recently been 
investigated for their antioxidant properties against ONOO- and as potential 
therapeutic drugs to limit oxidative damage occurring in inflammatory conditions. Van 
Dyke et. al. (2007) showed that free tyrosine in micromolar amounts had significant in 
vitro antioxidant activity against this physiological RS [196].  
 
The possibility that endogenous free tyrosine may be playing an important 
antioxidant role in vivo is supported by the study of van Overveld et al. (2000), which 
investigated the antioxidant activity of seminal plasma [66]. Reactive species are 
produced within this fluid which bathes spermatozoa. The presence of RS in seminal 
plasma is important for a number of spermatozoal functions [267]. However, 
spermatozoa are also particularly susceptible to oxidative stress because their 
constituent lipids are rich in polyunsaturated fatty-acid side-chains [219].  The large 
variety and high levels of antioxidant defenses present in this fluid are therefore 
crucial to maintaining a well-controlled prooxidant/antioxidant balance. The SOD and 
GPx enzymes are present, as are iron-binding proteins (lactoferrin and transferrin). 
High levels of urate (235M) and ascorbate (568M), and lower levels of hypotaurine 
(35M) present in seminal plasma have each been suggested to contribute to the 
LMW antioxidant defense [8, 268, 269]. Van Overveld et al [66] found deproteinised 
human seminal plasma to have an unusual, slow but continuous antioxidant activity 
using the ‘trolox equivalent antioxidant capacity’ (TEAC) assay, this being one of the 
established TAC assays. Using the same assay, they also evaluated the various 
putative LMW antioxidant substances (urate, ascorbate, tocopherol and hypotaurine). 
They included tyrosine since it is present at such high levels in spermatic fluid 
(2116M [65]). They found free tyrosine to have powerful antioxidant activity, and to 
have the same TEAC curve as that for seminal plasma, whereas urate for example 
showed immediate and complete radical-trapping ability. They concluded that, 
compared with all the other substances evaluated, tyrosine was the most important 
antioxidant contributor to seminal plasma TAC using the TEAC assay. They 
suggested for the first time that a high level of free tyrosine in seminal plasma is 
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As compared with seminal plasma, levels of free tyrosine in other tissues are 
relatively low, being approximately 60M in plasma. This level is however not very 
different to levels of the antioxidants ascorbate and -tocopherol in blood. Yet free 
tyrosine has not previously been considered to be an important naturally occurring 
antioxidant. It is worth considering that even if levels of free tyrosine are insufficient 
to prevent oxidative damage to other biomolecules, the preferential cross-linking of a 
protein-bound tyrosyl radical with a free tyrosyl radical formed in close proximity, 
rather than with another tyrosyl residue in the same protein, could limit protein 
damage/unfolding. Finally, it is noteworthy that patients with phenylketonuria, an 
autosomal recessive disease causing reduced tyrosine formation, show signs of 
increased levels of oxidative stress, and a deficient capacity to handle an increased 
level of RS [270].  
 
As in the case of tyrosine, free tryptophan is never included in the textbooks as being 
a physiologically relevant antioxidant. Many of the same RS that attack tyrosine are 
also reactive with tryptophan, both protein-bound and free amino acid forms [256, 
258, 271, 272]. Oxidative modification of protein-bound tryptophan, as for tyrosine 
residues, can be very detrimental. For example, oxidation of tryptophan and tyrosine 
residues of the SOD enzyme protein results in impaired enzyme activity [271]. As for 
tyrosine there is a small body of scientific evidence to indicate that free tryptophan, 
and/or its oxidative metabolites (Fig 30) do have antioxidant activity. Cadenas et. al 
(1989) showed that 5-hydroxytryptophan (5-OH-Tryp), the precursor to serotonin, 
was able to protect microsomal lipids from peroxidation [273]. Christen et. al (1990) 
investigated the possibility of a physiological role for free tryptophan and its oxidative 
metabolites as inducible antioxidants in lung tissue. They showed that low 
micromolar concentrations of hydroxylated tryptophan metabolites (but not their 
corresponding nonhydroxylated precursors) were able to scavenge peroxyl radicals 
with higher efficiency than equimolar amounts of either ascorbate or Trolox. They 
suggested that the 100-fold induction of indoleamine 2,3-dioxygenase (IDO) seen in 
mice suffering from acute viral pneumonia (IDO being the first enzyme in the catalytic 
formation of kynurenine oxidative metabolites from tryptophan), represents a local 
antioxidant defense in such inflammatory diseases (Notably, XO was also 
significantly induced in the lungs of these mice) [132]. Such an upregulation of IDO 
occurs in various tissues in response to infections and other pathological conditions, 










Chapter 2: Literature Review                                                                                                                         - 80 -  
 
Figure 30. Part of the tryptophan oxidative metabolic pathway (adapted from 
Streete et. al. (2004) [7]). 
 
 
A significant rate of synthesis of tryptophan oxidative metabolites (particularly 3-
hydroxykynurenine glucoside) occurs in the human lens [274, 275]. These UV filter 
compounds are poor photosensitizers and protect the lens against light of 
wavelength 300-400 nm (UVA) [276]. The possibility that some of these tryptophan 
oxidative metabolites may also be providing antioxidant protection in the human lens 
has been suggested [277]. Notably, Truscott and co-workers reported a decreased 
level of free tryptophan metabolites in cataract lenses compared with normal lenses, 
despite a higher tryptophan and normal kynurenine concentration in the cataract 
lenses. This appears to be due to a defect in one of the steps that converts 
kynurenine to 3-hydroxykynurenine glucoside [7]. Such an impairment may be a 
predisposing factor to cataract formation since evidence of oxidative stress and 
damage are detectable in cataract lenses [7, 278-280].    
 
Although the enzyme IDO, which can be induced in many cell types by interferon-
gamma [281], is not likely to be present in plasma or in red cells [1], tryptophan can 
also undergo non-enzymatic oxidative modification, as indicated by Halliwell et. al 
(2007) (Fig 31). Reaction of tryptophan with various RS forms N-formylkynurenine. 
Ring-hydroxylated products such as 5-OH-tryptophan may also be formed [8]. This 
implies that tryptophan oxidative metabolites may be formed non-enzymatically in 
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                                       Figure 31. Oxidative modifications of tryptophan [8]. 
 
In conclusion, it is therefore possible that free tyrosine and tryptophan (and/or its 
metabolites) may have antioxidant activity by serving as ‘sacrificial’ LMW substances, 
and may be contributing to the residual TACLMW of plasma. The TACLMW of red cell 
contents has not previously been reported, and the potential LMW antioxidant 
contributors have not been determined. The high levels of tyrosine in the red cells of 
some mammalian species, the high levels of urate found in the red cells of some 
horses, and the accumulation of tryptophan and urate riboside in bovid red cells as 
reported in Chapter 1, may each be contributing significantly to the LMW antioxidant 





To (i) compare the oxygen-radical absorbance capacity (ORAC) value of tyrosine, 
tryptophan, and urate, (ii) to determine the ORAC value of acid-extracts of red cells 
and plasma from humans, horses and bovines, and (iii) to determine the antioxidant 
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(D) MATERIALS & METHODS  
 
(i) Samples 
Thirty micromolar solutions of commercially available LMW substances were made in 
10mM potassium phosphate buffer (pH 7.4) (tyrosine, urate, xanthine, hypoxanthine, 
taurine and phenylalanine from Sigma, USA; NADH from Boehringer Mannheim, W. 
Germany; tryptophan from Hopkin & Williams Ltd, UK.). Diode array 
spectrophotometry was performed to confirm identity and concentration of solutions 
made. Aliquots of these solutions were frozen at -80oC, and thawed immediately prior 
to use in the assay. Some of the aliquots of frozen red cell and plasma acid-extracts 
from humans, horses, cows and buffalo that were made for HPLC analysis (as 
described in Chapter 1) were thawed and used for the ORAC assay in order to 
determine the ORAC value of the LMW substances (ORACLMW) for the red cells and 
plasma of each species. Prior et. al. (2003) showed that use of perchloric acid was 
best of the options tested to remove proteins for determination of ORACLMW [252].  
 
(ii) The oxygen-radical absorbance capacity (ORAC) assay 
This fluorometric, kinetic assay quantitates the ORAC value of antioxidant 
substances over time and to completion. The ORAC assay was first developed by 
Cao et. al. (1993) [251]. They used -phycoerythrin as the target - this was 
subsequently shown to be very unstable, and the improved ORAC developed by Ou 
et. al. (2001) used fluorescein (FL) as the target/probe [282]. Blackhurst et. al. (2007) 
further modified the assay [283]. In the current study the latter method was used, with 
some further minor modifications.  
 
The ORAC assay was performed on a top-reading fluorescence spectrophotometer 
(Varian, Australia), in white, flat-bottomed, 96-well microplates (Greiner Bio-One, 
USA) at ambient temperature. The excitation and emission wavelengths were 485 
and 520 nm respectively. Each 300l reaction was performed in duplicate (in 
consecutive wells) and allowed to proceed at ambient temperature. The final 
reactions contained:  
     50l of phosphate buffer, pH 7.4 (12.5 mM) 
      100l of fluorescein (31.9nM)(a) 
50l of the sample(b) or trolox standard(c) 
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The following control reactions were also included in each assay: 
300l buffer alone (background fluorescence) 
200l buffer plus 100l fluorescein (no free radicals) 
 
(a) Fluorescein (FL) is a stable molecule which is susceptible to oxidative degradation 
by peroxyl radicals. A stock-1 solution (1.196mM) of FL (Sigma-Aldrich, USA) was 
made in buffer (stable indefinitely when stored at 4oC). A stock-2 solution (5.98M) of 
FL in buffer was made from this every 2 months (stored at 4oC). A working solution 
(95.7nM) of FL in buffer was made from stock-2 on the day of the assay.  
 
(b) This consisted of either thawed 30M solutions of the commercially-available LMW 
substances, or thawed red cell (or plasma) acid-extracts which were 1 in 17 (or 1 in 
12) dilutions of the actual red cell water (or plasma) (see Chapter 1).  
 
(c) Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) represents a 
water-soluble form of tocopherol and serves as the antioxidant standard in the ORAC 
assay. A stock-1 solution (100mM) of Trolox (Sigma-Aldrich, USA) was made in 
absolute ethanol. A stock-2 solution (200M) of Trolox in cold buffer was made, and 
aliquots frozen at -20oC. An aliquot was thawed on the day of the assay, serial 
dilutions (200M -1.37M) were made in cold buffer and used immediately. A control 
(0M Trolox) reaction was always performed by adding 50l buffer instead of Trolox 
to the reaction. 
 
(d) AAPH (2,2’-azobis(2-amidinopropane) dihydrochloride) decomposes 
spontaneously at 37oC in aqueous solution to release a constant flux of peroxyl free 
radicals [8]. A working solution (330M) of AAPH (Sigma-Aldrich, USA) was always 
made in pre-warmed buffer (37oC) immediately before addition to each well, as this 
has previously been reported to improve reproducibility of the assay [252]. AAPH 
was always added last to the well to initiate the reaction. Some investigators use a 
temperature-controllable fluorescence plate reader, and maintain the reaction 
temperature at 37oC.  
 
All reaction constituents were added to each well, except for AAPH, and the plate 
was shaken for 10 seconds. Before reconstituting the AAPH, ‘time 0’ fluorescence 
readings of the two control reactions were made. The AAPH was added to the 
appropriate wells, the plate shaken for 10 seconds, and fluorescence measurements 
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5 min thereafter until 20 min, then every 10 min until 60min, and then every 15 min 
until all reactions had reached baseline (zero) fluorescence. The decrease in 
fluorescence over time reflects the oxidative degradation of FL. 
 
Graphpad Prism Statistical Software Version 4.01 (2004) was used to convert the 
data into an average fluorescence/time plot/curve for each duplicated reaction (Fig 
32), determine the area-under-curve (AUC) for each reaction, and perform the 
subsequent analyses. 
 





























Figure 32. Time-dependent fluorescence decay of fluorescein after the addition of AAPH in the 
presence of serial dilutions of Trolox antioxidant, and control reactions and a typical sample (black line). 




A Trolox standard curve (AUC versus Trolox concentration) was produced for each 
assay (Fig 33), and the AUC for each sample extrapolated to a Trolox concentration. 
The ORAC value of each sample is thus measured as mol Trolox equivalents 
(TE)/litre sample. The definition of one ORAC unit is the protection provided by a 




Figure 33. Trolox standard curve. The Goodness 
of Fit test was used to determine the linear 
regression. The ORAC value (as moles Trolox 
Equivalent per liter) of a sample is determined by 
extrapolation from the standard curve. 
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Where the samples were acid extracts of red cells or plasma, the ORAC value of the 
extract was multiplied by a further factor of 17 or 12 respectively, these being the 
dilution factors of the biological samples (see Chapter 1, Materials and Methods). 
 
 
(iii) Statistical considerations 
Unless otherwise indicated, data are presented as mean + SD. Linear regression 
was determined using the Goodness of Fit test. When comparing means, the 
Unpaired t test was used to determine statistical significance, unless the data was 
skewed, in which case the Mann Whitney test was used. The Paired t test was used 
when comparing plasma and red cell levels within the same species, except where 
the data was skewed, in which case the Wilcoxon signed rank test was used. The 
Pearson test was used to determine statistical significance of correlation, unless the 
data was skewed in which case the Spearman r was determined. A P value < 0.05 
was considered statistically significant. The intra-assay and inter-assay coefficients of 
variation (CV) for the ORAC assay were 17% and 4.5% respectively, using urate as 
the quality control solution. It was noted that well position in the 96-well plate 
significantly and consistently contributed to the large intra-assay CV. Ou et. al. (2001) 
also noted this effect and performed their duplicate reactions in a “forward-then-
reverse” order to correct possible errors due to signal drift associated with different 
positions of the same sample [282]. A large intra-assay variation was also shown by 
Prior et. al. - they determined this to be caused by a number of factors, and a lower 
CV could be obtained using 48-well plates, and when excitation/emission could be 
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(E) RESULTS AND DISCUSSION 
 
Many different assays exist to measure TAC [249]. These assays vary in terms of the 
pro-oxidant and target/probe used, as well as how the measurement is made (fixed 
time point versus assays that allow reactions to reach completion). The ORAC assay 
is one such well-established assay to measure TAC. It quantifies antioxidant 
scavenging activity of a substance/sample against the peroxyl radicals released by 
thermal decomposition of water-soluble AAPH, by measuring the protection it gives 
to the target or probe (namely FL) from oxidation. The protective effect of an 
antioxidant substance or sample is determined relative to the antioxidant activity of 
the known antioxidant Trolox, a water-soluble from of tocopherol [282], and given as 
moles TE/litre.  
 
When Cao et. al. first reported developing the ORAC assay, they measured the 
ORAC values of urate and vitamin C, two well established endogenous antioxidants 
present at high levels in human plasma [251]. However since then, investigations 
have focused more on using TAC assays such as the ORAC assay to evaluate the 
antioxidant capacity of food, beverages and potential therapeutic drugs, rather than 
on evaluating the antioxidant activities of baseline levels of LMW substances, and 
their contributions to the antioxidant capacity of biological tissues. In Chapter 1 the 
detection of unusually high levels of urate and tyrosine in the red cells of horses 
relative to man, and the accumulation of tryptophan in the red cells of cows and 
buffalo was reported. In order to determine if these LMW substances may have 
antioxidant ability, the ORAC values of equimolar solutions (30M) of tyrosine and 
tryptophan, as well as urate and various other LMW substances known to be present 
in red cells and/or plasma were determined. 
 
Examination of the fluorescence curves for each LMW substance revealed not only 
differences in AUC, but also very different kinetic profiles for the various substances 
(Fig 34). TAC assays that are designed to determine antioxidant capacity at a fixed 
time point (eg. the TEAC assay) would give very different results for the same 
substance, depending on the time point at which the measurement is taken. One of 
the advantages of assays like the ORAC assay that measure an AUC for reactions 
which are allowed to run to completion (i.e. back to baseline), is that this solves many 
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Figure 34. Time-dependent fluorescence decay of fluorescein after the addition of AAPH in the 
presence of 30M solutions of urate, tyrosine, tryptophan, xanthine, NADH, or 12.5M Trolox as 
standard, or no antioxidant. 
 
 
Figure 34 shows that reactions containing Trolox or urate have very similar FL 
degradation profiles. Urate and Trolox have the same high rate of reaction with the 
water-soluble peroxyl radicals formed from AAPH - after an initial plateau region, 
indicating complete FL protection, the fluorescence decreased rapidly and at a rate 
similar to that found in the control (no antioxidant), indicating complete oxidation of 
the urate/Trolox. These profiles are identical to that illustrated by Cao et. al. (1993) 
for urate and Trolox [251]. The extent of the plateau for a substance is related to its 
concentration in the reaction (see Fig 32). Although an equimolar solution of NADH 
showed a shorter plateau than for urate, the rate of FL-degradation after the plateau 
phase was slightly slower than for urate and Trolox, being identical to that in the 
control.  
 
Tyrosine showed a significantly lower affinity for the peroxyl radicals than Trolox and 
urate. Instead of a plateau region, tyrosine seems rather to be providing partial, 
continuous protection to FL. This same slow radical trapping curve was shown by 
van Overveld for tyrosine (and seminal plasma) using the TEAC assay, and 
suggested to be important in maintaining a careful balance between pro-oxidants and 
antioxidants for adequate spermatozoal function [66] (see also Literature Review). A 
similarly slow, fluorescence-degradation profile was evident for reactions containing 












Chapter 2: Results and Discussion                                                                                                                - 88 -  
Reactions containing tryptophan showed a strikingly different protective profile. There 
was an extended plateau-type phase, well beyond that for equimolar concentrations 
of urate. This plateau tended to drop off very slowly, up till a point where no further 
antioxidant protection was evident. Therefore tryptophan was more efficient to limit 
oxidation of FL (see below). 
 
The ORAC value for each of the LMW substances was then determined from the 
respective AUC (Fig 35).  
 














































































Figure 35. The mean (and SD) ORAC values of equimolar (30M) solutions of some LMW substances. 
Results represent 4-7 replicates (performed on different days) for each substance. 
 
 
A 30M solution of urate was determined to have an ORAC value of 29moles 
TE/litre, indicating that the antioxidant capacity of urate to protect FL against peroxyl 
radicals is just slightly less than an equimolar amount of Trolox. Extrapolated, one 
ORAC unit (which by definition equals 1M Trolox) equals 1.05M urate. This result 
is in agreement with the findings of Cao et. al. (1993) who found that one ORAC unit 
equals 1.08M urate [251]. Such extrapolations are possible since linear correlations 
between ORAC value and concentration of antioxidants tested have been shown 
[251, 284]. Quantitatively then, urate and Trolox must donate almost the same 
number of electrons, and at similar rates, to peroxyl radicals.  
 
Although tyrosine clearly reacts at a slower rate than urate or Trolox with peroxyl 
radicals (Fig 34 above), its AUC shows it to have a greater (almost 2-fold) ORAC 
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urate molecule may be donating 1 electron, forming stable and mildly oxidizing urate 
radicals, that 2 tyrosine molecules may donate 3 electrons via a disproportionation 
reaction between two tyrosine radicals (see Literature Review). Despite tyrosine’s 
greater ORAC value compared with urate, the very different kinetics between 
tyrosine and urate should nevertheless be kept in mind – levels of antioxidants are 
likely to be continuously renewed in vivo, and urate would be a more 
powerful/complete antioxidant than tyrosine against peroxyl radicals because of its 
greater rate of reaction (or higher affinity for) with these radicals.  
 
Tryptophan had an extraordinarily high ORAC value, this being almost 5-fold greater 
than the ORAC of the known antioxidant urate, the 30M tryptophan solution having 
an ORAC value of 119mol TE/litre. This reveals a complex antioxidant capacity for 
tryptophan, probably via the non-enzymatic, peroxyl-mediated formation of 
tryptophan oxidative metabolites (see Literature Review). Halliwell et. al. (2007) 
indicate that tryptophan can undergo non-enzymatic oxidative modification by RS to 
form these products, which have significant antioxidant activity as shown by Christen 
et al. (1990) and Cadenas et. al (1989), [132, 273]. An equimolar solution of 
tryptophan is therefore clearly able to donate many more electrons to peroxyl radicals 
than either urate or tyrosine. 
 
As expected, the hypoxanthine and phenylalanine (included as ‘negative controls’) 
solutions both showed no ORAC activity. The ORAC value for the 30M NADH 
solution was 18mol TE/litre, NADH being an important intracellular reducing agent 
and able to donate electrons directly to peroxyl radicals [8]. Although suggested by 
some to have antioxidant activity [70-73, 285], taurine showed no antioxidant activity 
against peroxyl radicals in the ORAC assay - this is in accordance with Auroma et. al. 
(1988) who showed that unlike hypotaurine, taurine does not react rapidly with 
H2O2, O2·, OH·, or HOCl [74]. Unexpectedly, xanthine, which has not previously 
been evaluated as an antioxidant, had an ORAC value a little greater than that of 
NADH. Based on this data, both tyrosine and tryptophan, neither previously 
considered to have significant antioxidant activity, have greater antioxidant activity 
against peroxyl radicals than urate, with the relative peroxyl radical absorbing 
capacity of 1M Trolox, urate, tryptophan and tyrosine being 1, 0.97, 4 and 1.5 
respectively. The relative peroxyl radical absorbing capacity of 1M NADH and 
xanthine were 0.67 and 0.6 respectively.  
 
In order to determine the contribution of tyrosine, tryptophan and urate to the LMW 
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perchloric acid-extracts of red cell and plasma samples from humans (n=5 and n=4 
respectively), horses (n=12), cows (n=4) and buffalo (n=6). Only deproteinised 
samples were evaluated firstly because it has been shown that proteins account for 
85-90% of the ORACT value of whole/total human plasma against peroxyl radicals 
[116, 251]. Hence, certainly if using the ORAC assay and the interest is in LMW 
antioxidant molecules, proteins in plasma samples should first be precipitated, 
allowing determination of the ORACLMW of the sample (ORACLMW) in order to prevent 
‘masking’ by the proteins. In addition, an ORAC value for total red cell contents 
cannot be determined, since hemoglobin quenches fluorescence [286].  
 
In comparison with the plasma extracts from the different mammalian species (Fig 36 
A), which all followed very similar kinetics (albeit surprisingly, considering the high 
urate in human plasma), the fluorescence curves in reactions containing red cells 
extracts (Fig 36 B) were unique for each species.  
 






































Figure 36. Time-dependent fluorescence decay of FL after the addition of AAPH in the presence of (A) 
plasma extracts, and (B) red cell extracts from humans, cows, buffalo and horses, illustrating the very 
different ORAC kinetics profiles for the red cell extracts from different mammalian species. Note that 
some profiles may start at different fluorescence intensities because the reactions were not all 
performed in the same run – this would however be taken into account when extrapolating the TE value 
from the respective Trolox standard curve performed with every run.  
 
 
The curve for horse red cell extracts was reminiscent of the slow continuous radical-
trapping ability of a tyrosine solution. The curves for human, cow and buffalo red cells 
each showed similar kinetics, although the AUC for buffalo and cows was clearly 
much larger than that for humans. The red cell LMW contents from cows in particular 
provided prolonged, complete protection to FL (as does urate) until a point where the 
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The ORACLMW value for each acid-extract was then determined (Fig 37 and Table 3). 
 





































































Figure 37. Box and whisker plots of the ORAC values of deproteinised red cell (empty boxes) and 
plasma (grey boxes) extracts from four mammalian species: humans (n=5), horses (n=12), cows (n=4) 
and buffalo (n=6). The Mann Whitney test for non-parametric data was used to determine P values 
between horses and humans where data was skewed, whilst the Unpaired t test was used otherwise. 
The Paired t test was used to determine P values when comparing plasma and red cell tyrosine levels, 
except for horses where the Wilcoxon signed rank test was used.  
 
 
Table 3. The mean (+ SD) ORAC values for red cell and plasma extracts from four mammalian species. 
 
 Plasma ORACLMW 
(mol TE/litre plasma) 
Red blood cell ORACLMW 
(mol TE/litre red cell water) 
Human (n=5) 1032 + 106 623 + 207 
Horse (n=12) 873 + 115 2631 + 948 
Cow (n=4) 782 + 148 3419 + 694 
Buffalo (n=6) 693 + 95 1633 + 305 
 
 
The ORACLMW of human plasma was 1032 + 106mol TE/litre plasma. This is similar 
to that previously reported by Prior et. al. (2003) [252]. Human plasma ORACLMW was 
significantly higher (P < 0.023) than that from all three other species evaluated - this 
is in agreement with Ninfali et. al. (1998), the only other report comparing plasma 
TAC from different species, including cows and horses with that found in humans 
[116]. These investigators suggested this to be due to the presence of significant 
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The ORAC value for red cells has not previously been reported. Whereas in humans, 
red cell ORACLMW values were significantly lower than plasma ORACLMW values (P = 
0.0197), for each of the other three species the relationship was reversed, with red 
cell ORACLMW values being significantly higher than the respective plasma ORACLMW 
values (P < 0.0029). The ORACLMW values of human red cells were also significantly 
lower than that of red cells from the other three species (P < 0.0012) – it is interesting 
to speculate why the red cell’s LMW antioxidant capacity would have evolved to be 
so much higher than the respective plasma LMW antioxidant capacity (although not 
for humans) (see also Chapter 3).  
 
The large intra-species variation in red cell ORACLMW for horses and bovids was 
reminiscent of the large intra-species variation in tyrosine and urate levels amongst 
horses, and urate riboside levels amongst bovids, as reported in Chapter 1, and is 
similarly intriguing as it implies significant differences in antioxidant defense amongst 
individual.  
 
It should be noted that the original ORAC assay, and as used in this study, is 
performed in aqueous solution. Therefore it measures the hydrophilic antioxidant 
activity, whilst lipophilic antioxidants have been found not to contribute to this value 
[282]. This may be because most of these antioxidants tend to be precipitated out 
with the plasma lipoproteins during the acid extraction step. The ORAC assay has 
been adapted by Prior et. al. (2003) to measure lipophilic and hydrophilic 
components separately (with hexane extraction of the lipophilic antioxidants), and 
using the same peroxyl radical generator for both components [252]. The total 
ORACLMW values indicated in table 3 above may be predicted to be about 30% 
greater if the lipophilic LMW antioxidant component was included [249]. 
 
The antioxidant contributions provided by tyrosine, tryptophan, urate and urate 
riboside to the LMW component of red cell and plasma TAC were then determined 
(Fig 38). The antioxidant activities of 0.97, 4 and 1.5 moles TE/litre as determined 
above for every 1mole of urate, tryptophan and tyrosine respectively present in red 


















































































Figure 38. Stacked bar graphs of the contribution of tryptophan, tyrosine, urate and urate riboside to the 
ORACLMW of red cells and plasma from a number of individual humans, horses, cows and buffalo. The 
red cell and plasma samples from the same individual are always aligned. 
 
 
From figure 38, it is clear that there was no correlation between red cell and plasma 
ORACLMW within each species. 
 
Although urate did contribute significantly (17-29%) to human plasma ORACLMW, 
urate levels did not correlate with the plasma ORACLMW. The only other study found 
to report on urate contribution using the ORAC assay (n=4) showed a 16% 
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contribution from tyrosine to plasma ORACLMW in humans was 8-10%. The 
contribution from tryptophan was as much as that from urate, being 16-29%.  
 
Red cell urate concentration on the other hand was found to correlate significantly 
with the respective red cell ORACLMW value in humans (P = 0.0125), and contributed 
between 11-17% of the LMW antioxidant activity against peroxyl radicals. Tyrosine 
contributed between 12-23%, and tryptophan between 3-5%. Unlike urate levels, 
levels of these two amino acids in the human red cells did not correlate with the 
ORACLMW values.  
 
In horses, the high levels of tryptophan present in horse plasma samples, and most-
likely diet-induced (see Chapter 1, Results and Discussion, section v), were found to 
be a large component of the plasma ORACLMW, contributing 26-38% of the LMW 
antioxidant capacity against peroxyl radicals. Tryptophan concentration also 
correlated significantly with plasma ORACLMW (P = 0.0112).  
 
In horse red cells, it was the tyrosine concentration, rather, which correlated 
significantly with the highly variable red cell ORACLMW values (P = 0.0002) (Fig 39 A). 
Tyrosine contributed between 10-24% of the ORACLMW value. Although urate 
contributed a large component of the ORACLMW in some horses (up to 30%), other 
horses had no red cell urate, and urate levels did not correlate with red cell 
ORACLMW. However, when the contribution from urate was added to the contribution 
from tyrosine for each horse, the correlation with red cell ORACLMW value was 
improved over that with the correlation with tyrosine contribution alone (P < 0.0001) 
(Fig 39 B).  
 







r = 0.8796 (P < 0.0002)
red cell tyrosine (mol/l red cell water)



































r = 0.9391 (P < 0.0001)
































Figure 39. Comparison of the horse red cell ORACLMW value and (A) horse red cell tyrosine 
concentration, and (B) combined ORACLMW contribution from red cell tyrosine and urate in horse red 
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In horse red cells, tryptophan contributed only 4-10% of the ORACLMW. The 
contribution from tyrosine, tryptophan and urate in the horse red cells combined 
accounted for 19-47% of the red cell ORACLMW. 
 
Despite the finding in Chapter 1 of an accumulation of tryptophan in the red cells 
from cows and buffalo, this being higher than in any of the other species evaluated, 
tryptophan was found to contribute only about 4-7% of the ORACLMW in cow red cells, 
and in buffalo the contribution from tryptophan was only slightly more, being 7-10%. 
This may be attributed to the fact that urate riboside must be contributing an 
overwhelmingly large amount to the ORACLMW of the red cells from these two 
species. Although the antioxidant contribution of urate riboside to the red cell 
ORACLMW could not be determined directly, urate riboside concentration correlated 
with red cell ORACLMW (Fig 40 A). Based on the linear regressions for cow and 
buffalo separately, as depicted in figures 40 B and C, a residual red cell ORACLMW 
value of 750 and 900 moles TE/litre was determined for cows and buffalo 
respectively (at x-axis = 0). In this way the contribution of urate riboside to red cell 
ORACLMW was thus determined to range from 57-73% in cows, and 18-45% in 
buffalo. The unlikely but small possibility that levels of another one, or more 
antioxidants are also correlated with these widely ranging red cell ORACLMW values, 
cannot however be excluded. 
 






r = 0.9844 (P < 0.0001)
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Figure 40. Comparison of red cell ORACLMW and 
urate riboside concentration in (A) cow and 
buffalo red cells. The Pearson test was used to 
determine statistical significance of correlation. 
Linear regression graphs of red cell ORACLMW 
and urate riboside concentration in (B) cows and 
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In red cells, high levels of reduced glutathione (GSH) are present (>2mM), and this 
antioxidant is likely to be contributing significantly to the residual ORACLMW in the red 
cells. Vitamin C has an ORAC of about 0.52 mol TE/litre according to Cao et. al. 
(1993) [251]. Therefore in humans, the known levels of Vitamin C [3, 218] would add 
only about 10mol and 25-100 mol TE/litre to the determined ORACLMW of red cell 
water and plasma respectively. Although reduced NADH does have ORAC activity 
(Fig 35 above), all the NADH in the red cells would have been converted to NAD+ 
during the extraction process, and hence would not contribute to the red cell extract 
ORAC values. If kept in the reduced form, its contribution would be about 30, 50, 60 
and 90mol TE/litre red cell water in buffalo, horses, humans and cows respectively. 
Other unsuspected antioxidants may also be contributing to the residual ORACLMW, 
as well as possible synergy between antioxidants (for example, the ability of 
ascorbate to reduce urate radicals, see Literature Review). 
 
What is the biological significance of the ORAC value in assessing antioxidant 
ability? No single TAC assay or other measure of antioxidant capacity can be 
considered as a “total antioxidant capacity assay”. In a biological system, whereas an 
antioxidant may be particularly reactive with a specific antioxidant, it may be less 
efficient in scavenging a different RS. The ORAC assay assesses antioxidant 
capacity against peroxyl radicals; further assessment of the antioxidant capacity of 
tyrosine and tryptophan against other oxidants, such as the OH· or O2·
 radicals, and 
ideally in a more complete biological system (for example cell-based in vitro assays) 
is required to generate an “antioxidant profile” and establish their antioxidant roles. 
The ORAC assay is however considered to be one of the most representative of the 
TAC assays of what may be occurring in the biological setting. The ORAC reaction 
proceeds as a classic hydrogen atom transfer (HAT) mechanism, rather than as a 
single electron transfer (SET) mechanism, as occurs in the TEAC and FRAP assays. 
Many scientists feel that the HAT reactions are most relevant to human biology. The 
AAPH provides a controllable source of organic peroxyl radicals, which is the 
predominant radical occurring in lipid oxidation in biological systems. Oxidation of 
proteins by the OH· radical and other reactive species is also proposed to occur in 
vivo to form protein peroxyl radicals [194, 195]. Therefore, the ORAC assay, unlike 
many of the other TAC assays, uses an oxidant that is clinically relevant to measure 
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(F) SUMMARY 
 
Both tyrosine and tryptophan have significant antioxidant activity against water 
soluble peroxyl radicals, as measured using the ORAC assay. The radical 
scavenging capacity of 1M Trolox, urate, tryptophan and tyrosine is 1, 0.97, 4 and 
1.5 respectively. The antioxidant contribution of physiological levels of tyrosine and 
tryptophan and urate ribosdie to the ORACLMW of plasma and red cells of some 
mammalian species is similar or greater to the contribution by urate, and in some 
instances correlations of these with red cell ORACLMW activity were demonstrable, 
e.g. for urate riboside in cows, and for combined urate plus tyrosine in horses. In 
conclusion, these results provide evidence to suggest that these free intra-
erythrocytic amino acids have effective in vivo antioxidant activity, and that their 
contribution to endogenous LMW antioxidant defense mechanisms is 
underestimated, particularly in mammalian species found to accumulate high levels 
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CHAPTER 3 






Most of the enzymatic and non-enzymatic antioxidant capacity of whole blood is 
located within the red cells, both because it has high levels of these established 
antioxidants, and because it is the most abundant cell type in blood. In Chapter 2 it 
was demonstrated that the red cells from cows, buffalo and horses (although not 
humans) have significantly greater LMW antioxidant activity against peroxyl radicals 
(analogous with hydroxyl radicals) than the respective plasma. It was also shown that 
the high levels of tyrosine, tryptophan, urate and urate riboside present in the red 
cells of some mammalian species (as reported in Chapter 1) are likely to be playing a 
physiological part in such antioxidant activity, as well as in neutralising a variety of 
other biologically-relevant reactive species. But why do red cells require such an 
extensive antioxidant capacity, and what might the advantages be for the 
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(B) LITERATURE REVIEW 
 
Compared with other tissues, a relatively low rate of superoxide (O2·
) and hence 
hydrogen peroxide (H2O2) production occurs within the mature mammalian red cell 
[287]. Having no nucleus or subcellular organelles, O2·
 production in the red cell is 
thought to arise exclusively from the auto-oxidation of ferrous Fe(II) oxyhaemoglobin 
(oxyHb) i.e. every so often a molecule of oxyHb releases O2·
, leaving behind ferric 
Fe(III) methaemoglobin (metHb) [8] (Fig. 41). It has been estimated that about 3% of 
the oxyHb present in human red cells undergoes such oxidation every day [288] (4% 
in mice red cells [289]). MetHb, which is unable to bind oxygen, is continuously 
converted back to ferrous haemoglobin by the NADH(NADPH)-dependent 
methemoglobin reductase enzyme (ascorbate can also reduce metHb back to ferrous 
Hb, but only at millimolar levels [290, 291]). Normally, the amount of metHb present 
in human red cells is approximately 1% of total Hb [289, 292]. The high level of 
copper-zinc superoxide dismutase (CuZnSOD) present in red cells [8] rapidly 
catalyses the dismutation of two molecules of O2·
 to form one H2O2 molecule. This 
maintains very low intra-erythrocytic levels of O2·
, calculated to be 1.9 x 10-13 M in 
human red cells [287], and 5 x 10-13 M in mice red cells [289]. This value is 300 times 
smaller than that calculated for liver [287].  
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H2O2 itself can accelerate the two-electron oxidation of oxyHb to form the Fe(IV) Hb 













SODO2 + H2O 
H2O 
 
Figure 42. Reactions of oxyhaemoglobin, ferrylhaemoglobin and methaemoglobin with H2O2 (as 
reviewed and proposed by Nagababu et. al. (2004) [9]). 
 
Nagababu et. al. reported that the subsequent reaction of H2O2 with ferrylHb to form 
Fe(III) metHb occurs via the one-electron oxidation of H2O2. A O2·
 radical is 
concurrently produced within the haem pocket, and leads to the formation of 
fluorescent heme degradation products, as well as reforming an H2O2 molecule [293-
295].  
 
H2O2 also rapidly oxidizes metHb to yield oxoferrylhaemoglobin (oxoferrylHb). 
OxoferrylHb is two oxidizing equivalents above metHb - it is an Fe(IV) Hb species 
that has an additional electron removed from globin to produce a protein-bound 
radical, and referred to as ·HbFe(IV)=O [9]. FerrylHb and oxoferrylHb, both being 
Fe(IV) Hb species, have identical absorbance profiles on spectrophotometry [293]. 
As for the reaction of H2O2 with other haem-containing proteins (eg. myoglobin, 
catalase, peroxidase enzymes), formation and dissipation of the free radical in 
oxoferrylHb has been found to proceed via a complex series of transfer and 
transformation steps [296, 297]. Many similarities exist particularly between Hb and 
myoglobin oxidation reactions - with both, the  formation of protein-bound tyrosyl 
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In the red cell, oxidation of Hb by H2O2 leads not only to loss of oxygen carrying 
capacity, but both the ferryl iron and the protein-bound radical of oxoferrylHb are able 
to initiate a range of oxidative chemical reactions with similar reactivity to the 
hydroxyl (OH·) radical [300-302]. The Hb itself also becomes modified/damaged, for 
example dityrosine formation has been shown to occur in vitro [254], whilst products 
reflecting the covalent modification of haem can be detected even in normal blood, 
and levels of these products increase significantly during acute oxidative stress 
(exercise) [300]. Therefore, although H2O2 itself is not a very reactive oxidizing 
species, the oxidative toxicity of H2O2 is greatly enhanced through its interaction with 
Hb within the red cell (the toxicity of oxidized Hb is hazardous not only within the red 
cell, but also systemically, for example with the use of Hb derivatives as a blood 
substitute [303]). H2O2 within red cells can also react rapidly with cytoplasmic LMW 
‘catalytic’ iron (presumably released from Hb, particularly in older red cells) [8] to 
form the highly reactive hydroxyl radical (OH·). The formation of these highly reactive 
oxidizing species within the red cell in particular could be detrimental because this 
long-lived, circulating cell, with a polyunsaturated fatty acid (PUFA)-rich membrane, 
no longer has a nucleus and protein synthesizing machinery, and therefore generally 
cannot replace oxidised biomolecules. 
 
In Chapter 2, using the Oxygen radical absorbance capacity (ORAC) assay it was 
reported that tyrosine, tryptophan, urate and urate riboside were each able to 
neutralize peroxyl radicals. The action of peroxyl radicals is believed to be similar to 
that proposed for the OH· radical [194]. Therefore, it is probable that accumulation of 
high levels of these LMW substances within the red cell cytoplasm may provide a 
physiological antioxidant role by neutralizing OH· radicals formed in the red cell. 
These LMW substances may also be involved in removal of the highly oxidizing 
oxoferrylHb species (see later).  
 
Despite these putative antioxidant strategies for the removal of such highly oxidizing 
molecules, removal of H2O2 before it induces significant Hb oxidation or forms more 
oxidizing species is clearly preferable. High levels of catalase and glutathione 
peroxidase (GPx, specifically GPx1 in the red cell) activity within the red cell [8, 206] 
imply that, in a closed system, a very low steady-state concentration of H2O2 would 
be maintained within the red cells. This has been calculated to be 2 X 10-10 M [287]. 
In mice, this value was determined to be even lower (5 X 10-11 M [289]). These red 
cell H2O2 concentrations are to be compared with levels of 4-5 X 10
-6 M reported for 
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Since H2O2 is freely able to permeate most biological membranes, including that of 
the red cell [8], the red cells with their low production of H2O2, and high H2O2-
removing capacity (and reserve), may act as ‘sinks’ for extracellular H2O2 [218]. 
Under conditions of increased systemic oxidative stress, red cell catalase and GPx 
activities can be further increased [108, 155, 158]. The red cell hexose 
monophosphate (HMP) shunt (see also Chapter 2, Literature Review) can also be 
activated several fold on exposure of red cells to oxidant substances that deplete 
reduced glutathione (GSH) or NADPH levels [40, 215]. As a consequence, healthy 
red cells do not easily undergo lipid peroxidation on in vitro exposure to H2O2 [8]. Red 
cell catalase, more than GPx, has been shown in vitro to be responsible for the 
removal of significant amounts of extracellular H2O2 [206, 305], and catalase activity 
has been shown to correlate with the ability of red cells to withstand H2O2-induced 
lysis [306, 307].  
 
The proposed ability of the red cells to act as scavengers for plasma H2O2 should, 
theoretically, not only protect themselves but also the tissues they perfuse (as well as 
other blood cells) – as the red cells decrease plasma, and hence extracellular H2O2, 
the H2O2 produced inside nucleated cells should exit these cells into the extracellular 
fluid. Therefore, despite its highly pro-oxidant intracellular environment, it has been 
suggested that red cells may be playing an important physiological role in limiting 
oxidative damage to other cells/tissues [8, 217, 308, 309]. Various investigators have 
shown that red cells are able to reduce the H2O2 -induced damaging effects when 
added to various cell cultures (leukemic cell line [206], endothelial cells [310], 
neutrophils [309] and T-lymphocytes [311, 312]) to isolated rat lung tissue [310] and 
also to mouse embryos [313]. By removing extracellular H2O2, red cells also limit the 
formation of extracellular hydroxyl radicals and hypochlorous acid (HOCl) by 
stimulated neutrophils [305]. 
 
In contrast to H2O2, O2·
 does not readily cross biological membranes except where 
specific channels occur [8]. Superoxide has however been shown by Lynch et. al. 
(1978) to be able to exit the red cell via the red cell anion exchange channel (band 3 
protein) [192]. Although it may be presumed that O2·
 would theoretically be able to 
enter the red cells via the same channel, Winterbourn et. al. (1987) found that O2·
 
(unlike H2O2) was not scavenged by red cells [305]. Therefore the red cell may not be 
involved in removing O2·
 from plasma.  
 
The red cell may be particularly permeable to various other RS because it possesses 
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Peroxynitrite (ONOO-), a strong oxidant formed by reaction between O2·
 and nitric 
oxide (NO·) (see also Chapter 2, Literature Review), is one such RS that is easily 
able to cross the red cell membrane. Inside the red cell, ONOO- is rapidly inactivated 
by reacting with the large amount of oxyHb present, which itself is oxidized to metHb. 
It has been calculated that approximately 50% of peroxynitrite generated in the blood 
enters the red cell [315, 316]. The red cell also limits extracellular ONOO- formation 
by rapidly removing its precursor, namely NO·, from plasma. This small, relatively 
unreactive free radical diffuses freely across all membranes, but in vivo is taken up 
and removed within seconds by red cells because it is rapidly destroyed by oxyHb 
[317, 318]. (The high level of CuZnSOD present within the red cell [8, 319] reacts 
rapidly with the O2·
 formed within the red cell, which may otherwise react with the 
NO· to form ONOO- within the red cell). The red cell may also serve to scavenge 
HOCl from extracellular fluids – HOCl can penetrate the red cell membrane and GSH 
appears to provide significant antioxidant protection to other cellular components 
from HOCl within the red cell [224]. By virtue of its membrane permeability to various 
RS, together with fact that most of the non-enzymatic, as for the enzymatic, 
antioxidant capacity of whole blood is localised in the red cells [217], the red cells 
may be playing an intricate role in maintaining circulating redox balance. 
 
Considering the reactivity of tyrosine, tryptophan and urate with various RS including 
ONOO- and HOCl (see Chapter 2, Literature Review), high levels of these LMW 
substances present in the red cells of some mammals relative to plasma levels may 
be promoting the scavenging ability of the red cells for such RS by serving as 
additional sacrificial antioxidant targets within the red cell. But if these LMW 
substances are indeed serving as direct antioxidants for RS that are being taken up 
from the plasma, then why not accumulate these LMW substances in plasma, for 
example as humans accumulate urate in their plasma? One possible explanation is 
that the kind of concentrations that are accumulating within the red cell may be 
hazardous if present in plasma (for example, gout, urate kidney stones, and the 
symptoms associated with hereditary tyrosinaemia). Therefore, high levels of these 
substances may rather have evolved safely packaged within the circulating red cells, 
which are then able to take up these RS from the plasma. Another possibility is that 
there may be a redox advantage for the accumulation of these LMW substances 
specifically within the Hb-rich milieu of the red cells – these LMW substances may be 
serving to promote completion of the peroxidase turnover cycle of metHb, and 
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Whereas much emphasis has been placed on the pro-oxidant potential of Hb, 
reactions of this abundant red cell constituent (approximately 300g/litre packed red 
cells [13]) with various RS make for a highly efficient antioxidant system which is 
perhaps not yet fully appreciated [308]. As mentioned above, oxyHb acts as an 
oxidant by rapidly destroying both NO· and ONOO- that enter the red cells [315, 316]. 
Another way, therefore, of looking at the oxidation of oxyHb and metHb by H2O2 is 
that, in-so-doing, H2O2 is removed. The efficiency of this particular antioxidant action 
of Hb is greatly enhanced by the fact that the product of oxidation, namely 
oxoferrylHb, can be reduced back to metHb, thereby setting up a catalytic cycle. One 
way in which this is suggested to occur is via a catalase-like, or catalatic-type, activity 



















Figure 43. Catalase-dependent removal of H2O2 (above), and the catalatic activity of  
metHb, as proposed by Nagababu et al. (2004) [9] (below). 
 
 
Both metHb and catalase (as was described in Chapter 2 Literature Review) are 
Fe(III) haem species. Both donate 2 electrons to reduce 1 molecule of H2O2 to H2O. 
In the process, metHb is oxidized to oxoferrylHb, whilst catalase forms compound I. 
Each of these products are Fe(IV) species with an additional electron having been 
removed from the globin chain in the case of oxoferrylHb, and from the porphyrin ring 
to produce a porphyrin cation in the case of compound I. The oxoferrylHb species, 
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degradation products observed when oxyHb reacts with H2O2 do not form when 
metHb reacts with H2O2 ([294], it has been suggested that this is because 
oxoferrylHb can abstract 2 electrons from one H2O2 molecule, reducing it to water 
and oxygen [293]. Therefore, unlike for the reaction of ferrylHb with H2O2, no O2·
 is 
formed when H2O2 reacts with oxoferryl. Nagababu et. al. (2004) have therefore 
proposed that reaction of metHb with H2O2 is analogous with the reaction of catalase 
with H2O2, i.e. that metHb can remove H2O2 via catalase-like activity [9].  
 
If metHb was able to function like catalase, then, as for catalase, 2 molecules of H2O2 
should be removed with every cycle of one metHb molecule (reviewed by Nagababu 
et. al. (2004) [9]). However, an earlier study by Guilivi et. al. (1990) found that 
oxoferrylHb did NOT have catalatic-like activity - they showed that only 1 molecule of 
H2O2 is decomposed by each oxoferrylHb molecule per cycle [320]. Therefore, 
although metHb appears to be reformed on reduction of oxoferrylHb by H2O2 (in 
order to explain the continued cycling), no net removal of H2O2 occurs in this step. 
One possible explanation is that, as for ferrylHb (see Fig 42 above), only one 
electron is removed from 2 different H2O2 molecules during the reduction of 
oxoferrylHb. Each H2O2 would be oxidized to form O2·
, and hence reform H2O2 (why 
this O2·
 would not be causing haem degradation of oxoferrylHb is unclear). Then on 
spectrophotometry, Guilivi et. al. (1990) also showed that the end-product of the 
reaction between oxyHb and a continuous flux of H2O2 is an Fe(IV) Hb species [320] 
(presumably oxoferrylHb) – this suggests that, at least at these concentrations of 
H2O2, the rate at which H2O2 reduces oxoferrylHb must be slower than the rate at 
which metHb is oxidized by H2O2, which is again unlike the activity of catalase [8]. 
 
In the same study, Guilivi reported that, under more physiologically-correct in vitro 
conditions of using a greater oxyHb concentration, Fe(IV) Hb was only an 
intermediate product, with metHb being the final product [320]. They provided 
experimental evidence to support their explanation that, under such conditions, most 
of the H2O2 would be consumed by the oxidation of oxyHb, and that oxyHb (rather 
than H2O2) would donate an electron to the ferrylHb intermediate via a 
comproportionation reaction, whereby 2 molecules of metHb would be formed. 
Although they proposed this to be occurring between oxyHb and ferrylHb, they also 
showed in a separate experiment that oxyHb, as well as some LMW substances (see 
below), were able to donate the electrons to reduce oxoferrylHb back to metHb [320].  
 
MetHb can therefore remove H2O2, by coupling its reduction to water using a suitable 
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the activity of the haem-containing, non-specific peroxidase enzymes (although these 
peroxidases are usually viewed rather as using H2O2 to actively oxidize substances 
for a specific purpose). As a result, Hb has been dubbed by some as a 
‘pseudoperoxidase’ or peroxidase ‘mimic’, although it in fact acts as a true 
peroxidase [8, 321]. Figure 44 illustrates how compound I of horseradish peroxidase, 
a classic example of a non-specific peroxidase, receives two electrons in two one-
electron steps, with each electron donor forming a radical (which may then dimerise). 
The exact steps whereby the oxoferryl iron and the protein radical of oxoferrylHb 
[322], as for the equivalent ferrylmyoglobin [323], are reduced are complex, but 
essentially as for the peroxidase enzymes, can involve the 2 electron reduction of 
























Figure 44. Non-specific peroxidase activity of horseradish peroxidase (HRP) (above),  
and the peroxidase-like activity of metHb (below). ED = electron donor. 
 
 
Guilivi et. al. (1990) showed that urate could reduce oxoferrylHb back to metHb [320]. 
This is in keeping with the findings of Kaur et. al. (1990) that, although urate is not 
oxidized by H2O2, addition of Hb (or hemin) to the reaction leads to the formation of 
urate oxidation products [235] because the oxoferrylHb species formed is able to 
oxidize urate. These investigators showed that the rate constant for the reduction of 
oxoferrylHb was significantly greater for urate than for oxyHb (153 M-1 s-1 versus 23 
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rate constant, whilst GSH, NADH, and NADPH showed no detectable reducing 
activity. Another study also reported that urate reduced oxoferrylHb much more 
efficiently than did oxyHb (100 M-1 s-1 versus 20 M-1 s-1) [321]. However, unlike in the 
Guilivi study, these investigators found that ascorbate had a 4-fold greater rate 
constant than urate to reduce oxoxferrylHb. Despite the significantly higher rate 
constants for urate and ascorbate for the reduction of oxoferrylHb, the concentration 
of urate (120M, see Chapter 1, Fig 16) and ascorbate (40-70M [292]) in human red 
cells compared with that of the oxyHb concentration (5mM [289]) means that oxyHb 
would by far be the most significant potential reductant for oxoferrylHb within the red 
cell [320].  
 
However, if one now considers the extremely high levels of urate reported in Chapter 
1 to be present in the red cells of elite-athlete horses (up to 800M, see Results and 
Discussion, section iv, Fig 16), it may well be that under such conditions urate can  
play a physiological role in the elimination of oxoferrylHb radicals to reform metHb. At 
this concentration, the rate of removal of oxoferrylHb (and hence removal of H2O2) by 
urate should theoretically be at least in a similar range to that which intra-erythrocytic 
concentrations of oxyHb would be removing. 
 
There are no reports on the reduction of oxoferrylHb back to metHb by tyrosine, 
tryptophan or urate riboside, these all being other LMW substances also reported in 
Chapter 1 to accumulate in the red cells of some mammalian species. However, it is 
known that the horseradish peroxidase enzyme can abstract electrons from either 
tyrosine (forming dityrosine) or tryptophan (unknown products formed) [324]. 
Similarly, myeloperoxidase (MPO) also catalyses the formation of tyrosyl radicals 
[197]. Harley et. al. (2004) showed that free tyrosine, like urate, although not oxidised 
by H2O2, is oxidized by H2O2 plus Hb (or hemin), and that dityrosine is formed [4], 
indicating at least that tyrosine (and possibly tryptophan also) can donate electrons to 
oxoferrylHb.  
 
More recently, interest has grown on the subject of using the peroxidase activity of 
metHb plus a suitable electron donor to protect acellular and cellular-type 
haemoglobins (developed as “blood substitutes”) from auto-oxidation, as well as to 
limit the toxicity associated with these haemoglobin-based oxygen carriers (HBOC) 
[321, 325]. It is for such purposes that Atoji et. al. (2006) considered the possibility 
that, because horseradish peroxidase can use tyrosine as electron donor to eliminate 
H2O2, metHb plus tyrosine may similarly eliminate H2O2. They showed that the 
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(1mM) was added to solutions of metHb (5M) and H2O2 (200M), and that by 
coencapsulating a mixed solution of metHb plus tyrosine with oxyHb into vesicles 
(cellular-type HBOCs), the oxidation of oxyHb was significantly delayed, both in vitro 
and in vivo. This clearly indicates that tyrosine must be able to reduce oxoferrylHb 
back to the original metHb form.  
 
It is proposed that a further evolutionary advantage for the novel finding of the 
accumulation of these LMW substances specifically within the Hb-rich milieu of the 
red cells may be to promote the peroxidase-like H2O2 -removing ability of metHb by 
being electron donors for the reduction of oxoferryl Hb, thereby providing antioxidant 
protection either specifically for the red cell, or more generally for the tissues 
perfused by red cells. The comparative effect of the presence of these and other 
putative electron donors on the metHb-dependent removal of H2O2 has not 





To compare the effect of urate, tyrosine, tryptophan and other putative electron 
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(D) MATERIALS AND METHODS 
 
(i) Reagents 
Tyrosine, urate, GSH, human Hb, BHT, methanol and xylenol orange were 
purchased from Sigma-Aldrich (USA); NADH from Boehringer Mannheim (W. 
Germany); tryptophan from Hopkin & Williams Ltd (UK).; ascorbate from Allied Drug 
Company (SA); Hydrogen peroxide and H2SO4 were purchased from Merck (USA), 
and Fe ammonium sulphate from Univar (USA).  
 
(ii) Hb-peroxidase reactions 
One milliliter reactions in 10mM potassium phosphate buffer (pH 7.4) were performed 
in eppindorfs at room temperature. All working solutions were made fresh. The H2O2 
was always added last to the reaction. 
 
The final reactions contained:   
- 50l Hb (10M)(a) 
- 900l of one of the putative electron donors(250M) (b)  
- 50l H2O2 (500M) 
Various control reactions were also performed: 
 
- 50l phosphate buffer 
- 900l of one of the putative electron donors 
(250M) 
- 50l H2O2 (500M) 
AND 
- 50l Hb (10M) 
- 900l phosphate buffer  
- 50l H2O2 (500M) 
AND 
- 950l phosphate buffer 
- 50l H2O2 (500M) 
 
 
(a) Commercially-available human Hb (approximately 0.008g) was reconstituted in 
phosphate buffer (800l). This was centrifuged at 10 000g for 10min to remove any 
precipitated Hb. The resulting concentration of this solution was determined 
spectrophotometrically according to Winterbourn et. al. (1990) [211]. This revealed 
that most (96%) of the soluble Hb was oxidized, being present as methaemoglobin 
as indicated by the manufacturer. A 200M working solution was made in buffer. 
No Hb catalyst 
No LMW reducing  
substance 
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(b) Urate, tyrosine, tryptophan, ascorbate, NADH and GSH solutions (278M) were 
made in potassium phosphate buffer (pH 7.4). The concentrations of these solutions 
were confirmed using spectrophotometry. This provided a final concentration of 
250M of each LMW substance when adding 900l of these solutions to the 1ml 
reactions. 
 
(iii) Ferrous ion oxidation-xylenol orange (FOX) assay 
The ferrous ion oxidation-xylenol orange (FOX) assay was used to determine how 
much H2O2 was still present in each of the reactions at various time points. The FOX 
assay was first developed (and later modified) by Wolff and coworkers (1990) as a 
sensitive peroxide-measuring technique [326-328]. It is a simple colorimetric method 
in which hydroperoxides (including H2O2) oxidise ferrous Fe(II) to ferric Fe(III) iron; 
this then forms a xylenol orange-ferric ion complex, which is a chromagen with 
maximal absorption at 560nm. The assay has been used to measure plasma lipid 
hydroperoxides [328], to determine H2O2 levels in human urine [329, 330], to 
compare the H2O2 scavenging ability (and by extrapolation the catalase activites) of 
red cell lysates from different mammalian species [307], and to determine the 
antioxidant capacity of various foods in preventing the formation of lipid 
hydroperoxides [331]. The method used in the current study is a modification of the 
original assay (protocol kindly obtained from Professor Dave Marais, University of 
Cape Town). 
 
The FOX reagent mix(c) was prepared just prior to performing the assay. A volume of 
180l of the FOX reagent mix was added to the required wells of a clear 96-well plate 
(Greiner Bio-one, Germany), and evaporation over time was prevented by sealing the 
tops of the wells with cellotape. At 0, 10, 20, 40min, and every 20 min thereafter for 
160min, 20l of each peroxidase and control reactions was added to the FOX 
reagent mix in the appropriate wells. The plate was tapped to ensure adequate 
mixing of the reaction contents at each time point, and the wells sealed again. Thirty 
minutes after the last time point (sufficient to reach the plateau in the reaction 
between H2O2 and the FOX reagent mix [332]), the plate was shaken for 10 seconds 
and the absorbance at 560nm was determined on a spectrophotometer (Labotech, 
USA).  
 
(c)  The FOX reagent mix was made from 1 part FOX mix A and 4.5 parts FOX mix B. 
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FOX mix A: 2.5mM Fe ammonium sulphate and 2mM xylenol orange in 0.25M 
H2SO4 
FOX mix B: 0.88mM butylated hydroxytoluene (BHT) in analytical grade methanol 
(BHT is a potent antioxidant which, if analyzing a biological sample, 
will prevent the formation of any further lipid hydroperoxides). 
 
A standard curve for H2O2 concentration (Fig 45), as well as measures of absorbance 
for the FOX mix A and the FOX reagent mix, were performed with each assay to 
control for consistency of the freshly made working solutions. The standard curve 







Figure 45. FOX assay standard curve for H2O2 
concentration. The Goodness of Fit test was used 




(iv) Statistical considerations 
The intra-assay coefficient of variation (CV) for the FOX assay was 0.8% (across the 
plate) and 2.2% (down the plate), using H2O2 concentration at 40min in a reaction 
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(E) RESULTS AND DISCUSSION 
 
Reaction of H2O2 with methaemoglobin (metHb), or oxyHb, leads to the formation of 
oxoferrylHb [294]. Both urate and ascorbate are able to efficiently reduce oxoferrylHb 
back to metHb, thereby providing the electrons for the peroxidase-like activity of 
metHb. Yet even in the absence of such reducing substrates, H2O2 is consumed, 
presumably because H2O2 itself can provide the electrons to reduce the highly 
reactive oxoferrylHb species. One possible evolutionary advantage for the high levels 
of urate, urate riboside, tyrosine and tryptophan within the red cells of some 
mammals may be that their presence may accelerate the metHb-dependent removal 
of H2O2, as has already previously been shown in vitro for tyrosine. The influence of 
equimolar amounts of urate, tyrosine and tryptophan on the peroxidase-like activity of 
catalytic amounts of metHb over time was therefore investigated, and compared with 
the control reaction of H2O2 plus metHb alone. Ascorbate, NADH and GSH (all 
established LMW antioxidants present in the red cell) were also compared. The FOX 
assay was used to determine the residual H2O2 present in the reactions at each time 
point.  
 
Figure 46 below depicts the decrease, over time, in absorbance at 560nm (reflecting 
H2O2 concentration) in reactions starting with 10M metHb plus 500M H2O2 
plus/minus one of various putative electron donors (each at 250M). The ability of 
metHb on its own to remove H2O2 was observed, which is in agreement with the 
findings of Guilivi et. al (1990), that reaction of oxoferrylHb with H2O2 results in 
removal of H2O2 (by reforming metHb that then reduces 1 molecule of H2O2 per 
cycle) [320]. This supports the proposal that H2O2 itself can act as the electron donor 
to reduce oxoferryl. Significantly, however, all the LMW substances, except GSH, 
increased (to different degrees) the amount of H2O2 removed compared with the 
reaction of metHb plus H2O2 alone. 
 
The overall rate of H2O2 removal in these reactions (if no catalase is present) is 
determined by the rates of the forward and reverse reactions of the peroxidase cycle. 
The forward reaction is dependent on the rate constant for metHb + H2O2, and the 
concentration of H2O2 and metHb. The reverse reaction is dependent on the rate 
constant(s) for oxoferryl + substrate(s), and the concentration of H2O2, metHb, and 
the LMW substrate if present. Initially, at least, since the rate of the forward reaction 
would be identical in each reaction, irrespective of the LMW substrate present, the 
difference in the initial rate of removal of H2O2 in each reaction with equimolar 
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constants for these reactions. Therefore, although in each reaction the electron 
contribution from H2O2 towards the reverse peroxidase reaction cannot be separated 
from that of the contribution from the LMW substances, it may at least be said (as 
seen from Fig 46A) that the initial rate constants (within the first 10 min) for these 
LMW substances to reduce oxoferrylHb would be increasing in the following order:  
 
NADH < GSH = tryptophan = tyrosine < urate < ascorbate 
 
 






H2O2 onlyHb + H2O2
Hb + H2O2 + UA
Hb + H2O2 + tyr
Hb + H2O2 + trypt
Hb + H2O2 + asc
Hb + H2O2 + NADH






































































Figure 46. (A) The initial and then (B) sequential absorbance readings (at 560nm) of reactions in which 
the removal of H2O2 by the peroxidase-like activity of metHb in the presence of equimolar amounts of 
various LMW substances was evaluated. Absorbance readings directly reflect the H2O2 concentration 
left in each reaction. Each profile represents the average of two separate experiments, and each of the 
curves in the separate experiments showed the identical trend. Reactions (pH 7.4) contained 10M 
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Although the rate constants for urate and tyrosine are lower than that for ascorbate, 
their concentrations within the red cell need to be considered. The high levels of red 
cell urate in horse (150M) and humans (120M), and high levels of tyrosine in 
rhinoceros (1000M), horses (280M) and cats (360M) may each be promoting the 
peroxidase activity of metHb (to be compared with ascorbate levels of 40-70M in 
human red cells). In this way, these LMW may be contributing to formation of the 
H2O2 gradient between the red cell interior and the surrounding plasma.  
 
Of note is that, although reactions with urate had a slower initial rate of H2O2 removal 
than reactions containing ascorbate, which is in keeping with the findings by Cooper 
et. al. (2008) who looked at oxidation rates of these substrates [321], a similar overall 
amount of H2O2 was eventually removed over time by both LMW substrates (Fig 
46B). Reactions containing tyrosine and tryptophan showed a very similar pattern 
over time, with a larger residual H2O2 concentration remaining after 160min than for 
ascorbate and urate. Even with a prolonged reaction time, reactions with equimolar 
NADH and GSH eliminated only a little more H2O2 than occurred in reactions where 
only H2O2 could have provided electrons.  
 
If H2O2 itself is able to provide the electrons for the reduction of oxoferrylHb, and 
hence for its own removal, then what would the advantage be of having additional 
electron-donating substances such as urate, tyrosine etc over the presence of H2O2 
alone in the red cells together with metHb? Although H2O2 may appear to perform the 
same role as the LMW substances for the peroxidase activity of metHb, it should be 
noted that exposure of metHb to H2O2 leads to the formation of detectable Hb 
oxidation products, such as dityrosine [254]. Ramirez et. al. (2003) used an antibody 
to detect DMPO nitrone adducts formed on metHb protein radicals, and showed that 
ascorbate (at micromolar concentrations) and GSH (at millimolar concentrations) 
significantly reduced the level of nitrone adducts formed during oxidation of metHb by 
H2O2 [298]. Similarly, it has been found that, whereas the presence of ascorbate and 
urate during oxidation of metmyoglobin prevented dityrosine formation and reduced 
the oxoferryl form back to the original metmyoglobin form, addition of these 
substances after the reaction of metmyoglobin with H2O2 did not prevent dimer 
formation, and a modified form of metmyoglobin became apparent [260]. The 
presence of free tyrosine also has been shown to lead to decay of the protein radical 
formed during oxidation of metmyoglobin [262]. Therefore, it is possible that the 
reduction of oxoferrylHb by H2O2 does not lead to the complete recovery of metHb 
(although on spectrophotometry it appears very similar to metHb), and that this 
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oxidation/reduction cycles. This may explain why the presumed peroxidase-like 
activity of metHb in the presence of H2O2 alone did not continue to remove all the 
H2O2. On the other hand, the presence of LMW substances such as urate and 
ascorbate with higher rate constants for reaction with oxoferrylHb may minimize the 
irreversible damage occurring to metHb on exposure to H2O2, thereby maintaining 
the integrity of the peroxidase enzyme system throughout a greater number of 
successive cycles, whilst sufficient concentrations of these substances are present.  
 
It has previously been shown that the oxidation of both urate and ascorbate by 
metHb/H2O2 is linearly dependent on the concentration of metHb. The same 
concentration-dependent effect was found when the removal of H2O2 was evaluated 
in this study (in the absence of any LMW-reducing substance) (Fig 47A). Figure 47B 
shows the linear dependence of the removal of H2O2 (at 15mins) on the 
concentration of metHb - this reflects that metHb acts as a true enzyme [321]. In 
order to ensure a sufficient rate of metHb catalytic activity, 10M metHb was used in 
the above reactions. This concentration has also been used by other investigators 
performing similar investigations.  
 
























































Figure 47. (A) Sequential absorbance readings (at 560nm) 
of control reactions (no metHb added) for the peroxidase-
like activity of metHb in the presence of equimolar amounts 
of various LMW substances. Absorbance readings directly 
reflect the H2O2 concentration left in each reaction. Each 
result represents the average of two separate experiments, 
in the same trend was obtained. Reactions (pH 7.4) 
contained 500M H2O2 and 250M LMW substance. (B) As 
determined from figure A, metHb concentration 
dependence of the peroxidase-like activity of metHb at 
15min. 
 







































Chapter 3: Results and Discussion                                                                                                             - 116 -  
An unexpected finding was obtained when performing the control reactions for the 
peroxidase-like activity of metHb. These reactions had the various LMW substrates 
plus H2O2, but no metHb. As anticipated, urate, tyrosine, tryptophan and NADH 
showed no direct scavenging of (and hence oxidation by) H2O2 (Fig 48). Ascorbate 
was able to remove significant amounts of H2O2 in the absence of metHb. To a much 
smaller extent, GSH also showed some ability to eliminate H2O2. 
 











































Figure 48. Absorbance readings (at 560nm), at time 0 and 160min, for control reactions (no metHb 
added). Absorbance readings directly reflect the H2O2 concentration left in each reaction. Each result 
represents the average of two separate experiments, in the same trend was obtained. Reactions (pH 
7.4) contained 500M H2O2 and 250M LMW substance.  
 
 
In vivo, catalase and the various peroxidase enzymes are responsible for removal of 
most of the H2O2. It is also possible that GSH and ascorbate may directly reduce 
H2O2, since although H2O2 is generally poorly reactive, it can however oxidise hyper-
reactive –SH groups from some enzymes, as well as certain keto-acids such as 
pyruvate and 2-oxoglutarate. Certainly, ascorbate and GSH are believed to be 
among the most important antioxidants protecting oxyHb against auto-oxidation 
inside the red cells [292]. Although GSH showed a much lower rate of H2O2-removal 
than ascorbate, its intra-erythrocytic concentration is at least 30 times higher than 
that of ascorbate. It cannot however be excluded that a rapid interaction between 
ascorbate (and also GSH) and the subsequently-added Fe3+ in the FOX mix may 
have lead to the false impression that ascorbate in isolation reacts directly with H2O2. 
 
Urate, although not oxidized by H2O2 alone, is known to be oxidised by the oxoferryl 
species produced on reaction of metHb (or hemin) with H2O2 [235]. Urate riboside, a 
LMW substance present in high concentrations in the red cells of cows and buffalo 
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to have similar antioxidant properties to urate [36-38]. It was therefore investigated 
whether urate riboside would similarly be oxidized in the presence of H2O2 and 
hemin. The red cell acid extract from a cow (see Chapter 1, Materials and Methods) 

























Figure 49. Anion-exchange HPLC of neutralized acid-soluble cow red cell extracts exposed, for 10min 




Whilst exposure of a cow red cell extract to 2mM H2O2 showed no change in HPLC 
profile, the addition of 10 M bovine hemin to the reaction caused significant 
oxidation of urate riboside, with no significant decrease evident in any of the other 
UV-absorbing substances present in the extract (Fig 4A). Although the rate of Hb-
dependant H2O2 removal by urate ribsoside could not be compared with the other 
LMW substance present in red cells, the very high levels of urate riboside (millimolar 
range) present in the red cell of the cow may, as may be the case with high levels of 
urate in the red cells of some horses, provide some contribution to H2O2 removal 
within these red cells.  
 
Therefore, it may be postulated that the presence of high levels of urate, urate 
riboside, tyrosine and even tryptophan may have evolved to improve the efficiency of 
the metHb peroxidase turnover cycle in removing H2O2. But how physiologically 
relevant is the peroxidase activity of metHb i.e. does it play a role in removing 
significant amounts of H2O2 in vivo?  
 
The conventional view in more recent years has been that the two enzyme systems, 
GPx and catalase, together account for all the H2O2-disposal within the red cell, with 
GPx handling ‘physiological’ levels of H2O2, and catalase playing a greater role at 
higher concentrations of H2O2 [8]. However, other studies indicate that catalase and 
GPx alone, cannot account for all the H2O2 removed by red cells, and that other 
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(Prx’s), a family of peroxidase enzymes requiring thioredoxin and the NADPH-
dependent thioredoxin reductase, in antioxidant defense in eukaryotic cells has only 
recently become appreciated [8, 289, 333]. They can also reduce organic peroxides 
and peroxynitrite [333]. They are widely distributed in animal, plant and bacteria cells 
[8]. In the red cell, the Prx enzymes (particularly Prx II) are some of the most 
abundant proteins (about 240M Prx II) [289], Although Prx’s can be inactivated by 
their substrate H2O2, and are slower at catalyzing H2O2 removal than GPx, their high 
cellular concentrations and low Km values for H2O2 has led some to believe that they 
may be even more important peroxide-removing systems in animal cells than 
catalase or GPx, especially in disposing of low physiological levels of H2O2 [8, 334, 
335]. Supporting this is the finding that knockout mice for Prx II gradually develop 
severe haemolytic anaemia and other signs of oxidative damage to their red cells 
[336].  
 
The possibility that Hb, via its metHb peroxidase-like activity, may also be 
contributing to H2O2-removal within the red cell has been suggested, [205, 320], but 
never further investigated, or considered to be significant in human red cells. 
Although metHb is highly unlikely to compete with the high levels of highly active 
catalase in human red cells, it may play a role in removing low levels of H2O2 
produced within red cells, as suggested for the peroxiredoxins. Given the extensively 
variable levels of catalase and GPx between different mammalian species (Table 1), 
it is also worth considering that the presence of high levels of LMW substances (eg. 
urate and tyrosine) in the red cells of some mammals may point to a greater 
contribution of the metHb-peroxidase system to H2O2 -neutralization in those red 
cells relative to human red cells.  
 
Notably, black rhinoceros have extremely low levels of red cell catalase activity (<2% 
that present in human red cells [60]), and a diminished red cell rate of glycolysis 
through the HMP shunt [40. These features are likely to be underlying factors 
contributing to their inherent sensitivity to oxidant-induced injury {Paglia, 2000 #405, 
337]. However, their red cells also have an unusually high level of free tyrosine, as 
reported by E.H. Harley and co-workers (2004) [2], and described in Chapter 1. It is 
conceivable that this may have evolved to promote the peroxidase-like activity of 
metHb as part of a compensatory H2O2-removal system. A similar concept was 
proposed by Galaris et. al. (1997) – they suggested that in myocytes, which have 
very low levels of catalase, the peroxidase-like activity of metmyoglobin (with 
ascorbate as electron donor) may be playing a significant role in the removal of H2O2 
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chemistry, the presence of large amounts of dispensible LMW electron donors for 
oxoferrylHb may also have evolved in some mammalian species to assist GPx in the 
removal of organic peroxides.  
 
Table 4. Comparative levels of various antioxidant enzyme activities and GSH content in the red cells of 
different mammalian species relative to levels in human red cells, which is set as the 100% control.  
 SOD Catalase G6PD GPx  GR GSH 
Human 100 100 100 100 100 100 

















































































Dog 904  1165 4064 414 1164 
905 
Cat 1234 1714 1605 4884 994 1194 
865 
 
Note. Because of the large variability in hemoglobin levels and size plus morphology of the red cells of 
the different species, the values obtained were all expressed per gram of Hb, and then extrapolated to a 
percentage of the human value (100%). All values that are equal to or greater than the respective 
human value are highlighted in blue.  
SOD=superoxide dismutase; G6PD=glucose-6-phosphate dehydrogenase; GPx=glutathione 
peroxidase; GR=glutathione reductase; GSH= reduced glutathione. 
Data referenced is from Maral et. al. (1977) [338], unless otherwise superscripted (1  = Godin et. al 
(1992)[339]; 2 = Avellini et. al. (1993)[340]; 3 = Suzuki et. al. (1984)[341]; 4 = Kurata et. al (1993)[342]; 
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An alternative way of looking at the evolutionary advantage of accumulating high 
levels of electron-donating LMW substances within the red cells of some species, for 
example tyrosine in the black rhinoceros, is that animals with lower levels of catalase 
or GPx may experience a higher level of oxidative modifications, including an 
increased rate of metHb and hence oxoferrylHb formation if their red cells. In such 
animals, electron-donating LMW substances could enhance the reduction of highly 
reactive oxoferrylHb radicals back to reusable unreactive metHb. Seen in this way, 
promoting the reverse reaction of the metHb-peroxidase cycle would be a defense 
mechanism, sacrificing tyrosine, for example, to prevent irreversible damage to haem 
or other nearby biological targets.  
 
The finding of high tyrosine levels in cats was unexpected, considering what appears 
to be an adequate level of catalase and GPx. The Hb of cats, however, is known to 
be uniquely sensitive to oxidative damage resulting primarily from its high number of 
free sulfhydryl groups [343]. As a result, Heinz body formation is a common 
haematological abnormality in cats, and haemolytic anaemia ensues if the primary 
cause of the oxidative stress is not removed/treated (Heinz bodies are spheroidal red 
cell inclusions composed of denatured Hb, and are a late sign of oxidative damage). 
It is conceivable that cats specifically may have evolved the ability to accumulate 
high levels of tyrosine in their red cells in order to limit oxidative damage to Hb, by 
using tyrosine to reduce sulfhydryl radicals formed on their globin chains. Although 
cats are nevertheless highly susceptible to oxidative damage of their red cells, this 
susceptibility may be significantly worse without high levels of red cell tyrosine, and 
oxidative damage to peripheral tissues may be more evident.     
 
Since certain physiological or pathological conditions may be associated with an 
increased rate of oxidation of oxyHb to metHb and then to oxoferrylHb, under such 
conditions it may be favourable to have an increased level of electron donors that 
can rapidly reduce oxoferrylHb radicals so as to limit further oxidative damage. In 
Chapter 1, it was suggested that the high stable levels of urate found in the red cells 
of some elite athlete horses may have been induced by their intense training 
schedule (exhaustive exercise is known to be associated with oxidative stress). It 
was further proposed that the ability to induce urate production within red cells (via 
the activation of inactive XO in these red cells by oxidative stress) may be a 
mechanism common to various/all mammalian species, rather than an evolutionary 
phenomenon limited to some horses. The increase in metHb concentration together 
with the increase in red cell urate level may lead to a greater rate of H2O2 -elimination 
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(F) SUMMARY 
 
In this Chapter, further evidence was provided to support the hypothesis that 
accumulation of high levels of urate, urate riboside, tyrosine and tryptophan within 
the red cells of some mammalian species may be species-specific evolutionary 
adaptations to increase the LMW antioxidant capacity of the red cell These LMW 
substances may not only serve as antioxidants to protect red cell contents against 
H2O2 and various other RS, but their presence at high levels within the red cell may 
promote the scavenging ability of the red cells to remove these RS from plasma.  
Accumulation of these substances may have evolved within the red cell in order to 
safely circulate high levels of these LMW antioxidants within a ‘permeable package’, 
in the same way that much of the antioxidant enzyme capacity of whole blood is 
conveniently packaged within the red cell. This data lends further support to the 
concept that the red cell is providing a convenient roaming ‘package’ of antioxidants, 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS  
 
Although considerable detail is available concerning metabolic and structural features 
of the human red cell, it is well known that significant differences in various 
biochemical pathways exist when comparing the human red cell with the red cells 
from other mammalian species [15, 26, 94, 344-348]. This includes clear interspecies 
differences in the ion-exchange HPLC profiles of the red cells from different 
mammals [24, 25]; however many of these species-specific differences in red cell 
contents were never clarified.  
 
In this thesis, a combination of reverse-phase and anion-exchange HPLC was used 
to further elucidate some of the differences in low molecular weight (LMW) content of 
the red cells from different mammalian species. By comparing the red cell and 
plasma profiles for each species, the unusual accumulation of substances such as 
tyrosine, tryptophan and urate within the red cells accounted for many of the 
interspecies differences. It was then proposed that the ability to accumulate such 
substances may play a role in red cell LMW antioxidant defense, and results of 
various in vitro experiments were consistent with such a hypothesis. These findings 
imply the existence of unsuspected antioxidant strategies in mammalian red cells, 
this being of interest to antioxidant biology in general, as well as having potential 
clinical application.  
 
Oxidative stress, defined as a disturbance in the prooxidant-antioxidant balance in 
favour of the former [198], is not only a primary cause of disease, but is also now 
generally recognized as an important consequence of a large variety of chronic and 
acute conditions that affect not only humans, but also many different animal species. 
If re-establishment of the antioxidant/pro-oxidant balance does not occur, oxidative 
stress can then be a contributing/potentiating factor in the pathogenesis of the 
disease, by leading to oxidative damage of cellular components, including proteins, 
lipids and DNA. Therefore, although control of the initiating disease process is 
paramount, concurrent management of the oxidative stress may also be essential to 
limit progression of the disease, or prevent additional pathology.  
 
Considering the likely role of the red cell as a roaming package of enzymatic and 
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species (RS), then changes in antioxidant levels of the red cells may provide an 
accurate and practical indicator of the extent of oxidative stress. Moreover, therapies 
that support the red cell in its ability to scavenge RS would not only protect the red 
cell, but may also protect the rest of the body against oxidative damage; however 
species-specific differences in antioxidant defenses may need to be considered. The 
fact that different mammalian species seem to have evolved different LMW red 
antioxidant strategies (probably as a consequence of differing environmental 
pressures) may have relevance to the management/prevention of veterinary 
conditions associated with oxidative stress.  
 
For example, in mammalian species that accumulate high levels of red cell tyrosine, 
therapies aimed at increasing (or at least maintaining) red cell tyrosine levels may 
help to support endogenous antioxidant strategies, potentially useful for treatment in 
the acute situation of oxidative stress, or more generally as a preventative measure. 
Cats for example, which are particularly susceptible to oxidant drug-induced Heinz 
body haemolytic anaemia [343], may benefit from tyrosine supplementation to 
maintain their red cell free tyrosine levels under conditions of oxidative stress. 
Similarly, the black rhinoceros (Diceros bicornis) is a species particularly susceptible 
to developing a potentially lethal acute haemolytic anaemia when placed in captivity 
[30, 40, 61, 349], and dietary iron overload leading to oxidative stress is suspected to 
be a likely precipitating factor [350, 351] - the use of tyrosine supplementation for 
black rhinoceros in captivity may reduce this risk.  
 
In addition, high levels of red cell tyrosine in various species may have the potential 
to be exploited as biomarkers of oxidative stress (although in some species such as 
horses, the large intraspecies variation in red cell tyrosine level is likely to be a 
limiting factor). Harley and co-workers (2004) have previously reported that black 
rhinoceros in captivity had significantly lower red cell tyrosine levels compared with 
their free-ranging counterparts [2]. Significant interest has also arisen more recently 
in the measurement of dityrosine as a biomarker of oxidative stress. This is a stable 
product of oxidative damage to proteins from various tissues (see Chapter 2) and is 
released into plasma. Elevated levels can be detected in urine samples from humans 
suffering from conditions associated with an elevated level of oxidative stress [6]. 
Therefore, in animals that have high levels of free tyrosine in their red cells, 
measures of red cell tyrosine, or of its oxidation product dityrosine, in red cell extracts 
may be useful biomarkers of oxidative stress. In preliminary investigations, it was 
found that a significant level of dityrosine was evident in the red cell extracts from 
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tyrosine. This may be an indication that cats particularly rely on an increased level of 
baseline oxidative modification of red cell free tyrosine, which may be serving to 
maintain the reduced state of their oxidant-susceptible haemoglobin. 
 
Red cell urate riboside levels may, in an analogous fashion, provide a biomarker of 
oxidative stress in bovids (although a large degree of intraspecies variability in urate 
riboside level may be a limiting factor). In vitro 
experiments indicate that urate riboside levels 
decrease in a manner proportional to the 
amount of hydrogen peroxide that cow red cells 
are exposed to. Various infectious diseases in 
cows and buffalo may give rise to oxidative 
stress; and since tuberculosis (TB) in humans 
has been shown to be associated with systemic 
oxidative stress [352, 353], bovine TB may be 
associated with changes in urate riboside 
levels. A small, preliminary study is currently underway to determine urate riboside 
levels in a TB-positive buffalo herd versus a TB-negative herd from the same area in 
South Africa. Bovine TB is endemic in African buffalo and a number of other wildlife 
species in South African game reserves [354]; such a biomarker may therefore prove 
to be useful as a rapid screening test for increased levels of oxidative stress in 
buffalo herds in such areas.  
 
Attempts to increase the level of red cell urate riboside, by providing more substrate 
for the enzyme for example, may be another possible research area - improving the 
endogenous antioxidant defenses of TB-infected buffalo may limit the contribution of 
oxidative damage to the pulmonary tissue destruction associated with TB. The 
practicality of this may present a challenge, however, and more feasible may be a 
preventative approach - if the antioxidant defense system of healthy buffalo/cows can 
be increased, a better adaptive immune response may develop on exposure to the 
organism, either during infection or during vaccination. This should theoretically 
increase resistance to the development of active TB.  
 
Perhaps most fascinating and with the most potential for further translational 
research, is the unprecedented finding of high levels of urate accumulating within the 
red cells of some horses sampled for this thesis. Unlike the ability to accumulate 
tyrosine or make urate riboside, which are most likely due to evolutionary red cell 
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mutation(s) for tyrosine), it was proposed in Chapter 1, that the ability to accumulate 
urate in horse red cells was reflective of the presence of XO/XD within red cells of 
some (or even perhaps all) mammalian species.  
 
Although red cells have historically been presumed to have no XO/XD because no 
enzyme activity was detected, both active and inactive levels of this enzyme are now 
known to exist in various nucleated cells; red cells however were never re-evaluated 
for the presence of inactive XO/XD. Moreover, it has been shown that the activity of 
XO/XD can be further increased in these other tissues by various factors including 
oxidative stress [117]. The elite-athlete horses sampled for this thesis are believed to 
have inadvertently provided an in vivo model of repeated oxidative stress - their 
extreme fitness regime would have been associated with regular episodes of 
oxidative stress which may have lead to an adaptive (‘hardening’) antioxidant 
response, including the activiation of otherwise inactive red cell XO/XD, detected as 
an increase in red cell urate level.  
 
This proposal, that red cells are able to produce urate under conditions of oxidative 
stress by virtue of the presence of red cell XO/XD, has never been investigated to 
date, and may be an unsuspected red cell strategy to ‘upregulate’ its antioxidant 
defenses when required. Further research to investigate these ideas is to be 
undertaken shortly as part of post-doctoral work. If these hypotheses are 
substantiated, this may have potential application to various fields of veterinary and 
human medicine, including sport’s science.  
 
Finally, significant variation in red cell urate and tyrosine in horse red cells (as for 
urate riboside in cows) seems to reflect a large degree of intraspecies genetic 
heterogentity for those substances in these two species - it is fascinating to speculate 
what such intraspecies variability implies for individual animals within each species, if 
indeed these substances are providing significant antioxidant protection; and under 
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APPENDIX 
 
(a)Most investigators wash the red cells twice or even three times [23, 125, 173, 181]. 
In this study, red cells were washed once only as it has been shown that washing red 
cells can cause mechanical disruption [307], and also more relevant to this study, 
several amino acids including tyrosine [83], as well as urate [5], are easily washed 
out of human red cells. Considering the paucity of UV-absorbant LMW substances 
detectable in the plasma of all animals evaluated (see Fig 11, Chapter 1, Results and 
Discussion, section iii), urate in human plasma is the only UV-absorbing substance 
with potential to be problematic with one wash of red cells. In order to determine if 
plasma urate could be contributing to the red cell urate concentration when using one 
wash step only, the following control experiment was done: A human blood sample 
was obtained and the red cells separated from the plasma. After one wash step, 
200µl of the N/S supernatant above the red cell pellet was extracted as per the red 
cell protocol, and an HPLC profile created. The only substance detectable (as 
expected) was a very small urate peak. It was determined that even if as much as 
10% of the 200µl of ‘packed red cells’ extracted was actually trapped N/S plus 
residual plasma, by extrapolation, this amount of contaminating plasma in the N/S 
would contribute no more than 5µM to the red cell’s urate concentration of  
approximately 115 µM (i.e. 4%). One wash step is therefore optimal to obtain a 
representative red cell HPLC profile. 
 
(b)The addition of 300l N/S to the 200l packed red cell prior to the addition of the 
PCA, was found to prevent clumping of the red cells that occurs otherwise on 
addition of PCA to packed red cells. The use of ice-cold PCA has been previously 
recommended in order to minimize acid hydrolysis of the nucleotides [17]. However, 
no difference in extract ATP concentration was evident whether the subsequent 
10min centrifugation step was performed at room (22oC) temperature or at 40C.  
 
(c)The slow addition of K2CO3 is recommended because significant bubbling (release 
of CO2) occurs on reaction of K2CO3 with PCA. 
 
   2HClO4 + K2CO3 → 2KClO4 + H2CO3  
   ↓ 
        H2O + CO2 
 
(d)Either KOH or K2CO3 are usually used by others to neutralize PCA-extracts, both 
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with a number of problems: it is very easy to overshoot the neutralization step with 
the strong alkali KOH, and other investigators tend to use the alkaline base K2CO3. In 
this study it was found that, even with K2CO3, a constant final extract pH of 7 was 
difficult to obtain, and a constant amount of K2CO3 gave variable final pH. Careful 
and time-consuming titration of the K2CO3 was therefore required, particularly 
because it was easy to overshoot the correct pH with the high molarity K2CO3 
required (so as not to dilute the extract too much further). Despite this, the final pH 
still seemed unpredictable. It was determined that a number of other factors also 
contributed to a variable final extract pH when using K2CO3: On addition of the K2CO3 
to the acid extract, the time-dependent bubbling off of the CO2 meant that pH would 
not be stable (rising slowly) until all the H2CO3 (which is a weak acid) had 
dissociated, and all the CO2 had bubbled out of the sample. This often resulted in 
overshooting the final pH because too much K2CO3 had been added before the pH 
had stabilised. After addition of K2CO3, the pH of the extract was also affected by 
whether or not a lid was placed on the tubes whilst left on ice. Lastly, the pH of the 
thawed extracts was very often more alkaline than originally determined.  
 
The significance of this altered pH of the extracts was that the elution position of 
certain substances, particularly urate, was effected, its peak often being more difficult 
to separate from other peaks. Urate also is known to degrade more rapidly in alkaline 
solutions [244]. Finally, equimolar (50µM) uric acid solutions at different pH (in buffer 
of pH 7, versus in water pH<7) vary quite significantly in their diode array scans, with 
more acidic solutions showing a left shift, as well as reduced peak absorbance. Since 
this work was performed using fixed UV-absorbance readings of 260nm and 280nm, 
quantification of pH-sensitive substances such as urate would be affected by final 
extract pH.  
 
For these reasons, a modification of part of the extraction was developed towards the 
end of the thesis work, using 1M K2HPO4 which is a much weaker alkali.  
 
   HClO4 + K2HPO4 → KClO4 + KH2PO4  
 
Some of the red cell and plasma suspensions were extracted using this improved 
method, which ends up with the same final dilution of the red cell contents: One 
milliliter of ice-cold 0.9M PCA was added to the 500l red cell or plasma suspensions 
whilst vortexing vigorously, giving a final PCA concentration of 0.67M. The acidified 
samples were immediately centrifuged at 4000rpm for 10 minutes at 22oC to 
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transferred to a fresh 5ml tube, and neutralized by the addition of 1200µl of a 1M 
K2HPO4 solution. Since no CO2 is produced, no bubbling occurs when using K2HPO4, 
and the resultant pH is very consistently 7 on Whatman’s pH paper, even after 
prolonged storage at -80oC. The only potential disadvantage of using K2HPO4 as the 
alkalinizing agent is that the resultant high phosphate concentration in the extract has 
significant UV absorbance throughout the spectrum used for nucleotide detection (i.e. 
260nm and 280nm). However, with reverse-phase HPLC the potassium phosphates 
are not retained at all, and the peak does not interfere with other substances. With 
anion-exchange, the phosphates are retained, but the peak created does not co-elute 
with any other major UV-absorbant red cell LMW substance, and can easily be 
subtracted from the extract profile using computer editing. Diode array 
spectrophotometry cannot however be performed on K2HPO4-neutralised extracts 
because of this buffer’s significant UV-absorption. 
 
(e)For practical purposes, HPLC analysis of the animal extracts had to be batched. 
This meant that some extracts would need to be stored for up to one week prior to 
HPLC analysis. It was therefore decided to freeze all extracts at -80oC after the 
extraction step and prior to HPLC, as recommended by Bartlett (1986) [17]. Although 
the effect of a delay in the extraction of whole blood and washed red cells on LMW 
substances has been substantially reported [78, 81, 82]), the effect of delayed HPLC 
analysis on the extracts has not actually been described. The effect of freezing, and 
then storage at -80oC on levels of some of the LMW substances in a human red cell 
(Fig 50A) and a plasma extract (Fig 50B) was therefore investigated. 
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Figure 50. Stability, whilst in storage at -80o C, of (A) urate, tyrosine and NAD+ in a human red cell 
extract, and (B) urate and tyrosine in a human plasma extract. Multiple aliquots of the extracts were 
made and then frozen simultaneously. An aliquot of the red cell and plasma extracts were thawed at 
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It is therefore probable that in this study some measurements of urate in the red cell 
extracts, and NAD+ to a lesser extent, may have been underestimated (possibly up to 
30%); nevertheless, urate levels were in agreement with textbook values. Although 
reverse-phase HPLC is suboptimal for ATP determination, levels of this nucleotide 
appeared unaffected by long-term storage at -80oC. The results indicate that extracts, 
particularly red cell extracts, should ideally be analysed fresh without prior freezing, 
especially if measuring urate. Interestingly, plasma urate was found to be a lot more 
stable to freezing than was red cell urate. Plasma urate levels were only minimally 
decreased, even after 5 months of storage at -80oC. It was determined that the 
routine spectrophotometric assay used to determine plasma urate (based on the 
method of Praetorius using purified uricase [355]) could not be used to alternatively 
and rapidly measure red cell urate, as there seemed to be a large amount of a 
substance in the red cell extracts that interfered with the assay, giving a very large 
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